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Psychiatric diseases are triggered by the interaction of genetic and environmental risk factors
(G×E). To model G×E in mice, we developed an approach to analysing huge behavioural data
sets, which allowed us to compare mice tested in independent cohorts. In a battery of tests, we
analysed and compared mice subjected to Isolation rearing (IR), Social defeat (SD) or the control
condition Enriched environment (EE). By using multivariate statistics, we merged experiments
measuring similar behaviours into higher-order categories (dimension reduction). This allowed us
to create clinically relevant behavioural profiles of mice and visualise them in a single radar chart.
We show that IR as a paradigm models positive symptoms of psychotic diseases, while SD models
negative-like symptoms.
We used this approach to study G×E in transgenic mice overexpressing the schizophrenia
risk gene Tcf4. They displayed deficits in fear memory and behavioural flexibility upon IR and
SD, while EE rescued the phenotype. Ageing did not influence these impairments. This result
points at the role of Tcf4 in cognition. Tcf4 overexpressing mice also displayed enhanced LTD in
hippocampus as well as increased dendritic spine frequency and upregulation of proteins: CaMKII,
HOMER1 and synaptobrevins in prefrontal cortex. RNA sequencing revealed deregulation of
BC1, Top3b and Mov10 involved in regulation of translation by microRNAs, and other genes, e.g.
Adora2a, Penk and Plxna1.
We also tested behaviour of Tcf4-/+ mice, which showed strong cognitive impairment specific
to hippocampus-dependent spatial learning. Analysis of Tcf4 expression in these mice revealed
downregulation mainly of the isoforms that are highly expressed in the hippocampus, which is in
line with the behavioural phenotype. We conclude that in mice Tcf4 is important predominantly for
cognition, which declines upon both overexpression and deficiency of the gene.
In the last project, we focused on mechanisms underlying pain insensitivity, which we observed
in the IR animals. We show that IR reduces expression of pronociceptive genes Vgf, Bdnf and
Npyr1 in dorsal root ganglia, which may contribute to pain insensitivity. In hypothalamus, IR
reduced expression of oxytocin and arginine vasopressin, potentially adding to the pain phenotype
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SHIZOPHRENIA is a highly debilitating psychiatric disease that affects around 1% of theworld-wide population1. It drastically reduces quality of life by leading to disruption ofsocial relationships, unemployment and homelessness2. It also shortens life expectancy by
more than 15 years (more than bipolar disorder3), due to high rate of suicides (12× higher than in
general population4), poor health care, heavy smoking, substance abuse, medication and comorbid
disorders. The symptoms typically emerge in adolescence and are more severe in men than in
women5.
Schizophrenia was first identified as dementia praecox (“premature dementia”) by Emil Krae-
pelin in 19196. A quarter-century later Eugen Bleuler coined the term schizophrenia (“split mind”).
At that time the disease was mainly seen as cognitive decline and emotional dullness emerging
already in young patients6. Later, in the 60s, Kurt Schneider drew attention to distortion of reality,
which he called the first-rank symptoms, and proposed it as a diagnostic criterion6.
Nowadays, according to DSM-5, the hallmarks of schizophrenia include: delusions, hallucin-
ations, disorganized speech and behaviour, catatonia and negative symptoms and possible social
dysfunctions7. Psychotic features occur also in schizoaffective disorder, depression or bipolar
disorder, but in contrast to them, schizophrenia has no affective component7.
Symptoms of schizophrenia are divided into three classes: positive, negative and cognitive.
Positive symptoms represent exaggerated functions of the nervous system that do not occur in
healthy people — hallucinations and delusions. Negative symptoms on the other hand, indicate
a loss in function, e.g. reduced motivation, social withdrawal and blunted affect5,6. Cognitive
symptoms include a broad spectrum of impairments8. Even though positive symptoms are the
key diagnostic criteria, the negative symptoms and illness duration associate stronger with poor
outcome5. Schizophrenia has a neurodevelopmental aspect2,9. The onset is typically in late
adolescence or early adulthood10–12, but certain behavioural abnormalities appear already during
the prodromal phase, years before the first episode of psychosis2,5.
Some of the characteristic abnormalities occur also in the healthy relatives of the patients, and
are called endophenotypes. Endophenotype is a concept similar to the concept of biomarker, but
it implies genetic underpinnings and heritability — it is a measurable behavioural, anatomical,
physiological or biochemical feature of a disease13. Endophenotypes are often shared between
several diseases and can also be reliably studied in animal models. Schizophrenia has many
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endophenotypes14, e.g. disruption of Prepulse inhibition (PPI) (a measure of sensorimotor gating),
perseveration, enlarged lateral ventricles, reduced hippocampal volume, thinning of frontal gray
matter, reduced P300 and enhanced P50 event-related potentials5, hypoalgesia (see section 4.4 on
page 61) and abnormal beta- and gamma-oscillations (reviewed in15), to name only a few.
Cognitive impairment is the core symptom of schizophrenia16 and also the most debilitating
one2. Even though cognitive deficits are common also in other psychiatric diseases7, in schizo-
phrenia they are more severe and have a broader spectrum8,16. The impairments affect several
cognitive domains, e.g. working memory, social cognition, executive functions, attention inhibition
(reviewed in8) and cognitive flexibility17,18. Such impairments, particularly of social cognition19,
lead to difficulties in finding a job and establishing social bonds and may provoke social defeat.
It is not clear what changes occur in schizophrenic brains, but different neurotransmitter systems
seem to be involved. According to the dopamine hypothesis of schizophrenia, aberrant dopamine
transmission is involved in positive and negative symptoms20. Hyperactivity in the mesolimbic
pathway is thought to cause inappropriate assignment of salience to stimuli, and therefore gives
raise to delusions (reviewed in5,21). Hypoactivity of prefrontal dopamine transmission contributes
to negative symptoms20.
Current treatment for schizophrenia is based on antypsychotic drugs (neuroleptics), which are
dopamine D2 receptor antagonists22. They have poor efficacy and many side effects, particularly
strong in first-generation (typical) antypsychotics23. Medication reduces positive symptoms, but
fails to counteract negative and cognitive symptoms5,22.
Aetiology of schizophrenia is not well understood, because it seems to depend on the interplay
of genetic (see below) and environmental factors5 (see section 1.3).
Genetics of schizophrenia Heritability of schizophrenia is high — around 80%5, but despite the
strong genetic component, the disease does not follow Mendelian patterns. The reason for this is
a complex polygenetic architecture where occurrence of the symptoms depends on gene× gene
interactions24 as well as other factors, e.g. epigenetics and environment25.
Numerous Genome Wide Association Studies (GWAS) and polygenic inheritance tests have
sought to map schizophrenia risk genes. Through these, researchers have identified several copy
number variants (CNVs) and hundreds of common single nucleotide polymorphisms (SNPs)
in different parts of the genome, confirming the polygenic character of the disease. A few of
the candidate genes have been repeatedly found in several GWAS, for example: the MHC re-
gion26–30, microRNA-137 (MIR-137)28,30,31, Transcription factor 4 (TCF4)26–31, Neurogranin
(NRGN)26–29, Neuregulin 1 (NRG1), Voltage-dependent L-type calcium channel subunit alpha-1C
(CACNA1C)28,30,31, genes repressed by Fragile X mental retardation protein (FMRP)31,32, D(2)
dopamine receptor (DRD2)29,31, matrix metalloproteinase 16 (MMP16)29,30, NOTCH426 and
proteins of the ARC complex32 (reviewed in33).
The SNPs identified in GWAS are common in the general population. They have low penetrance,
which means they have a very small effect on the schizophrenia phenotype and explain only a small
fraction of the genetic variation. This missing heritability probably results from various sorts of
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gene× gene interactions (epistasis)25, for example, TCF4 and CACNA1C are targets of MIR137 34.
Presumably, accumulation of SNPs in the genes controlling certain biological pathways result in an
overall impairment. Thus schizophrenia is postulated to be seen as a pathway disease24.
Because schizophrenia is a polygenic disease, the type and severity of its symptoms differ
between individuals. Psychosis is a continuum35, which means that psychotic symptoms, such as
hallucinations, occasionally occur also in healthy people. These psychotic-like traits in the general
population are displayed as psychoticism — one of the three dimensions of personality, according to
the P-E-N (Psychoticism-Extraversion-Neuroticism) model of personality by Eysenck36. Common
risk alleles may increase psychoticism in an individual within the healthy range. However, if one
carries many of such alleles, or in a bad combination, his/her traits may reach a pathological level,
referred to as psychosis.
Genetic risks are shared between psychiatric diseases32. GWAS revealed a genetic overlap
between schizophrenia and bipolar disorder37, which also share clinical features, e.g. psychosis
and cognitive decline5,7 and are both treated with antipsychotic drugs32. Differential diagnosis is
problematic. Some patients display features of both diseases and are diagnosed for an intermediate
form, schizoaffective disorder32. Schizophrenia also has some commonalities with major depressive
disorder and autism5,7,32. Since these genetic and clinical overlaps impede diagnosis, the Research
Domain Criteria (RDoC) project was founded to develop a new diagnostic approach based on
neurobiological parameters instead of observed symptoms38. This classification system would be
organized hierarchically into five domains — Negative Affect, Positive Affect, Cognition, Social
Processes, Arousal/Regulatory systems — each of which consists of subordinate constructs, e.g.
Fear39. Such a revolution in the psychiatric classification system is expected to improve diagnosis
and, consequently, introduce more efficient, domain-targeting treatment strategies in the patients.
1.2 TCF4 transcription factor
TCF4 (ENSG00000196628), also known as E2-2, SEF2 and ITF2, encodes Transcription factor 4.
Next to MIR137, CACNA1C and the MHC region31, it is one of the most replicated GWAS schizo-
phrenia risk genes26–31. TCF4 should not be confused with TCF7L2 (T-cell-specific transcription
factor 4, ENSG00000148737), which traditionally is often referred to as “TCF4” too.
TCF4 belongs to the class I basic helix-loop-helix (bHLH) transcription factors, which are
broadly expressed in various tissue types (reviewed in40–42). They are also called E-proteins, since
they recognize palindromic CANNTG motifs known as E-boxes (Ephrussi-boxes)43, via the basic
region of the bHLH domain44,45. To gain transcriptional activity, E-proteins need to dimerize with
tissue-specific class II bHLH transcription factors. The preference for different E-boxes will depend
on the protein combination within a heterodimer. E-proteins can also dimerize with dominant
negative HLH proteins (ID family), which lack the basic region and consequently, prevent DNA
binding (reviewed in40,46). Thus by interacting with various tissue-specific bHLH partners or
HLH repressors, E-proteins have pleiotropic functions40,46. Brain development is regulated by less
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than 10 class II proneural proteins, which interact with ubiquitously expressed E-proteins (Fig. 1.1).
While the fate of neuronal precursos and differentiation are precisely determined by the class II
tissue-specific proneural factors, E-proteins seem to be interchangeable between each other47.
Tcf4 is ubiquitously expressed with highest levels in fetal brain, cerebral cortex and spleen48–50.
In the brain, its expression is particularly high in neocortex and hippocampus40 and within the
immune system — in dendritic cells and B lymphocytes49. Tcf4 expression starts in embryonic life
(Fig. 1.1) and is crucial for cell differentiation during neurodevelopment and differentiation of B
and T lymphocytes51. Due to the developmental function Tcf4-/- mice die after birth47,52. Though
they display no major anatomical defects except from disrupted pontine nucleus development47.
Figure 1.1: TCF4 and neurodevelopment. TCF4 expression in the central nervous system starts in
embryonic life, reaches its peak around birth and remains stable during adulthood. By interacting with other
bHLH proneural proteins (e.g. NEUROD family) or differentiation inhibitors (ID2 and 4), TCF4 regulates
neuronal differentiation during development. Figure from Quednow et al. 201446.
TCF4 may also be involved in regulation of apoptosis. Knockdown of TCF4 in human neuro-
blastoma SH-SY5Y cells led to upregulation of proapoptotic genes and downregulation of genes
involved in signalling and neurodevelopment53. In mice Tcf4 is a direct target of ZAC1 (Zinc finger
protein regulator of Apoptosis and cell Cycle arrest 1)54.
The TCF4 gene is located on the reverse strand of the chromosome 18 in humans and on
the forward strand in mice. In humans, the forward strand encodes additionally MIR4529 and
RPL21P12655 (Fig. 1.2). The gene size is large (413.6 kb in humans and 343.5 kb in mice) and was
gradually increasing during vertebrate evolution40.
TCF4 has 48 known splice variants56 and 18 predicted protein isoforms with distinct N-termini48
Full-length protein has two activation domains (AD1 and AD2) that regulate transcription, and a
Nuclear Localization Signal (NLS). Shorter isoforms may lack AD1 or NLS, but known isoforms
contain AD2 and the N-terminally located bHLH domain48 (Fig. 1.2).
The bHLH domain was conserved in evolution and mutations in that region cause Pitt-Hopkins
syndrome (PTHS)40 (see section 1.2.2 below). bHLH is critical for dimerization and binding
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Figure 1.2: Structure of human TCF4. Human TCF4 gene is 413.6 kb long and contains 21 exons (odd
and even introns and exons are marked in gray and black, respectively). Two activation domains (AD1 and
AD2) are encoded by exons 3–6 and exons 14–16. Exons 8–9 encode Nuclear localisation signal (NLS)45.
The conserved basic helix-loop-helix (bHLH) region is encoded in exon 19 (red arrow). Two miR137 binding
sites (blue arrow) are located within exon 134. Point mutations within the region containing exons 10–19
result in Pitt-Hopkins syndrome (PTHS) (marked in orange). Four schizophrenia risk SNPs (red dots) are
located within TCF4 introns, three of which are in the intron ENSE00003675281, the longest intron of the
gene. Two more schizophrenia SNPs are downstream of the TCF4. Additionally, two SNPs in the intron
ENSE00003675281 are associated with Fuchs’s corneal dystrophy (blue dot) and sclerosing cholangitis and
ulcerative colitis (yellow dot)64,65).
E-boxes in promoters or enhancers of other genes40. TCF4 regulates transcription predominantly
as heterodimer with class II bHLH proteins and homodimers have no known function. Proneural
partners of TCF4 include NEUROD1, NEUROD2 (NDRF)57 and NEUROD6 (NEX), while the
HLH protein ID2 acts as a repressor58. TCF4 has many potential partners and should be considered
as a hub in the network of bHLH proteins interactions46.
Direct target genes of TCF4 are largely unknown, but it has been shown that it regulates
expression of Somatostatin receptor type II (SSTR-2)59 and Tyrosine hydroxylase60.
Activity of E-proteins, including TCF4, is inhibited by Ca2+/calmodulin61,62. Ca2+ levels,
which indicate synaptic activity, could possibly modulate TCF4 functions by affecting its splicing,
shuttling, dimerization or its partners46. Such regulation of TCF4 by neuronal activity might allow
adaptation to environmental changes and indeed, TCF4 genotype intearcts with smoking63.
1.2.1 TCF4 and schizophrenia
Several schizophrenia-risk SNPs were found in introns of TCF4 and in the intragenic region down-
stream of it (Fig. 1.2). Two of these polymorphisms are located in the intron ENSE00003675281
(intron 4–5) which also contains SNPs independently associated with Fuchs’s corneal dystrophy and
sclerosing cholangitis and ulcerative colitis64. Moreover, TCF4 has also been linked to intellectual
disability31 and to bipolar disorder66. Thus TCF4 is a validated risk gene for schizophrenia that
may play a role in other psychiatric diseases.
The TCF4 SNPs contribute to schizophrenia-relevant endophenotypes. Patients carrying the
risk allele of rs9960767 display decreased PPI67 and auditory P50 suppression, which is worsened
in heavy smokers63. Risk variant of rs17512836 was associated with reduced auditory P300
amplitude68, thus may affect attention and working memory68. Both SNPs are associated with
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predispositions for paranoia in adolescents in general population69. Surprisingly, risk variants of
rs9960767 in Caucasians and rs2958182 in a Chinese population correlated with worsening of
verbal memory70 or attention71 in healthy subjects, but with improvement in the patients.
It is unclear whether these SNPs affect TCF4 expression levels, but elevated TCF4 mRNA was
found in blood of schizophrenic patients72 and postmortem brain tissue73–75.
Interaction of TCF4 with other schizophrenia risk genes is possible, since their expression
patterns largely overlap76. In cultured non-neuronal cells, TCF4 regulates the schizophrenia and
autism-related genes CNTNAP2 and NRXN 77 and is regulated by miR-137 34 (Fig. 1.2), a microRNA
involved in schizophrenia28,30,31. TCF4 is also predicted to be a target of several other microRNAs
associated with diseases of the central nervous system40.
Interestingly, many murine microRNAs (miR-137, -183, -200b, -200c and -42978,79) are bound
by Tcf4 circular RNA (circRNA) — huge RNA molecules composed of exons. It is not clear what
determines which exons are incorporated into circRNAs, but it is known that the introns neighboring
the chosen exons tend to be 3 times longer than other introns. It may be interesting, concerning
that the TCF4 intron ENSE00003675281, where most of the risk SNPs are, is the longest intron of
TCF4 (over 12 kb)56.
1.2.2 TCF4 and the Pitt-Hopkins syndrome
The Pitt-Hopkins syndrome (PTHS) is an autosomal dominant disorder caused by haploinsufficiency
of TCF4. It is very rare — the number of patients is estimated to be around 200–300 worldwide41.
The hallmarks of PTHS are mental and developmental retardation, absence of speech, epis-
odic hyperventilation and distinct facial features, e.g. strabismus, wide mouth with M-shaped
Cupid’s bow, fleshy lips and broad nasal bridge42,80,81. Patients often also display other bodily
deformities, abnormal EEG, epilepsy, diminished startle response41,42,82 and anatomical changes
of the brain: thin corpus callosum, hypoplasia of the frontal lobes and small hippocampi42. Pa-
tients typically display autistic-like behaviours; including stereotypy, perseveration and impaired
social interaction41,80,81; and can be easily misdiagnosed for Rett, Angelman or Mowat-Wilson
syndrome82–84
PTHS is caused by various kinds of mutations within the TCF4 gene. Some of them are
deletions that affect the whole TCF4 transcript or the AD2 and bHLH domains42,45. Nonsense
mutations or small indels occur mainly in the exons 10–19, encoding AD2 and bHLH, and generate
a premature stop codon or elongate the reading frame45. PTHS missense or elongating mutations
impair TCF4 functions via protein destabilization, changing dimerization preferences or disrupting
DNA-binding and transactivation activity45. Ultimately, all these mutations lead to TCF4 loss of




Mutations in NRXN1 and CNTNAP2, potential TCF4 targets77 and members of the neurexin
superfamily, lead to PTHS-like syndromes, which have similar symptomes except from the facial
features41. These genes are regulated by TCF4 in vitro77 and possibly belong to the same pathway.
In contrast to PTHS, which is an autosomal dominant disease, the PTHS-like syndromes are
autosomal recessive41.
Modelling PTHS in animals would be possible by using appropriate Tcf4 knockouts. Different
Tcf4 knockout mouse lines are commertially available on the market (reviewed in41). In our project
we used a mouse line from the Sanger Institute with floxed Tcf4 exon 4 (see section 2.4 on page 17).
1.3 Gene×Environment interaction
Both genes and environment play a role in psychiatric disorders. Whether an individual will develop
symptoms or not, depends on Gene×Environment interaction (G×E)5,86. According to the Two-
hit hypothesis, genetic vulnerability (first hit) followed by exposure to environmental risk factors
(second hit) can trigger psychotic disorders87. Numerous environmental factors, often of social
nature9,88, contribute to the risk of schizophrenia (reviewed in5,9,86,87,89,90). Some affect embryonic
development, e.g. pregnancy and birth complications, maternal malnutrition, maternal immune
activation or being born in winter. Other factors occur during early life: childhood adversity,
childhood viral infections, cannabis consumption86,89, migration91,92 and urban upbringing93–95.
The latter two come down to chronic social exclusion, isolation and defeat, which may be the
essential factors for schizophrenia5,96,97. Social support, on the other hand, may protect from
psychopathology96.
Timing of environmental adversities can determine the type and severity of symptoms that will
emerge in adulthood90,98,99. Schizophrenia typically has its onset during adolescence or shortly
after10–12,32, which is a time of high vulnerability, considered as the critical period for developing
social skills and executive functions86,100,101. The adolescent brain undergoes intensive changes,
predominantly in the frontal cortex, e.g. enhanced plasticity101 and pronounced synapse elimination
(pruning)102,103.
Pruning is a natural developmental process common in many species. During healthy ad-
olescence gray matter gets thinner in the frontal lobes (thought to result from loss of synapses),
which correlates with improvement of verbal and spatial memory101,104. Reduction of dendritic
spines105,106 and excessive pruning in the cortex are proposed as mechanisms of cortical thinning
in schizophrenia2,101,107,108. Interestingly, in a computational model, moderate elimination of
synapses improved speech recognition, but excessive synapse loss led to hallucinations, compared
to hearing “voices”109. Perhaps, common “pro-pruning” genes, that normally enhance cognition,
in bad combinations (G×G) can exaggerate pruning and lead to psychosis109. Pruning is mediated
predominantly by long-term depression (LTD)101. It selectively reduces excitatory synapses in the
cortex and thereby increases inhibition/excitation ratio and refines interneuronal activity (reviewed
in101,108). It seems that pruning proceeds in an activity-dependent manner (used connections are
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reinforced, unused eliminated), which would make room for environmental and epigenetic factors
to get involved in the whole process108.
Post-weaning period is the puberty in mice (e.g. around P29 in C57Bl/6 males)110, analogous
to human adolescence. However, some differences occur — human frontal cortex and amygdala
develop more extensively and human hippocampus maturates faster (in the age of 2 years, while in
rodents after weaning)90. Puberty is a time of high vulnerability in rodents111 and can be a useful
model of the critical period in human adolescence.
Several environmental paradigms are used to model environmental risk factors for schizophrenia
in animals (reviewed in112. Models based on pharmacological treatment, e.g. psychostimulants113,
phencyclidine (PCP)114,115, NMDA receptor antagonists116, have long tradition; however, these
approaches usually have low clinical relevance, as they do not mimic the factors encountered by
the patients. Other models include neonatal ventral hippocampal lesion117,118 and prenatal immune
activation119. Probably a better approach is to model risk factors commonly encountered in human
adolescence, like cannabis exposure120 and psychosocial adversities modeled by social isolation
and social defeat90 (see below).
Finally, G×E approaches have been gaining more and more attention during the last dec-
ade121. Several genetic mouse models of schizophrenia — e.g. Disc1, Nrg1–Erbb4 mutants90,112
and Tcf4-overexpressing mice57 — have been analysed using various G×E paradigms (reviewed
in90,122–126). In our project we focused on adolescence-related psychosocial factors, which we be-
lieve to be particularly relevant for schizophrenia, and on their interaction with Tcf4 overexpression.
1.4 Modelling environmental factors in mice
Using rodents as disease models has several advantages compared to human studies. By testing an-
imals of a defined genetic background in strictly controlled and standarized experimental conditions,
we reduce between-subject variability. This way we can dissect even subtle influences of a given
factor, e.g. mutation or environment, on the phenotype. Modeling psychiatric diseases in rodents
requires performing behavioural experiments. Since animals do not speak, creating valid models
is challenging, particularly in case of the the positive symptomes of psychotic diseases. What
can be reliably measured in behavioural tests, is cognition and several other disease-associated
endophenotypes, e.g. PPI.
Various paradigms are used to model environmental influences in laboratory conditions. To
mimic environmental risk factors for schizophrenia, we subjected our mice to isolation rearing (IR)
and social defeat (SD). As a control condition we used enriched environment (EE) which provides
various kinds of stimulation and best resembles the natural environment of wild mice.
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1.4.1 Isolation rearing (IR)
Social isolation in rodents induces a set of somatic and behavioural changes — the isolation
synrome127,128. Detrimental effects of isolation have been observed also in opossum129 and other
mammalian species kept in zoological gardens in the 60s130.
In laboratory conditions IR is achieved by housing rodents individually in a barren cages after
weaning. The first reported symptoms were aggressiveness128, nervousness during handling and
tendency to bite127, which makes these animals difficult to work with. Isolated rodents (particu-
larly males131) display numerous symptoms, including learning and memory disruption128,132,133,
reduced pain sensitivity134,135, hypersensitivity to psychostimulants131, locomotor hyperactivity in
novel environment131,136–142 and impaired PPI138–140,143. IR has been proposed and as an animal
model of schizophrenia in numerous studies128,131,143.
The post-weaning period is considered as rodent puberty110 and corresponds to the critical
period of risk for psychiatric diseases in humans144. IR can cause irreversible changes, some of
which (e.g. PPI deficits) occur only if the animals are isolated shortly after weaning138,142,144). and
other (e.g. novelty-induced hyperactivity) are independent of developmental stage138. Therefore
isolation rearing shortly after weaning should be distinguished from isolation housing in adulthood.
IR has three aspects: social deprivation, sensory deprivation and lack of physical activity —
each of which produces different symptoms. In rats, sensory deprivation in barren cageing impairs
hippocampus-dependent spatial learning in Morris water maze (MWM), while social deprivation
specifically impairs reversal learning145 and in mice pseudoisolation (animals in one cage but
separated by a perforated transparent partition) induces hyperactivity in the Open Field (observed
in many schizophrenia models124) without changes in acoustic startle response146. On the cellular
level sensory deprivation diminishes cortical spine elimination during adolescence in mice147.
Social isolation in humans has detrimental effects, first observed in hospitalised children in
the 40s148,149. In adults, isolation and sensory deprivation trigger hallucinations, intrusive thoughts,
confusion of dreams with reality, emotional instability and irrational fear — reported in psycholo-
gical studies150,151 and case reports, e.g. explorers, soldiers on guard duty or isolated patients152.
Conceivably, in absence of sensory input, brain generates hallucinations as a replacement. Sensory
deprivation has been proposed as a human model of schizophrenia152, albeit criticized150. Long-
term isolation cannot be studied for ethical reasons, but short-term (few days long) isolation in
adults was shown to have temporary, yet striking, outcomes150,152. Prolonged isolation, particularly
in the critical periods, may cause life-long impairments. The famous case of Kaspar Hauser153 — a
19th century’s German boy kept in complete isolation until the age of 17 — is an extreme example
of detrimental effects of social deprivation on development of language, cognition and social skills.
Rosenzweig152 suggested that psychosis-like symptoms upon sensory deprivation are in fact
caused by relevance deprivation (lack of salient stimuli that would evoke a response). This state
could be also induced by perceptual distortion (incorrect understanding of perceptual experience 154)
or sensory overload — possible alternative models of schizophrenia152. Schizophrenics hallucinate
less in isolation150,151, which may denote that they normally suffer from sensory overload.
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1.4.2 Social defeat (SD)
Numerous evidence show that early life stress (e.g. emotional neglect, sexual abuse, violence,
bullying) can trigger psychopathology in adulthood86,155–159. Schizophrenia risk factors: urban
upbringing and migration, are associated with chronic social defeat and social exclusion, which
underlies the Social Defeat Hypothesis of Schizophrenia96,97. It seems that stressors in adulthood
do not contribute to the risk of schizophrenia, but the patients and their relatives are more reactive to
daily hassles156, which emphasizes the importance of the critical developmental period. Most of the
stressors in Western societies are of psychosocial nature, therefore mouse models of psychosocial
stress are expected to be the most relevant for psychiatric disorders.
In rodents, social defeat is one of the paradigms used to model psychosocial stress. Typically
the resident-intruder paradigm is applied, which resembles bullying in humans160. Experimental
mice are introduced to cages (territories) of more aggressive and bigger mice120. To assure the
stress is psychosocial and not physical, experimental mice are protected by wire-mesh cages
after the first attacks, but are still exposed to the aggressor. Because the procedure is repeated
for 3 weeks, the stress is chronic. SD has been extensively studied in rodents and was found to
cause a depressive-like phenotype161,162, impaired cognition and PPI deficits163. It also affects
hippocampal functioning164 and the mesocorticolimbic dopaminergic system165.
1.4.3 Enriched environment (EE)
Enriched environment is virtually the opposite of isolation rearing. Enrichment in laboratory
conditions typically means housing rodents in groups in large cages equipped with various objects,
e.g. toys, tubes and running wheels121,166. Such defined EE has three major aspects: sensory
stimulation, social stimulation and physical stimulation. Sensory stimulation is required for correct
functioning and connectivity of sensory cortices167 while social stimulation allows them to develop
necessary social skills. Sensory and social stimulation seem to influence different behaviours
independently145,168. Physical activity is provided by the running wheel, which is willingly used by
laboratory as well as wild mice169,170 and enhances cognitive performance171,172. Similarly, sport
for humans — particularly during childhood — improves cognition172,173 and restores hippocampal
function in schizophrenic patients174.
Because of its positive effects on rodent behaviour and resemblance to the natural environment,
EE is recommended as an appropriate control condition, which is better than standard housing
(group housing in barren cages166). EE positively influences rodent brain and behaviour — increases
long-term potentiation (LTP), neurogenesis, dendritic branching, vascularisation and synaptic spine
density, improves cognition and exploration and reduces anxiety (reviewed in121,167). In numerous
studies addressing G×E, EE rescued the phenotype of mouse models of various nervous system-
related diseases, e.g. Fragile X syndrome, Alzheimer’s disease or schizophrenia (reviewed in121,175)
and abolished effects of juvenile stress176,177.
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1.5 Aims of the project
In this project, we focused on analysing Gene×Environment interaction in transgenic (Tcf4tg)
mice overexpressing Tcf4 in postnatal forebrain.
To better relate the studied mouse models to psychiatric diseases, we developed an approach to
analysing complex behavioural data sets and creating clinically relevant behavioural profiles mice
(published in Badowska et al.178). Initially we focused on environmental factors in wildtype (wt)
mice and next, on G×E in Tcf4tg mice.
Previous studies by Brzózka et al.57 showed that Tcf4tg mice display mild impairments of fear
conditioning and PPI. Therefore we tested whether environment can influence the manifestation of
this phenotype in these mice. Therefore we subjected them to IR and EE and analysed them in a
battery of behavioural tests.
We also aimed at identifying molecular and cellular mechanisms that could underlie the
behavioural phenotype. To find potential candidate genes downstream of TCF4, we analysed the
transcriptome and proteome of Tcf4tg mice in hippocampus and prefrontal cortex (PFC). We also
investigated whether Tcf4 overexpression influences synapse morphology and electrophysiological
properties of neurons.
To understand Tcf4 function, we combined the gain-of-function approach (Tcf4 overexpression
in Tcf4tg mice) with the loss-of-function approach (Tcf4 depletion). We generated a Tcf4-/+ mouse
line and analysed the impact of the knockout on murine behaviour.
In summary, in this project we adressed the following issues:
• Creating behavioural profiles of wildtype mice based on huge data sets
• Modelling G×E in Tcf4tg mice and analyses on behavioural, molecular and cellular level





2.1 Chemicals, reagents and laboratory supplies
Table 2.1: Chemicals and reagents.
Chemical Supplier Chemical Supplier
2-Propanol VWR Lithium dodecyl
sulfate
Sigma
Agarose AppliChem MES Sigma
Bis-Tris Sigma Methanol J.T.Baker




Non-fat milk powder frema-
Reform
Chloroform J.T.Baker Paraformaldehyde Serva
dNTP 10 mM (2.5 mM
each)1 cat. no. 1969 064
Roche Pellet Paint, cat.no.
70748-3
Millipore
DTT (Dithiothreitol) 0.1 M PJK SDS Sigma
EDTA Sigma Serva Blue G250 Serva
Ethanol Sigma Sucrose Merck
Ethidium bromide Sigma Tris Roth
Glycerol Merck Tris base Sigma
Glycogen Tris-HCl Sigma
HEPES (stock 200 mM) Lonza Triton X-100 Sigma
Inorganic salts Merck, Sigma,
Roth
Trizol Roth
Lauryl sulphate Sigma Tween20 Merck
PhosSTOP Phosphatase Inhibitor Cocktail Tablets, cat.no. 04 906 837 001 Roche
Complete Mini Ultra EDTA free protease-inhibitor tablets, cat.no. 05892791001 Roche
Markers:
DNA ladder (100 bp, 1 kb) Fermentas
Spectra Multicolor Broad Range Protein Ladder, cat.no. 26634 Thermo-
Scientific
1diluted 1:5 with water before use, final concentration in the PCR 200 µM (50 µM each)
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Table 2.2: Laboratory supplies.
Laboratory supplies Supplier
ECL-hyperfilms Amersham Biosciences
PVDF Membrane Hybond P Amersham Biosciences
96-well plates for RT-qPCR Applied Biosystems
384-well plates for RT-qPCR Roche
NuPAGE Novex 4-12 % Bis-Tris Protein Gels,
1.0 mm, 10 well (cat.no. NP0321BOX)
Life Technologies
Kits
Agilent RNA 6000 Nano Kit Agilent
DC Protein Assay Bio-Rad
ECL Plus Western-Blot Detection Reagents Amersham Biosciences
RNeasy Mini Kit (cat.no. 74106) Qiagen
Invisorb Spin Tissue Mini Kit (cat.no. 1032100300) Stratec biomedical
Cloud-Clone Corp ELISA Kit (cat.no.
CEA806Mu)
Uscn Life Science Inc.
Enzymes
GoTaq DNA polymerase & 5× buffer Sigma
RedTaq DNA polymerase & 10× buffer
Proteinase K (10 mg/ml) Invitrogen
SuperscriptIII Reverse Transcriptase Invitrogen
Power SYBR Green Master Mix (2×) Applied Biosystems
HRP-conjugated-goat secondary antibodies Dianova
Table 2.3: Laboratory equipment and software.
Equipment Supplier




Stepper pipette HandyStep R© electronic Brand
Intas Chemocam Imager ECL HR-16-3200 Intas UV-Systems
Homogenizer: Polytron PT 1200E Polytron Hand
Arium R© pro VF Water Purification System Sartorius
SDS-PAGE Gel Electrophoresis System Invitrogen
Eon microplate reader BioTek
Open Field System TSE Systems
Fear Conditioning System TSE Systems or Ugo Basile
Prepulse Inhibition System TSE Systems or SR-LABTM
Digital camera ProgRes C14 Jenoptik
Software Source
Adobe Illustrator CS5, Adobe InDesign CS5 Adobe Design Standard CS5
Any-maze software (cat.no. 60000-FC) Ugo Basile
Continued on next page
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Table 2.3 – Continued from previous page
Software Source
DNASTAR Lasergene Core Suit 9 DNAStar
GraphPad Prism 5 for Windows ver. 5.04 www.graphpad.com
ImageJ http://imagej.nih.gov/ij/
LATEX (MiKTeX) http://miktex.org/
Moti4, VideoMot2 TSE Systems
R www.r-project.org
Universal Probe Library Assay Design Center www.roche-applied-science.com
Zotero www.zotero.org
2.2 Primers
Primers were designed using the Assay Design Center for Universal Probe Library by Roche
(http://lifescience.roche.com). All oligunucleotides were produced in by the DNA Core
Facility of the Max-Planck-Institute of Experimental Medicine, Göttingen, Germany. Each oligo
has been given an in-house identification number (ID). Primers are listed in the Tables 3.2 and 3.6.
2.3 Buffers
Blocking buffer (western blotting) 5% non-fat milk in TBS-T or 5% BSA in TBS-T
Buffer A (synaptosome isolation) 4 mM HEPES, 0.32 M sucrose
DNA extraction buffer (1×) 0.5 % SDS, 0.1 M NaCl, 0.05 M Tris (pH 8.0), 3 mM EDTA with
0.5 mg/ml Proteinase K
MGB (1×) 67 mM Tris pH 8.8, 16.6 mM (NH4)2SO4, 6.5 mM MgCl2, 0.5% Triton-X-100
NuPAGE MES running buffer (1×) 50 mM MES, 50 mM Tris Base, 0.1% SDS, 1 mM EDTA,
pH 7.3
NuPAGE sample buffer (1×) 106 mM Tris-HCl, 141 mM Tris base, 2% Lithium dodecyl sulph-
ate, 10% Glycerol, 0.51 mM EDTA, 0.22 mM SERVA Blue G250, 0.175 mM Phenol Red,
pH 8.5
NuPAGE Transfer buffer (1×) 25 mM bicine, 25m M Bis-Tris (free base), 1 mM EDTA, 0.05 mM
chlorobutanol, 20% methanol pH 7.2
PBS (Phosphate buffered saline) (1×) 10% NaCl, 0.25% KCl, 0.72% Na2HPO4•2 H2O, 0.25%
KH2PO4, pH 7.2
Sucrose buffer (always freshly made) 320 mM sucrose, 10 mM Tris, 1 mM NaHCO3, 1 mM
MgCl2, Protease-inhibitor tablets, PhosSTOP Phosphatase Inhibitor Cocktail Tablets or self-
made phosphatase inhibitor coctail (4.5 mM Na4P2O7, 5 mM NaF, 1 mM Na3VO4, 1 mM
ZnCl2)




TBS-T buffer (1×) 50 mM Tris-Base, 150 mM NaCl, 0.01-0.1% Tween20, pH 7.4
TE buffer (1×) 10 mM Tris-HCl (pH 7.4), 1 mM EDTA
2.4 Mouse strains
C57Bl/6N wildtype mice, from Charles River (Sulzfeld, Germany) or in-house-bred, used for
behavioural tests, hormone measurements, breeding and as strangers in Social Interaction test
FVB/N in-house-bred, used for breeding and as residents in SD paradigm
TMEB heterozygotic Tcf4tg ad wt mice on FVB/N background (see section 2.4 below)
TMEBBl6 heterozygotic Tcf4tg and wt mice on mixed background C57Bl/6N×FVB/N (see
below). These hybrids were chosen for most of the experiments, as the most “healthy” strain
(see hybrid vigour below).
TMEBl6 F10 heterozygotic Tcf4tg and wt mice on C57Bl/6N background i.e. bred to C57Bl/6N
mice for 10 generations (see below)
Tcf4E line MDXP EPD0103 3 A07, (C57Bl/6N background) from the Sanger Institute, carrying
the EUCOMM allele Tcf4tm1a(EUCOMM)Wtsi (project ID: 26368).
Tcf4F offspring of Tcf4E mice bred to FLIR mice (C57Bl/6N background) in order to delete the
lacZ-neo cassette (Fig. 2.1). Tcf4 function is restored in this line (see below).
Tcf4C heterozygotic a whole-body Tcf4 knockouts (C57Bl/6N background), offspring of Tcf4E
and Ella-Cre mice (Fig. 2.1). Tcf4 exon 4 is lacking but the lacZ-neo cassette is maintained.
The gene is disrupted in all body cells from the early development (see below).
Ella-Cre line B6.FVB-Tg(EIIa-cre)C5379Lmgd/J from Jackson Laboratory (stock number: 003724).
Cre-recombinase expression starts in all body cells before implantation in the uterine wall.
FLIR Flp1 recombinase expressing line 129S4/SvJaeSor-Gt(ROSA)26Sortm1(FLP1)Dym/J line from
Jackson Laboratory (stock number: 003946).
TYFB mice (C57Bl/6N background) expressing EYFP under Thy1.2 promoter179.
Transgenic lines TMEB, TMEBBl6 and TMEBl6 F10
To explore the effect of TCF4 gain of function, we used Tcf4tg lines TMEB, TMEBBl6 and
TMEBl6 F10, which were previously published by our group57. These mice overexpress full-
length Tcf4 var.1 open reading frame (2010 bp, 667 AA, 71.3 kDa) with an N-terminal Flag-tag and
C-terminal double Tandem Affinity Purification tag (TAP tag) (585 bp). Therefore the construct
(2595 bp, 92 kDa) constitutes of exons only and is missing introns. Overexpression is driven by
Thy1.2 promoter and occurs in projection neurons of postnatal forebrain. As reported by Brzózka et
al, Tcf4 mRNA levels in Tcf4tg mice are increased to 150% compared to their wt littermates. These
mice exhibit strain-independent mild cognitive impairment and sensorimotor gating deficits57.
Animals on mixed C57Bl/6N× FVB/N background were used in most of the experiments, as they
are more “healthy” than inbred strains — they display no anatomical and behavioural abnormalities
of their paternal strains and perform better in learning tasks (known as hybrid vigour)180.
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Tcf4 knockout mouse strains Tcf4E, Tcf4F and Tcf4C
Eucomm mouse line Tcf4E We purchased commercially available EUCOMM Tcf4 knockout
line (Tcf4E) from the Sanger Institute: the EUCOMM allele Tcf4 (see Mouse strains on page 16).
As the knockout-first strategy181 was applied, expression of Tcf4 in these mice is partially reduced
by a promoterless lacZ-neo cassette introduced before the exon 4. The cassette is flanked by two
FRT sites and the exon 4 is flanked by two loxP sites (see section 2.4 below and Fig. 2.1 and 3.5).
This mouse line can be bred to appropriate tool mouse lines and give origin to various knockout
lines.
Line Tcf4F To delete the LacZ-neo cassette the Tcf4E mice were crossed with the Flp1 recom-
binase expressing mice (the FLIR strain, see section 2.4 above). The offspring line was named
Tcf4E×FLIR (Tcf4F). Deletion of the cassette in restores the Tcf4 gene function. The Tcf4F mice
can be bred to a Cre-line of choice to generate a conditional knockout line. However, Flp1 is not
expressed in all body cells, thus the offspring knockouts show mosaic genotype. To solve this
problem we plan to breed the mosaic Tcf4F animals to wild type mice and then select only the
Tcf4F allele positive but Flp1 negative offspring for further breeding.
Line Tcf4C — heterozygotic Tcf4 knockout Breeding the Tcf4E mice directly with the Ella-Cre
line (see section 2.4 above) allowed us to generate a Tcf4 knockout without the time consuming
Tcf4F breeding and selection. The offspring line, named Tcf4E×Cre (Tcf4C), lacks the Tcf4 exon 4
but maintains the lacZ-neo cassette. It is a heterozygotic whole-body knockout from an early
embryonic stage.
Figure 2.1: Breeding strategy of the Tcf4 knockout mouse lines. All Tcf4 knockout lines were derived
from the commercial EUCOMM line Tcf4E. In this line FRT-flanked lacZ-neo cassette is introduced before
the floxed exon 4 (knockout-first approach). Crossing with FLIR mice (left panel) deletes the lacZ-neo
cassette and restores the gene function. The offspring (line Tcf4F) can be bred to appropriate Cre-line to
obtain a desired conditional knockout line Tcf4FC. Another approach (right panel) is to breed Tcf4E mice
directly to Ella-Cre mice, which deletes the exon 4 in all body cells from an early developmental stage, but





All mice were maintained in colony rooms under standard conditions with 12 h light/dark cycle and
21±2 ◦C room temperature. Food and water were provided ad libitum.
Isolation rearing (IR) From the age of 4 weeks animals were housed individually in Makrolon 2
cages (26.5× 20.5× 14.5 cm) that contained only the bedding (Fig. 3.1A,C). No tissue or
other materials that could enrich the cage were provided and animals were handled only
during the cage change.
Social defeat (SD) To induce psychosocial stress the resident-intruder paradigm (Fig. 3.1B) was
used as described in120. Single-housed male FVB/N mice (Charles River, Sulzfeld, Germany)
were used as residents. In brief, from the age of 4–5 weeks the experimental animals
(intruders) were introduced in the cages of residents. After the first attack occurred each
intruder was protected by a wire mesh cage to prevent injuries and left in the resident’s
cage for 1 h. The procedure was repeated daily for 3 weeks and every day intruder mice
were exposed to different residents in a Latin-square manner. Between and after the stress
sessions the intruders were housed individually (cages contained bedding and tissue) to
prevent abolishment of stress effects by social support163. The FVB/N residents were kept in
a separate room to avoid olfactory habituation in experimental mice.
Figure 3.1: Environmental paradigms: IR, EE and SD. A) Animals were subjected to post-weaning
isolation rearing (IR) or enriched environment (EE) from the age of 4 weeks remained during the testing
period (from the age of 8 weeks) and after it. B) Animals were subjected to social defeat (SD) (daily for
3 weeks) from the age of 4–5 weeks. The control group was housed in EE. C) Photographs present isolation
rearing (left), social defeat (middle) and enriched environment (right).
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Enriched environment (EE) From the age of 4 weeks animals were group-housed (usually 5–8
mice per cage) in Makrolon 4 cages (60× 38× 20 cm). Cages were divided into two com-
partments: bigger compartment containing a running wheel and tunnels made of PCV pipe
fittings and smaller compartment providing access to food pellets and drinking water. Anim-
als could freely move between the compartments by climbing a ladder or passing through a
one-way gate (Fig. 3.1A,C).
3.1.2 Behavioural tests
Most of the experiments were described in our publication178. All tests were performed during the
light phase. The experiments were approved by the appropriate ethics committee of Lower Saxony
and have been performed according to the ethical standards of the Declaration of Helsinki (1964)
and its later amendments. The experimental chambers and mazes were washed with 70% ethanol
before and after each use, unless stated differently.
Open field (OF) and Hole board (HB) Animals were placed into a grey box (45× 45× 55 cm)
and allowed to explore the surrounding for 10 min. In the OF test, time moving, covered
distance, rearing and time in the centre were quantified using an infrared monitoring system
and the Moti4 software (TSE Systems, Bad Homburg, Germany).
The HB experiment was performed in the same boxes, but with a floor insert containing
16 symmetrically deployed holes (2 cm diameter). During the 10 min long test, the number
of nose pokes into the holes and total time of hole exploration were measured automatically
by the Moti4 software.
Light-dark preference (LD) The experiment was performed in a chamber divided into two com-
partments: black-walled “dark” chamber and transparent “light” chamber, both connected by
a door-like opening. Mice were placed into the light chamber, with their heads facing the
wall opposing the gate. The test lasted 5 min from the first entry into the dark chamber. The
latency to enter the dark chamber and the total time spent there were measured manually.
Elevated plus maze (EPM) The EPM setup was built in a shape of a “plus” sign with two oppos-
ing open and two closed arms (30× 5 cm arms, walls 15 cm high) and raised 50 cm above
the floor. Each animal was placed at the crossing of the arms. The time spent in the open and
closed arms were manually measured for 5 min.
Tail suspension test (TST) Mice were suspended upside-down and attached to a fixed rod by an
adhesive tape by the tip of the tail. Fighting time, which reflects the escape motivation of the
mice, was manually scored for each mouse for 6 min.
Y-maze Mice were inserted into a gray plastic maze in the shape of “Y” with arms identical and
symmetric to each other. Animals were allowed to explore the maze for 10 min. The number
of arm explorations (choices) and number of alternations were scored. Alternation was
defined as a sequence of thee arms explorations without visiting the same arms twice.
Social interaction We used the Crawley test of sociability182 to analyse social behaviour. The test
box consisted of three compartments separated by transparent plexi walls with entrances.
In the acquisition phase (5 min) the experimental animal was placed in the middle, empty
compartment and the entrances to other compartments were blocked. Next, in the sociability
phase, an unfamiliar mouse (stranger 1) was introduced to one of the compartments and
covered by a wire-mesh cage. And empty wire mesh cage was placed in the opposite
compartment. The experimental mouse was allowed to explore all compartments for 10 min.
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In the last phase (social memory) another unfamiliar mouse (stranger 2) was placed in the
previously empty wire-mesh cage and the experimental animal was allowed to explore the
box for 10 min. Experiments were recorded by a camera placed above the test box and the
time spent in each of the side compartments was then manually measured. Sociability and








where ts1 and ts2 are times spent in the compartments with stranger 1 and stranger 2 and te is
the time in the compartment with the empty wire-mesh cage.
All stranger mice were C57Bl/6N males younger than the experimental mice. To avoid
any repulsive stress or anxiety signals from the strangers, before the experiment they were
habituated to the wire-mesh cages several times and during the experiment different pairs of
strangers were used in consecutive sessions, to let the mice recover.
Prepulse inhibition (PPI) Diminished PPI is an endophenotype of schizophrenia14, therefore
we measured it also in our animals. The experiment was performed as described in works
by Brzózka et al.57,183. Two different commercial PPI systems were used: 4-station PPI
system from TSE Systems (Bad Homburg, Germany) for the Tcf4tgIR-EE-young cohort and
The SR-LABTM Startle Response System (San Diego Instruments) for the Tcf4C#1 cohort.
Animals were habituated to experimental cages for few days before the experiment.
TSE Systems. The instrument contained 4 soundproof stations with sensors recording ver-
tical movements of the floor. In each station a metal grid cage of dimensions 90×40×40 mm
would restrict animals locomotory movements and during the whole experiment 65 dB white
noise was played from speakers on both sides of the grid cage. Animals were placed one by
one into the stations and after 2 min habituation baseline recording was done for 1 min. Then
six 40 ms long 120 dB sound were played to stabilize the startle response and diminish the
impact of within-session habituation. The intensity of startle responses to acoustic stimuli
were recorded for 100 ms, starting from the onset of the stimulus. Next, in the PPI test, we
measured response to non-startling 20 ms-long prepulses of 70, 75 or 80 dB and 40 ms-long
120 dB startling stimuli played 100 ms later. The prepulses were presented in pseudorandom
order with 8–22 s long intervals between the trails. The amplitude of startle response was
calculated as the difference between the intensity of the strongest recorded startle and in-
tensity of startle directly before pulse onset. Means of maximal amplitudes (expressed in
arbitrary units, AUs) were calculated separately for startle pulses with or without a prepulse.





where SAp+p− stands for amplitude of startle response and SAp− is startle amplitude after
pulse only.
SR-LABTM The protocol was as described above. The measurement was performed ac-
cording to the manufacturer’s instructions with the use of two cabinets (type: ABS) and
enclosures for mice (type: Small).
Fear conditioning (FC) The test was performed as described in57,183. Commercial fear condition-
ing systems were used: TSE Systems (Bad Homburg, Germany) for the Tcf4tg vs. wt cohorts
and Ugo Basile (Siena, Italy) for the Tcf4C cohort. The paradigm is presented in Fig. 3.2.
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Figure 3.2: Fear conditioning paradigm. Day 1) Mice were tested in the context chamber. Baseline
freezing was assessed for 2 min, after which animals were subjected to two 30 s long tones (cues) paired
with 2 s footshocks. Day 2) Frezing was measured in the context chamber for 2 min to assess context fear
memory. Day 3) Baseline freezing was measured in a novel chamber. Next cue was played for 30 s and
freezing was measured to assess cue fear memory.
TSE Systems. Foot shocks were applied in the context chamber (36×20×20 cm), using an
electric metal grid made of stainless rods (4 mm in diameter, spaced 6 mm apart). To prevent
conditioning to external sounds, background noise was played in both chambers during all
phases of the experiment. On day 1 animals were placed in the context chamber and baseline
levels of freezing were manually scored for 2 min every 5 s. Next, an auditory stimulus (cue)
of 10 kHz and 75 dB was played from a speaker for 30 s and immediately afterwards an
electric shock of 0.4 mA was applied for 2 s. After 30 s pause, the tone–shock pairing was
repeated once. On day 2 mice were placed in the same context chamber and freezing was
scored for 2 min to assess contextual memory. On day 3 animals were tested in a novel box
(grey, triangle-shaped chamber, washed with water). Cue baseline freezing was measured for
2 min. For the next 2 min, the freezing levels were determined in the presence of the sound
(cue) of the same intensity as during conditioning. To assess remote fear memory context
and cue procedures (day 2 and 3 respectively) were repeated one month later.
Ugo Basile System no. 46000. The procedure was performed like in the TSE Systems,
but with following modifications: i) freezing was recorded by an infra-red CCD camera
(47400-025) and measured automatically by the Any-maze software (cat.no. 60000-FC);
ii) shocks were applied in the Ugo Basile 46003 Mouse Boxes (inside dimensions: 17×17×25(h) cm
with the vertical stripe patterns on the walls; iii) for cue memory Mouse Boxes were replaced
by a transparent Plexiglas cylinders (diameter 19.5 cm, height 25 cm).
Morris water maze (MWM) The paradigm184 is presented in Fig. 3.3. The test was performed
as described in57,183, in a white pool (diameter 120 cm) filled with water dyed with white
paint. White platform (diameter 10 cm) was located in one of the target quadrants (TQs),
1 cm under the water surface. To allow navigation, a single cue was placed on the wall. The
animals’ position, time, distance, route and speed of swimming were tracked using TSE
VideoMot-Systems. The test consisted of several phases and different behavioural qualities
were tested in each phase.
Learning curves. For several consecutive days mice had four swimming trials per day, each
time at the different pole of the pool (the order of the poles was different every day). Animals
were tested in batches of 4–5 mice, so the trials were separated by intervals of around 5 min.
During each trial (max. 90 s long) animals were supposed to find for the hidden platform and
remain on it for 10 s. If a mouse failed to find the platform, it was gently guided to it and
21
METHODS
Figure 3.3: Morris water maze paradigm. Mice were inserted to the maze for several consecutive days;
each day is represented by a box. A) The experiment consisted of distinct phases: I) Visible platform (2 days,
4 trials per day) – mice learn to find a platform marked by a flag. II) Initial learning (6 days, 4 trials per
day) – mice search for the platform hidden under the water. III) Probe test’ (1 day, 1 trial) – the platform is
removed and the time they spend in target quadrant (TQ) is measured. IV) Reversal learning (6 days, 4 trial
per day) – the hidden platform is moved to a different position. V) Probe trial” (1 day, 1 trial) – like probe
test’. VI) Remote probe test (1 day, 1 trial) – probe test” repeated after 1 month to assess long-term memory.
B) In another version of the paradigm probe test” was followed by delayed matching to place (DMP) (5 days,
4 trials per day) in which the platform was located in different position every day.
allowed to sit for 10 s. The time and distance needed to reach the platform were measured.
The means of all four trials were used to draw the learning curves. The test was composed of
an initial acquisition phase - visible platform (2 days) - , an initial learning - hidden platform
(6 days) - where the animals had to navigate based on the position of the cue, showing spatial
learning abilities, and a reversal learning phase (6 days) where the platform was moved
to the opposite quadrant to asses rigidity and perseveration. In the modified version of the
experiment (Fig. 3.3B) five additional days of delayed matching to place (DMP)185 were
included to test perseveration in a more challenging task (platform in a different location
every day).
Memory recall was assessed in probe tests (1 day) in which the platform was removed and
mice were allowed to swim in the pool for 90 s in a single trial. The time and distance spent
in TQ were recorded. Probe tests were performed after initial and reversal learning and a
remote probe test 1 month later (remote test not done if DMP was included).
Hot plate (HP) Thermal pain sensitivity was assessed by putting mice on a hot plate preheated to
52 ◦C. The latency until licking the hind paws or jumping was measured. Afterwards animals
were immediately removed from the hot plate and put on a metal top to cool down their paws.
Pain threshold Pain sensitivity to electric shocks was measured in the TSE System that was
used for Fear conditioning. Animals were placed on the shock grid and a series of 2 s
electric shocks of different intensities (0.1–0.7 mA) was applied. The shock intensities were
presented in a randomized order and with randomized intervals between them. The animals
were observed and the lowest shock intensities that induced reaction (jumping, vocalizing)
were noted.
Statistical analyses of behavioural profiles
All behavioural data were initially analysed using t-tests, Mann-Whitney tests, t-tests with Wesch
correction or Two-way ANOVA, when appropriate. For MWM RM Two-way ANOVA was applied.




wtIR 28 male C57Bl/6N mice (Charles River, Suzfeld, Germany) housed in IR (n=15) or EE
(n=13) from the age of 4 weeks and subjected to behavioural testing from the age of 8 weeks.
Order of tests: OF, HB, LD, TST, EPM, HP, Y-Maze, FC
wtSD 29 in-house-bred male C57Bl/6N mice at the age 4-5 weeks were subjected to either EE
(n=14) or SD (n=15) for 3 weeks and then subjected to behavioural testing. All experimental
procedures for this cohort were performed by Ananya Chowdhury during her lab rotation
under my supervision.
Order of tests: OF, LD, HB, EPM, TST, Social Interaction, Radial Arm Water Maze, Social
Avoidance, FC, HP.
Tcf4tgIR-EE-young or Tcf4tg Young cohort. 59 male Tcf4tg and wt mice on C57Bl/6N× FVB/N
background were housed in IR or EE from the age of 4 weeks and tested from the age of
8 weeks. The cohort consisted of 16 wt IR, 15 Tcf4tg IR, 16 wt EE and 12 Tcf4tg EE animals.
Testing was performed in cooperation with Dr Magdalena M. Brzózka1.
Order of tests: LD, OF, HB, Y-maze, PPI, Social Interaction, TST, FC, HP, MWM, pain
threshold.
Tcf4tgIR-EE-aged or Ageing cohort. 59 male Tcf4tg and wt mice on C57Bl/6N×FVB/N back-
ground were housed in IR or EE from the age of 4 weeks and tested from the age of 12 months.
The cohort consisted of 14 wt IR, 16 Tcf4tg IR, 13 wt EE and 16 Tcf4tg EE animals.
Order of tests: LD, EPM, OF, HB, Y-maze, Social Interaction, TST, Grip strength, FC,
MWM, remote FC, HP.
Tcf4C# 1 30 male mice (14 wt, 16 Tcf4C) on C57Bl/6N background were housed in IR from
4 weeks of age and tested from the age of 10–13 weeks. The animals were not the same age –
difference between the oldest and the youngest animals was 3 weeks – but there was no age
bias between the genotypes. Based on our experience with Tcf4tg mice, IR was chosen to
enhance the potential phenotype of the knockouts.
Order of tests: LD, EPM, OF, HB, Y-maze, Social Interaction, TST, FC, MWM (variant
with DMP), PPI, remote FC, HP.
3.1.4 Behavioural profiling of mice
Our approach was described in details in our article Data calibration and reduction allows to
visualize behavioural profiles of psychosocial influences in mice towards clinical domains 178. The
data were analysed in collaboration with Dr. Dörthe Malzahn (Department of Genetic Epidemiology,
University Medical Center, Georg-August University, 37099 Göttingen, Germany). Analyses were
done in R software version 2.15.2 using R-package nlme and R-functions gls and anova. Graphs
were generated using R-package plotrix, exported as .eps files and edited in Adobe Illustrator CS5.
The procedure below is described for comparison of two wt cohorts: IR vs. EE-1 and SD vs. EE-2
(see “Behavioural cohorts” on page 23). The analysis involved several steps (see Fig. 3.4):
1Dept. Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany
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1. Directionality Different behavioural parameters, called measures, are expressed in different
units (i.d. seconds, meters, indexes etc.). To allow comparisons, each of the 14 measures was
given an arbitrary sign, such that higher values indicate improved performance and lower
values indicate impairments (Fig. 3.4 panel 2). All raw data were multiplied by 1 or −1
according to the assigned directionality. The signs of all measures are presented in Tab. 3.1
(column Dir.).
2. Data calibration Experimental groups were calibrated to appropriate controls (i.e. IR group to
EE-1 and Tcf4tg to wt) using z-transformation. After this procedure the means of control
groups were set as zero and the values of experimental groups were relative to the controls
(Fig. 3.4 panel 3).
3. Reduction to traits The measures of the same behaviours were merged into single sum scores
called traits, e.g. exploration time and nose pokes in HB were compressed to HB-exploration
(Fig. 3.4 panel 4). Consequently, we reduced the number of dimensions from 14 measures to
11 domains.
4. Reduction to domains Traits reflecting similar behaviours were analysed together as single
domains by using multivariate statistics (Fig. 3.4 panel 5), e.g. OF-time in the centre, Dark
preference and EPM-anxiety were analysed collectively as Anxiety. In the wt IR–SD study,
we reduced the number of dimensions to 6 domains. To analyse bigger data sets, i.e. Tcf4tg
and Tcf4C mice, the reductions were made even further into Superdomains and Symptom
classes (see Table 3.1), which could be compared to clinical symptom classes of psychiatric
patients.
5. Visualisation of behavioural profiles Calibrated data from different levels of reduction can be
visualised in a single figure by plotting them in a radar chart. Thin black line indicates EE,
which is set to zero and coloured lines indicate experimental groups in reference to EE —
here IR in blue and SD in red. Such plots can be then overlaid to compare their profiles and
the strength of alterations (Fig. 3.4 panel 6 and Fig. 4.9).
6. Severity scores To compare the overall level of impairment between experimental groups, we
calculated severity scores, which were average squared treatment effects that were calculated
on the trait level, but can be also calculated on other levels. Higher scores indicate greater
difference from the reference group (improvement or impairment).
Statistical comparisons by 1-way ANOVA were done in a hierarchical order — first on the domain
level and then, if significant, on lower levels. This approach reduced the loss of statistical power
caused by correction for multiple testing.
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Figure 3.4: Creating behavioural profiles of mice. Panel 1: Two cohorts were analysed. In cohort 1
IR (blue) was referred to EE-1 control (black); in cohort 2: SD (red) was referred to EE-2 (black). Raw
data had different units and scales, partially due to experimenter effects. Bar graphs represent mean with
standard deviation. Panel 2: Raw data were assigned directionality such that higher values indicate improved
performance. Panel 3: Data were calibrated within cohorts by z-transformation with EE controls set as
zero. Boxplots represent means, interquartiles and range of data. Panels 4 and 5: Calibrated data were
reduced (merged) to traits and domains by summarizing measures into single sum scores (measures to traits)
or by multivariate statistics (traits to domains). Panel 6: Behavioural profiles of calibrated effect sizes
(deviances from EE: black line) were plotted in radar charts. IR (blue) or SD (red) deviations from the black
line towards the middle of the chart indicate impairments. Abbreviations: isolation rearing (IR), social
defeat (SD), enriched environment (EE), Open field (OF), Hole board (HB), Hot plate (HP). Figure adapted
from Badowska et al178.
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Table 3.1: Directionality and dimension reduction. To analyse huge behavioural data sets, we applied
the strategy of synchronizing data and grouping them into hierarchically organized dimensions (Traits,
Domains, Superdomains and Symptom classes) based on similarity of measured behaviours. In the first step
all behavioural parameters (Measures) were given arbitrary directionality 1 or −1 (column Dir.), which
determined that higher values of the raw data would always mean better performance in a given test. Measures
of the same behaviours (e.g. time moving and distance) were merged into Traits and then grouped into
hierarchical categories: Domains, Superdomains and Symptom classes. The last category refers to the three
symptoms classes of psychotic patients5.
Abbreviations: Fear conditioning (FC), Morris water maze (MWM), Open field (OF), Light-dark preference
(LD), Elevated plus maze (EPM), Hole board (HB), Tail suspension test (TST), Hot plate (HP)
Superdomain Domain Trait Measure Dir.
Symptom class: COGNITIVE
Fear memory
Context memory Context memory FC: context 1
Remote context memory FC: remote context 1
Cue memory
Cue memory FC: cue 1
Remote cue memory FC: remote cue 1
Social fear memory
Remote social fear memory remote social avoidance -1




MWM-recall MWM: probe test’ 1
MWM-remote recall MWM: probe test” 1
Perseveration MWM-reversal learning
MWM: reversal learning (latency) -1
MWM: reversal learning (distance) -1
Spatial learning
MWM: initial learning
MWM: initial learning (latency) -1
MWM: initial learning (distance) -1
MWM-visible platform
MWM: visible platform (latency) -1
MWM: visible platform (distance) -1
Working memory Y-maze-alternations Y-maze: altenations 1
Symptom class: NEGATIVE
Anxiety
Thigmotaxis OF: time in centre 1
Dark preference LD: time in dark -1
EPM-anxiety
EPM: time in open arms 1
EPM: time in closed arms -1
Curiosity
Curiosity OF: rearing 1
HB-exploration
HB: exploration time 1
HB: nose pokes 1
Motivation
LD-latency LD: latency to enter dark -1
TST-motivation TST: fighting time 1




Y-maze-choices Y-maze: choices 1
HB-ambulation HB: time moving -1
LD-ambulation LD: crossings -1
OF-ambulation
OF: time moving -1
OF: distance -1
Speed OF-speed OF: speed -1





Animals were genotyped by polymerase chain reaction (PCR) with tail DNA used as template.
MGB tail prep Tails were incubated overnight in the MGB buffer with Proteinase K at 55 ◦C with
shaking. Next day the samples were incubated 20–30 min at 90 ◦C and diluted 1:1 with water.
Chlorophorm extraction Tails were incubated in 400 µl of extraction buffer and 20 µl 0.5 mg/ml
Proteinase K 40 min at 56 ◦C. Next, 75 µl of 8 M potassium acetate and 400 µl of chlorophorm
were added. Samples were mixed and centrifuged 10 min at 13000 rpm, at room temperature.
200 µl of the upper phase was transferred to a fresh tube with 400 µl cold 100% ethanol.
Tubes were inverted 10 times and centrifuged 10 min at 13000 rpm, at room temperature.
Supernatant was removed and DNA pellets were air dried and resuspended in 200 µl TE
buffer.
1 µl of the tail DNA extract was used for 20 µl PCR. Genotyping reactions (Table 3.2), were
performed using the programs presented in Table 3.4 and the master mixes in Table 3.3. PCR
products were loaded on 1.5–2% agarose gels in TAE buffer and separated by electrophoresis. DNA
was visualised with ethidium bromide (around 1 µg/ml in the gel) or 1× GelRed in the samples,
under UV light. Representative gel pictures (GelRed) are shown in Fig. 3.6. Genotyping primer
sequences are listed in Table 3.2.
Figure 3.5: Genotyping strategy of the Tcf4 knockout mouse lines Animals were genotyped by PCR
using DNA from tail biopsies. The primer IDs and locations are indicated in the pictures.
Table 3.2: Genotyping primers. Genotyping of alleles marked with (*) require chlorophorm DNA isolation.
For others, MGB protocol was used. Column Prog. indicates which PCR program from Tab. 3.4 is
appropriate.
Allele fwd fwd 5’– 3’ sequence rev rev 5’– 3’ sequence Band
[bp]
Prog.
EllaCre 4192 CAGGGTGTTATAAGCAATCCC 4193 CCTGGAAAATGCTTCTGTCCG 550 60 ◦C
Sry 28741 GTGAGAGGCACAAGTTGGC 28742 CTCTGTGTAGGATCTTCAATC 147 SRY
TAP tag 4873 TCATAGCCGTCTCAGCAGCCAACCGC 4872 CATCGTGTTGCGCAAGAGCCGCGG 140 TAP tag
Tcf4C 29647 TCAGCCATATCACATCTGTAGAGG 30030 AAATGACTTCCCGCCAGAC 497 60 ◦C
Tcf4F* 24897 AGGCGCATAACGATACCACGAT 24395 GAACCAGGCACAGGGCTAC 464 60 ◦C
Tcf4E 26828 CCGATGACAGTGATGATGGT 26827 TCGTGGTATCGTTATGCGCC 172 TCF4
Tcf4 wt* 26828 CCGATGACAGTGATGATGGT 26829 AAGTTAAGCTGAAGTAAATACCCACA 300 TCF4
TYFB 4858 CGCTGAACTTGTGGCCGTTTACG 4859 TCTGAGTGGCAAAGGACCTTAGG 300 TYFB
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Table 3.3: PCR master-mixes
TAP tag
gDNA 1 µl
primer 4872 0.1 µl








primer 28741 1 µl








primer 29647 1 µl








primer 24897 0.1 µl








primer 26827 1 µl
primer 26828 0.5 µl








primer 4858 0.5 µl






Table 3.4: Standard PCR programs
TAP tag PCR program
95 ◦C 3 min
68 ◦C 30 s
72 ◦C 60 s 36×
95 ◦C 30 s
68 ◦C 1 min
72 ◦C 10 min
10 ◦C pause
SRY PCR program
95 ◦C 3 min
60 ◦C 30 s
72 ◦C 60 s 36×
95 ◦C 30 s
68 ◦C 1 min
72 ◦C 10 min
10 ◦C pause
60 ◦C PCR program
95 ◦C 3 min
60 ◦C 30 s
72 ◦C 60 s 36×
95 ◦C 30 s
68 ◦C 1 min
72 ◦C 10 min
10 ◦C pause
TCF4 PCR program
94 ◦C 5 min
94 ◦C 30 s
58 ◦C 30 s 34×
72 ◦C 45 s
72 ◦C 5 min
10 ◦C pause
TYFB PCR program
94 ◦C 3 min
94 ◦C 30 s
60 ◦C 30 s 36×
72 ◦C 60 s




Figure 3.6: Genotyping PCR electrophoresis. Products of genotyping PCRs were separated by electro-
phoresis in agarose gels and visualised using ethidium bromide or GelRed under UV light. Photographs
show representative genotyping gels for: A) TAP tag, B) Tcf4E (172 bp) and wt allele (300 bp), C) Tcf4C
allele, D) Tcf4F allele.
3.2.2 Tissue isolation and processing
All animal studies have been approved by the appropriate ethics committee of Lower Saxony and
were performed in line with the ethical standards in Declaration of Helsinki (1964) and its later
amendments. Animals were anesthetised with chloroform and sacrificed by cervical dislocation,
unless stated differently. Brain tissues were isolated, frozen on dry ice and stored at −80 ◦C.
Blood treatment and hormone measurements
Blood samples were collected by cardiac puncture from chlorophorm-anesthetised mice.
Serum Blood samples were stored overnight at 4 ◦C to coagulate. The next day they were
centrifuged 20 min at 1000×g at 4 ◦C. The supernatant – serum – was transferred to fresh
tubes, stored at 4 ◦C overnight and used for ELISA.
Plasma Blood was transferred to tubes containing 12 µl of 50 mg/ml EDTA, mixed and centrifuged
15 min in 3000 rpm at 4 ◦C. Supernatant was kept on ice until measurement on the same day.
Corticosterone, adrenaline and noradrenaline Mass spectrometric measurements in plasma
were performed by Dr rer.nat Frank Streit2.
β -endorphin Cloud-Clone Corp ELISA Kit (cat.no. CEA806Mu) was used to measure β -endor-
phin in serum of IR (n=5) and EE (n=6) mice. The test was performed according to the
manufacturers instructions. Serum samples were measured in triplicates and standard curve
in quadruplicates. Absorbance was detected at the wave length 450 nm in BioTek Eon
microplate reader with correction for volume differences. The standard curved and β -endor-
phin concentrations were calculated using BioTek software.





To isolate proteins and nucleic acids, tissue samples were homogenized in fresh sucrose buffer
(250–300 µl per sample) using the Polytron Hand homogenizer. 100 µl of the lysate was transferred
to a tube containing 600 µl RLT buffer (Qiagen), mixed and kept at room temperature until they
were stored at −80 ◦C for RNA analysis. The rest of the lysate, used for protein analysis, was
kept on ice. Unless transmembrane proteins were analysed, the protein lysates were centrifuged
5 min at 13000 rpm and 4 ◦C. Supernatant was transferred to fresh tubes. Protein concentration
was measured in 1:5 dilutions in sucrose buffer, using the Biorad kit. BSA dilutions in sucrose
buffer were used as a standard curve. Proteins were then appropriately diluted with water to obtain
equal concentrations between the samples. Finally the diluted proteins were mixed with 4×NuPage
loading buffer and 10×DTT and incubated 10 min at 70 ◦C. Undiluted proteins were stored at
−80 ◦C and proteins in sample buffer were stored at −20 ◦C.
3.2.3 RNA analysis
RT-qPCR
The procedure of reverse transcription quantivative polymerase chain reaction (RT-qPCR) involved:
1) tissue homogenization (see section 3.2.2 above); 2) RNA purification; 3) RNA precipitation
(optional); 4) complementary DNA (cDNA) synthesis; 5) quantitative PCR.
RNA purification RNA was purified with the RNeasy kit (Qiagen). All steps were performed at
room temperature and filtered tips were used during the whole procedure. Samples stored
in RLT buffer were thawed at 37 ◦C , mixed with 700 µl of 70% ethanol and immediately
loaded on the columns provided in the kit. Columns were centrifuged at 1 min at 13000 rpm
and the flow through as discarded. Next, 500 µl of RW1 buffer was loaded and centrifugation
was repeated. Then 500 µl of RPE buffer was loaded, and columns were centrifuged — this
step was repeated once. The flow through was discarded and columns were centrifuged again
2 min at 13000 rpm to dry. Finally the columns were inserted into fresh tubes, 50–100 µl of
RNAse-free water was loaded and columns were centrifuged 1 min at 13000 rpm. To increase
the yield the flow-through was reloaded and on the column and centrifugation was repeated.
From that step RNA samples were kept on ice and stored at −80 ◦C. Concentration and
quality of RNA was measured in 2100 Bioanalyzer (Agilent) using Agilent RNA 6000 Nano
Kit. Only good quality samples (RIN=8 or higher) were included in further experiments.
In case of dorsal root ganglions (DRGs), a fat-rich tissue, RNA was obtained by homogeniza-
tion in 1ml Trizol at room temperature, adding 200 µl chlorophorm, vortexing 15 s, incubating
3 min at room temperature and centrifuging 15 min at 13000 rpm and 4 ◦C. 400–500 µl of
the upper, aqueous phase was transferred to 600 µl of 70% ethanol, vortexed 15 s and loaded
on RNeasy Mini Kit columns (Qiagen). Next series of RW1 and RPE washes were done as
described earlier. RNA was eluted in 60 µl water.
RNA precipitation Desired amount of RNA (e.g. 1 µg) was adjusted with water to the volume of
50 µl . 2 µl of Pellet Paint (Millipore, cat.no. 70748-3) was added to the sample and votexed.
Next 25 µl of 7.5 M ammonium acetate was added and vortexed, followed by mixing the
sample with 180 of ethanol. Samples were centrifuged 15 min at 13000 rpm. Supernatant
was removed, pellet was washed with 70% ethanol and air dried. RNA was resuspended in
4 µl of water for generation of cDNA or in 2 µl of freshly diluted 2 pmol/ µl T7-B-Mix primer
for Illumina sequencing. Samples were kept 10 min on ice to dissolve.
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cDNA synthesis cDNA was synthesized using SuperScript III First-Strand Synthesis System for
RT-PCR (Invitrogen, cat.no. 18080-051). 400–600 ng RNA was used for each 10.5 µl
reaction. 4 µl of RNA was transferred into a PCR tube containing 1 µl of 0.6 pmol/ µl dT-mix
primer (ID 9578) and 1 µl of 120 pmol/ µl N9 random primer (ID 4542) and the mix was
incubated 10 min at 70 ◦C. Next, the tubes were put on ice and to each reaction 2 µl of 5×1st
strand buffer, 1 µl 0.1 M DTT, 0.5 µl deoxynucleotides (dNTPs) (10 mM each) and 1 µl of
superscript III reverse transcriptase (200 U/ µl ) were added. The tubes were incubated in the
thermocycler 10 min at 25 ◦C , 45 min at 50 ◦C and 45 min at 55 ◦C. Afterwards cDNA was
diluted with water and immediately used for qPCR or stored at −80 ◦C.
RT-qPCR The master mix and standard RT-qPCR program are shown in Tab. 3.5. 4 µl cDNA
(typically 1:80 or 1:100 dilution in water) was used as a template. Samples were ampli-
fied in triplicates or quadruplicates and detected in LightCycler 480 (384-well plates) or
7500 Fast Real-Time-PCR System (96-well plates). Ct values and melting curves were ob-
tained using the software provided. Data were normalized to housekeeping genes (Cyc1 and
Rpl13) and expressed in reference to the mean of wt samples (or mean of wt exons 1–2 in








where ε is expression normalized to mean of housekeepers, ε ′ is expression relative to wt, ¯εwt
is the mean normalized expression in wt group, E is the efficiency of qPCR reaction and ∆Ct
is the difference between Ct of a replicate and mean Ct of housekeepers for this sample−10.
Efficiency was determined to compare different Tcf4 exons. To determine efficiency, qPCR
reactions were run with 5 serial logarithmic cDNA dilutions measured in triplicates on a




where E is the efficiency and a is the slope of the efficiency curve. Obtained E values and
primer sequences are shown in Table 3.6. In other cases a typical E value 1.96 was used.
Table 3.5: Standard RT-qPCR
(a)
Stardard RT-qPCR program
50 ◦C 2 min
95 ◦C 10 min
95 ◦C 15 s
40×




primer fwd 0.1 µl






Table 3.6: Primers used for RT-qPCR. In-house IDs are indicated columns fwd ID and rev ID for forwards
and reverse primers respectively. Efficiency of qPCR reactions is indicated in the column E. Primers
for genes marked with a star (*) were designed without intron spanning. Genes marked in bold are the
housekeepers used for reference.
Gene fwd ID fwd 5’– 3’ sequence rev ID rev 5’– 3’ sequence E
Actb 11280 ACGGCCAGGTCATCACTATTG 11281 AGGAAGGCTGGAAAAGAGCC
Adora2a 18619 GGTCCTCACGCAGAGTTCC 18620 TCACCAAGCCATTGTACCG
Atp5b 10568 GGCACAATGCAGGAAAGG 10569 TCAGCAGGCACATAGATAGCC
Avp* 33703 CTACGCTCTCCGCTTGTTTC 33704 GGGCAGTTCTGGAAGTAGCA
Bc1 31920 GTTGGGGATTTAGCTCAGTGG 31921 AGGTTGTGTGTGCCAGTTACC
Bdnf 10659 AATGGGAGGGGTAGATTTCTG 10661 CGCTTTATCAACCAGAATGGA
Cyc1 10572 CAGAGCATGACCATCGAAAA 10573 CACTTATGCCGCTTCATGG
Fos 8879 GAATGGTGAAGACCGTGTCA 8892 TCTTCCTCTTCAGGAGATAGCTG
Npyr1 28528 TCACAGGCTGTCTTACACGACT 28529 TTTCTCCTTTTCAAGCGAATG
Oxt* 33701 CACCTACAGCGGATCTCAGAC 33702 CGAGGTCAGAGCCAGTAAGC
P2ry1 33707 GCAGTCCAGTCTTTGGCTAGA 33708 AGTTTCAACCTTTCCATACCACA
Penk 21048 CCCAGGCGACATCAATTT 21049 TCTCCCAGATTTTGAAAGAAGG
Plxna1 33753 CTCAGATGTGCGCCATACC 33754 TTAATCACATTCACCCAGAAGC
Rpl13 10574 ATCCCTCCACCCTATGACAA 10575 GCCCCAGGTAAGCAAACTT
Tcf4 ex1-2 33456 CATATTTGTGGCCATTGAAGG 25642 GTCCCTAAGGCAGCCATTC 1.95
Tcf4 ex5-6 31143 GGATCTTGGGTCACATGACAA 31144 GCAACCCTGAACGTTTTCTC 1.93
Tcf4 ex7-9 33466 GTATTCAAGCAATAATGCCCG 33467 GGCGAGTCCCTGTTGTAGTC 1.92
Tcf4 ex9-10 3205 CCTAGCTCCTTCTTCATGCA 3200 GCTGATTCATCCCGCTGGAG 1.98
Tcf4 ex15-16 3207 CAGGGTACGGAACTAGTCTT 3202 GAGAGAATGGCTGCCTCTCA 1.76
Tcf4 ex18-19 8756 CTGGAGCAGCAAGTTCGAG 8757 TTCTCTTCCTCCCTTCTTTTCA 2
Top3b 33751 GGTCGCTTTTCCAACGAG 33752 AGACCCAGAACAGCAGCAAT
Vgf 33705 CGACCCTCCTCTCCACCT 33706 CCCAACCCCTGGATCAGTA
Illumina sequencing
Preparation of RNA samples for Illumina sequencing was done according to the protocol described
in186 and performed by Dr Elena Ciirdaeva3. In brief, double-stranded cDNA was synthesized and
used for antisense RNA (aRNA) generation. Based on aRNA, another round of cDNA amplification
was performed and Illumina adaptors were added by PCR. Such prepared sample library were sent
to the Max-Planck Genome Centre in Cologne, Germany and single-end sequencing was performed
in Illumina Sequencer HiSeq2500 (type TruSeq RNA) with Phix control and 20 000 000 required
reads. All sequencing data analyses were carried out by Nirmal Kannaiyan4. Reads were barcode
sorted, quality analyzed and mapped to to UCSC Mm10 reference genome using Tophat1187,
which allows for split mapping against splice junctions. Expression abundance estimates and
differential gene expression analysis were computed using Cufflinks188. Gene set enrichment
analysis (GSEA)189,190 was performed using the gene expression values using the GO gene sets.
This pipeline of analysis was performed using a local installation of GenePattern genome analysis
platform191. Gene set size filters were set to minimum of 5 and maximum of 500 and false discovery
rate (FDR) was set to 25%.
3Dept. Neurogenetics, Max-Planck-Institute of Experimental Medicine, Göttingen, Germany
4Department of Psychiatry and Psychotherapy, Ludwig Maximilian University of Munich, Germany
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3.2.4 Synaptosome isolation and proteome analysis
Synaptosomes were isolated according to a modified protocol from Gray & Whittaker192,193 in
cooperation with Dr Magdalena M. Brzózka5 and Dr Christoph Biesemann6. All centrifuga-
tion steps were done at 4 ◦C and samples were kept on ice between steps. 4 weeks old male
TMEBBl6 mice (Tcf4tg n=4, wt n=4) were sacrificed and PFC (600–900 mg) was isolated,
washed with ice-cold PBS and homogenized 10 times by 12–15 up and down strokes in
900 µl of ice-cold buffer A suplemented with phosphatase inhibitor coctails I and II (Sigma,
1 µl per 100 µl buffer). Left PFC was pooled within genotypes in 900 µl buffer A and right
PFC was treated individually for each animal. Homogenate was centrifuged at 3200 rpm
for 10 min. Supernatant (S1-nuclei) was transferred to a different tube using a 200 µl pipette
with a cut tip and kept on ice. Pellet (P1-cell debris) was resuspended in 800 µl of buffer A
(without phosphatase inhibitors) and centrifuged at 3200 rpm for 10 min. Supernatant S1’
was combined with S1 and 100 µl S1 was saved for further analysis. Pellet (P1) was resus-
pended in 800 µl buffer A and 100 µl was saved for further analysis. The supernatant S1 was
centrifuged at 11500 rpm for 15 min and 100 µl of supernatant (S2) was saved. Pellet (P2)
was carefully resuspended with a pipette in 1 ml of homogenization buffer (0.32 M sucrose)
and pipetted on top of a discontinuous sucrose density gradient (from bottom: 4 ml 1.2 M,
4 ml 1 M and 3 ml 0.8 M) and centrifuged in and Ultracentrifuge with rotor Sv40Ti 2 h at
25000 rpm. The synaptosomal fraction, obtained from 1.2–1 M interphase, was diluted 1:1 in
water (water added drop by drop with mixing) and centrifuged 20 min at 30000 rpm with rotor
TLA 100.3 in polyallometer centrifuging tubes 13× 51 mm. The pellet (S4, synaptosomes)
was resuspended in 10 µl water for proteomic or in 50 µl for western blotting and stored at
−20 ◦C.
Proteome analysis of cytosolic fractions (S1) and synaptosomes (S4) and the western blots were
performed in collaboration with Dr Daniel Martins-de-Souza7, according to his established
protocol194. In brief: samples (100 µg total protein) underwent isotope-coded protein labeling
(ICPL)195 and 50 µg proteins were prefractionated by on a 12% SDS-PAGE minigel. Shotgun
mass spectrometry was performed and proteins were identified using an in-house version
of MASCOT Distiller 2.2.3 software (Matrix Sciences, London, UK) and searched against
a decoy Uniprot mouse protein database (release 2012 06). Proteins were considered as
differentially expressed when they had more than 2× fold change or 1.5–2× when quantified
by minimum 5 peptides. Then, proteins were divided to classes based on Human Protein
Reference Database http://www.hprd.org196.
Western blot analysis was done using 10 µl of protein extracts run individually on 12%
SDS-PAGE minigels and transferred on PVDF membranes. Proteins were detected using
primary antibodies against CamKII, VAMP1, VAMP2 and HOMER1 (SySy) followed by
anti-c-MYC-peroxidase antibody (GE Healthcare, Uppsala, Sweden), incubated with ECL
solutions and scanned in a Gel DocTM XR+ System (BioRad).
3.2.5 Western blotting
Samples (prepared as in section 3.2.2 on page 30) and the protein ladder were loaded on a NuPAGE
Novex 4–12% Bis-Tris Protein Gels and run in the MES buffer at constant voltage 200 V. Next,
the proteins were transferred on a PVDF membrane in the NuPAGE transfer buffer at 30 V for
2.5–3.5 h. Afterwards the membrane was rinsed with TBS-T, blocked in 5% milk in TBS-T for
5Dept. Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany
6Dept. Molecular Neurobiology, Max Planck Institute of Experimental Medicine, Göttingen, Germany
7Department of Psychiatry, Ludwig Maximilians Universität, Munich, Germany
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30 min and incubated with the primary antibody overnight at 4 ◦C. The next day the membrane was
washed 3–5 times with TBS-T (5–10 min each wash), incubated for 1 h at room temperature with
the secondary antibody, washed 5–6 times with TBS-T. Membranes were incubated 30 s with ECL
solutions and imaged in the Intas developer.
3.3 Morphological analyses
3.3.1 Electron microscopy
Sample preparation Samples were prepared by Torben Ruhwedel8. Mice were anaesthetized
with avertin (SigmaAldrich,) and perfused with 15 ml of Hanks balanced salt solution (HBSS,
PAA laboratories, Pasching, Austria) and then by fixative as described in197 using a Heidolph
PD5201 Peristaltic Pump. The brain tissue was dissected and 200 µm coronal sections were
cut with a Leica VT1200S Vibratom (Leica Microsystems, Wetzlar). The medial orbitofrontal
cortex (MO), anterior cingulate cortex (ACC) and cortex transversal areas (Fig. 4.3A–C) were
punched out of the section by using a 2 mm Harris Uni-core Punch. After postfixation with 2%
OsO4 (Science Services, Munich, Germany) and dehydration with ethanol and propylenoxid
(automated system EMTP Leica Microsystems, Wetzlar) samples were embedded in Epon
(Serva) and cut in the microtome (Ultracut S, Leica). Semi-thin (500 nm) and ultra-thin
(50 nm) sections were prepared using diamond knifes (Histo 45◦and Ultra 45◦, Diatome
Biel CH). Semi-thin sections were collected onto a glass slide and dried on a 60 ◦C hot
plate to verify the area of interest by using a Leica Dialux 20 light-microscope. Ultra-thin
sections were placed on 100 mesh hexagonal copper Grids (Gilder Grids Ltd. Grantham
UK) coated with “Formvar” (Plano Wetzlar) and stained with Uranylacetat (SPI-Chem West
Chester,USA) and Lead citrate (Merck, Darmstadt)(REYNOLDS, 1963). Ultra-thin sections
were analyzed using a Zeiss EM900 Elektron-Microscop (Zeiss, Oberkochen, Germany)
with the 3000×, 12000× and 30000× magnification. Digital pictures were taken by the
wide-angle dual speed 2K-CCD-Camera (TRS, Moorenweis, Germany). Photos of of the
transverse cortical sections were taken by Bogusława Sadowska.
Image analysis Pictures of MO and ACC regions were taken under 12000× and 30000× mag-
nifications. Total number of synapses, perforated synapses and mitochondria was counted
within 20 randomly taken images under 12000× magnification. The synapse structure was
analysed under 30000× magnification with 50 synapses per animal. The average length
and width of the active zones, number of synaptic vesicles per synapse and the synaptic
vesicle cluster density (number of vesicles divided by the area they occupy) were calculated
separately for symmetric and asymmetric synapses. Additionally the average distance of the
vesicles from the active zone was measured using the Concentric Circles plugin for ImageJ
software: 5 differently sized circles with the centre in the middle of the active zone were
overlaid on the synapse images. Circles divided the synapse area into 5 zones, each 100 nm
wide. Zone 6 is the area outside of the biggest circle, more than 500 nm away from the active
zone. The number of vesicles in each zone was counted for each synapse and the averages
were calculated. 30000× pictures were analysed for 6 wt animals and 4 Tcf4tg animals and
12000× pictures were analysed for n=6 per group.
8Electron Microscopy facility, Max Planck Institute of Experimental Medicine, Göttingen, Germany
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3.3.2 High-resolution microscopy via STED nanoscopy
The stimulated emission depletion (STED) nanoscopy experiment was performed in collaboration
with Dr Payam Dibay9. To analyse spine morphology, TMEB mice were bred to TYFB mice
that express EYFP in postnatal forebrain under Thy1.2 promoter179,198. TMEBBl6×TYFB mice
were aesthetised by intraperitoneal injections of pentobarbital (120 mg per kg body weight) and
Buprenorphine (2 µg) and perfused with 4 % PFA in 0.1 M phosphate buffer (pH 7.4). After an
overnight postifxation in 4 % PFA at 4 ◦C, the brains cut on Vibratome into 70 µm sections. Images
of spine morphology were taken in ACC using a home-built STED microscope. Recording of
image stacks x-y-z (18 µm× 18 µm× 3 µm) was performed with a STED resolution around 60 nm
and pixel dwell time of 10 µs. Images of dendrites parallel to the slice surface were processed using
the “Simple Neurite Tracer” function of ImageJ or Fiji software.
TMEBBl6×TYFB male mice were analysed at the age of 4 weeks (wt n=5, Tcf4tg n=7; 19 dendrites
per mouse) and 12 weeks housed under control condition (wt n=4, Tcf4tg n=4; 15 dendrites per
mouse) or subjected to social defeat (wt n=7, Tcf4tg n=11; 12 dendrites per mouse).
3.4 Electrophysiology
LTP and LTD in hippocampus Tcf4tg and wt TMEBBl6 animals were sacrificed at the age of
4–5 weeks and LTP and LTD were measured in transverse hippocampal slices. Schaffer
collateral afferents were stimulated and field excitatory postsynaptic potentialss (fEPSPs)
were measured in the stratum radiatum of CA1 with a GABA inhibitor. e-LTP was induced
by 1 s of high frequency stimulation and LTD by applying low frequency stimulation for
15 min. fEPSP slopes were expressed relative to normalized baseline. For Input-output curves
mean fEPSPs from three consecutive responses were used. The data were analysed using
t-test. The experiment was performed in collaboration with Dr Jeong Seop Rhee10.
9Dept. Neurogenetics, Max Planck Institute of Experimental Medicine, Göttingen, Germany





TO ASSESS Tcf4 FUNCTIONS in adult murine brain, we combined gain-of-function (Tcf4overexpression in Tcf4tg mice) and loss-of-function approach (Tcf4 knockout line Tcf4C).To exclude the developmental aspect of Tcf4 function, we analysed Tcf4tg mice that
overexpress Tcf4 in neurons of postnatal brain, under Thy1.2 promoter57. Due to the big gene
size (343.5 kb), the mice overexpressed not the full Tcf4, but a tagged open reading frame. In all
experiments with Tcf4tg mice, we used animals on C57 × FVB background, since hybrid strains are
considered as healthier than inbred strains180. We performed analyses on molecular, cellular as well
as behavioural level. The knockout strain was generated from the Tcf4 Eucomm line Tcf4E on C57
background. Therefore all analysed Tcf4C animals were on C57 background. In all experiments
described below, we used Tcf4tg or Tcf4C male mice. Unless stated differently, in molecular and
cellular experiments, we analysed them at the age of 4 weeks, because the postweaning period is a
critical developmental window in rodents144. Behavioural experiments were performed on older
animals.
4.1 Molecular and cellular analyses in Tcf4tg mice
4.1.1 Electrophysiology: enhanced LTD in Tcf4tg mice
Since Tcf4tg mice exhibit cognitive deficits57, we tested they show any alterations in synaptic
plasticity. To do this, we performed electrophysiological recordings in collaboration with Dr Jeong
Seop Rhee1. We used 4–5 weeks old animals. Early phase LTP (e-LTP) and LTD were measured
in hippocampal slices, in the CA1 region upon stimulation of Schaffer collaterals (28 Tcf4tg and
32 wt animals were used for the e-LTP experiment and 24 Tcf4tg and 15 wt were used for the
LTD experiment). Overall e-LTP was unaltered, but during the first 15 min after stimulation it
tended to be higher in the Tcf4tg mice (Fig. 4.1A). LTD was significantly enhanced in the Tcf4tg
animals (p<0.001)(Fig. 4.1B). Finally, we checked the input/output curves, which were comparable
between the genotypes (Fig. 4.1C). This suggests that Tcf4 overexpression did not change basal
receptor levels in the hippocampal synapses.
1Dept. Molecular Neurobiology, Max Planck Institute of Experimental Medicine, Göttingen, Germany
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Figure 4.1: LTP and LTD in hippocampal CA1 of Tcf4tg mice. A) Early phase LTP (first 40 min after
stimulation of Schaffer collateral) was unchanged in Tcf4tg mice (Tcf4tg n=28, wt n=32). However, during
the first 15 min Tcf4tg mice showed an increase of LTP. B) LTD was enhanced in Tcf4tg mice compared to wt
(p<0.001)(Tcf4tg n=24, wt n=15). C) The input/output curves are unaltered in Tcf4tg mice. Abbreviations:
long-term potentiation (LTP), long-term depression (LTD), field excitatory postsynaptic potentials (fEPSP)
4.1.2 STED: increased spine frequency in Tcf4tg mice
Spine morphology, frequency and density were analysed with STED microscopy in PFC of 4 weeks
old Tcf4tg and wt male mice. Frequency of five types of spines were assessed: filipodium/stripe,
stubby/stump, mushroom/racket, cup/sickle and branch. Tcf4tg mice displayed no obvious changes
in spine morphology (Fig.4.2A), but increased overall number (p=0.0055, two-way ANOVA) and
frequency (p=0.0303, Mann-Whitney test) of spines (Fig.4.2B,G). However, no alterations in spine
morphology and frequency were observed in 12 weeks old Tcf4tg mice neither in control condition
nor after social defeat (Fig.4.2C–F).
4.1.3 Electron microscopy: unchanged synapse morphology in Tcf4tg mice
To confirm the increased number of spines observed in STED microscopy (see: section refsec:spines-
results) and myelin alterations in RNA sequencing (RNAseq), we analysed 4 weeks old Tcf4tg
(n=5) and wt (n=5) male mice with the use of electron microscopy. We looked at several parameters:
number of excitatory synapses, percentage of perforated synapses, average length and width
of active zones, number of synaptic vesicles (SVs) per synapse, synaptic vesicle cluster density,
number of mitochondria, number of myelinated axons and myelin thickness (Fig. 4.3). Hippocampal
knockdown of mir137, an upstream regulator of Tcf434, increases distances of SVs from the active
zone (personal communication with Sandra Siegert2). Therefore, we analysed the SVs distances
in Tcf4tg mice, by using the concentric circles function in ImageJ software. We observed no
significant difference in any of the parameters (Fig. 4.4).
2Dept. of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, UK
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Figure 4.2: Spine analysis in Tcf4tg mice. Spine density (mean spine number per dendrite) and morphology
in PFC were analysed using STED microscopy in collaboration with Dr. Payam Dibaj. Animals at the age of
4 weeks (wt n=5, Tcf4tg n=7) and 12 weeks under control (wt n=4, Tcf4tg n=4) or social defeat conditions
(wt n=7, Tcf4tg n=11) were used. A) Spine morphology at 4 weeks. B) Spine density at 4 weeks was
increased in Tcf4tg mice (p=0.0055, two-way ANOVA). C) Spine morphology at 12 weeks in control mice.
D) Spine density at 12 weeks in control mice. E) Spine morphology at 12 weeks. F) Spine density 12 weeks
after SD stress. G) Total spine frequency was increased in Tcf4tg mice at the age of 4 weeks (p=0.0303,
Mann-Whitney test) but not at 12 weeks neither in control nor in SD stress group.
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Figure 4.3: Electron microscopy. Synapse morphology in Tcf4tg mice was examined in: A) anterior
cingulate cortex (ACC) and B) medial orbitofrontal cortex (MO). C) Myelin abundance was analysed in
cortical transverse sections. D–E) Exemplary asymmetric synapses in a wt (n=5) and Tcf4tg animals (n=5).
F–G) Exemplary symmetric synapses in a wt and Tcf4tg animal. H) The length (I) and width (II) of synaptic
active zone and area occupied by synaptic vesicles (III) were measured. I) Distances of synaptic vesicles
from the active zone were measured by counting numbers of synaptic vesicles in each of the 6 zones marked
by the red concentric circles. J) Numbers of mitochondria were counted in ACC and MO. Picture shows an
exemplary mitochondrion. K) Myelin thickness was measured in the cortical transverse region.
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Figure 4.4: Synapse morphology in Tcf4tg mice. A) Total number of synapses within 20 random pictures.
B) Percent of perforated synapses within all counted synapses. Because the numbers of symmetric synapses
were too low, further analysis was done only on asymmetric synapses. C) Mean width D) and length of the
active zones. E) Mean number of synaptic vesicles (SVs) per synapse. F) Mean SVs cluster density. G) Mean
distances of SVs from the active zone in anterior cingulate cortex (ACC) and in H) medial orbitofrontal
cortex (MO). Zones 1–5 represent distances within 100–500 nm from the active zone; zone 6 contains all
SVs that are more than 500 nm away from the active zone. I) Total number of mitochondria counted within
20 random pictures. J) Total number of myelinated axons in the transversal coronal section within 20 random
pictures. K) Mean myelin thickness in transverse coronal sections.
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4.1.4 RNA sequencing in Tcf4tg mice
We performed RNAseq of total mRNA isolated from PFC and hippocampal tissue of Tcf4tg and wt
mice at the age of 4 weeks. The samples contained both male and female mice with a gender bias,
therefore sex-related genes Xist (inactive X specific transcripts ), Uty (ubiquitously transcribed
tetratricopeptide repeat gene, Y chromosome), Ddx3y (DEAD (Asp-Glu-Ala-Asp) box polypeptide
3, Y-linked) and Eif2s3y (eukaryotic translation initiation factor 2, subunit 3, structural gene
Y-linked) were not considered as interesting.
In PFC of Tcf4tg mice only few genes were upregulated (Table 4.1), e.g. Mov10 (Moloney
Leukemia Virus 10, Homolog (Mouse)), and we observed more genes that were downregulated,
including Adora2a (Adenosine receptor 2A), Penk (Proenkephalin), Tac1 (Tachykinin 1 ), Pde10a
(Phosphodiesterase 10a) and Drd1a (Dopamin receptor 1A), Foxp2 (Forkhead box protein P2) and
Mag (Myelin-associated glycoprotein).
Analysis of the hippocampal transcriptome (Table 4.2) revealed upregulation of Top3b (topoi-
somerase (DNA) III beta), Bc1 (brain cytoplasmic RNA 1) and Plxna1 (Plexin-A1) while Ttr
(transthyretin) and Mov10 (Moloney Leukemia Virus 10, Homolog (Mouse)) were downregulated.
Table 4.1: RNAseq: Genes deregulated in PFC of Tcf4tg mice. In 4 weeks old Tcf4tg mice, Mov10 was
upregulated and Adora2a, Penk, Tac1, Pde10a and Drd1a were among the most downregulated genes.
Gene log2 fold change) p-value q-value
upregulated
Uty 2.356857478 0.001467616 1
Ddx3y 1.723449998 0.003841885 1
Eif2s3y 0.760359651 0.01139759 1
Zfp825 0.505726137 0.119585625 1
Smc1b 0.505127544 0.552853233 1
Mov10 0.455759192 0.122597818 1
downregulated
Erdr1 -0.453932657 0.08753336 1
Sez6 -0.457338401 0.003414727 1
Nnat -0.457694739 0.003194241 1
Tbc1d16 -0.461461299 0.000807181 0.994823224
Gm606 -0.465440907 0.00038319 0.708402521
Pkn2 -0.468443581 0.006862101 1
Unc13c -0.468956547 0.047570356 1
Spock3 -0.469166189 0.011697411 1
Mag -0.472136197 0.011366762 1
Nrsn2 -0.480792086 0.000790263 0.994823224
Kcna5 -0.486999425 0.000235968 0.484704209
Rxrg -0.490025564 0.013795055 1
Slc32a1 -0.491767384 0.001923278 1
Eif2s3x -0.519751609 0.000494012 0.761067362
Gad2 -0.525564658 0.031027759 1
Continued on next page
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Gene log2 fold change) p-value q-value
Foxp2 -0.536091408 0.010973279 1
Musk -0.536407446 3.15E-05 0.13148404
Tmem158 -0.546487678 0.004270464 1
Habp2 -0.56130833 0.007219107 1
Inf2 -0.566855678 0.006885522 1
Dgkb -0.567402036 0.000772139 0.994823224
Htr2c -0.580735425 0.003939147 1
Rarb -0.583095508 9.75E-05 0.257547479
Slc25a17 -0.593233112 0.023893995 1
Gnal -0.624961572 8.63E-07 0.006980159
Rgs2 -0.631042192 1.13E-06 0.006980159
Ddx1 -0.634459242 0.03789148 1
Nexn -0.635960819 0.001689473 1
Comp -0.675562054 0.000156554 0.361777556
Pde1b -0.680827771 0.00610263 1
Rasd2 -0.723349409 0.00223994 1
Pou3f4 -0.746025845 4.42E-05 0.136221867
Klhl13 -0.780688718 3.56E-05 0.13148404
Rasgrp2 -0.855435392 0.001321307 1
Tmem90a -0.898297515 0.000909174 1
Gng7 -0.992907322 2.49E-07 0.004598419
Tsix -1.02551036 0.002900251 1
Drd1a -1.050470631 0.012557658 1
Pde10a -1.1368682 0.002083819 1
Gpr88 -1.305308987 0.00547236 1
Ppp1r1b -1.329720023 0.002964721 1
Six3 -1.429692733 0.004368645 1
Tac1 -1.450904913 0.010563382 1
Penk -1.513621123 0.011187743 1
Adora2a -1.806484974 0.010113878 1
Xist -1.97678391 0.000487009 0.761067362
Table 4.2: RNAseq: Genes deregulated in hippocampus of Tcf4tg mice. In 4 weeks old Tcf4tg mice
Top3b, Bc1 and Plxna1 were among the top upregulated genes and Ttr and Mov10 were downregulated.
Gene log2 fold change) p-value q-value
upregulated
Uty 2.442874226 0.001315171 1
Ddx3y 1.724531248 0.005048596 1
Eif2s3y 0.792626035 0.011974287 1
Ptpru 0.649270556 0.123836496 1
Hba-a1 0.610615334 0.435888831 1
Slc16a2 0.587998895 0.117722223 1
Continued on next page
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Gene log2 fold change) p-value q-value
Hba-a2 0.559955061 0.456840867 1
Beta-s 0.514627276 0.45416861 1
Top3b 0.505075697 0.004112155 1
Bc1 0.499641295 0.002435527 1
Plxna1 0.464333382 0.001436315 1
Hbb-b1 0.452633697 0.477009567 1
Gabra2 0.447062357 0.560010346 1
downregulated
Mtbp -0.472120572 0.290811705 1
Sla -0.474072765 0.000776867 1
Lama2 -0.477137387 0.418796431 1
Hells -0.492922504 0.02587771 1
Snx9 -0.501069661 0.014061808 1
Tshz3 -0.508746358 0.00319265 1
Vmn2r37 -0.510533543 0.11145069 1
Ptgds -0.52422796 0.177935037 1
Kremen1 -0.544589284 0.026354096 1
Peg12 -0.550935688 0.052007167 1
Cda -0.560754252 0.000880105 1
Ttr -0.587735293 0.342253302 1
Mov10 -0.610776663 0.053019467 1
Zfp414 -0.621446643 0.021644652 1
Ddx51 -0.629219058 1.97E-06 0.036421
Ccdc75 -0.636729247 0.055702478 1
Ppp2r2b -0.687181646 0.037507286 1
Zfp825 -0.722028253 0.039964472 1
Acaca -0.725513955 0.030772285 1
Lin7b -0.77422458 0.041785881 1
Tsix -0.82256129 0.022262926 1
Zfp248 -0.920663422 0.005238188 1
Slc25a17 -0.955280143 0.000343368 1
1700020D05Rik -1.010106539 0.047582604 1
Xist -1.961134529 0.00124231 1
RT-qPCR of candidate genes in Tcf4tg mice
To validate the RNAseq results we used an independent cohort of 4 weeks old Tcf4tg and wt
male mice (n=3 per group). The cDNAs were prepared by Dr Magdalena Brzózka3 and Nirmal
Kannayian4. The experiment failed to validate the candidate genes found in sequencing of PFC
3Department of Psychiatry and Psychotherapy, Ludwig Maximilian University of Munich, Germany
4Department of Psychiatry and Psychotherapy, Ludwig Maximilian University of Munich, Germany
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and hippocampus (Fig. 4.5A–B). This may be due to the low number of animals or possibly, the
RNAseq results were affected by the gender bias, therefore couldn’t be replicated in the sex-matched
sample used for validation.
Comparison of different housekeeping genes revealed that Actb tended to be higher expressed
in Tcf4tg mice in both PFC and hippocampus. This may be in line with upregulation of cytoskeletal
and actin-related proteins in proteomic analysis (see: section 4.1.5).
Figure 4.5: RT-qPCR with the RNAseq candidates in Tcf4tg mice. Candidate genes from RNAseq were
measured by RT-qPCR in 4 weeks old male Tcf4tg and wt mice (n=3 per group) in A) PFC and B) in
hippocampus. The experiment failed to confirm deregulation of any of the analysed genes. C–D) Rpl13 and
Cyc1 were used as reference genes. Actb was excluded, due to its higher levels in Tcf4tg animals.
4.1.5 Proteome analysis in Tcf4tg mice
The experiment was performed in collaboration with western blots were performed in cooperation
with Dr Magdalena Brzózka5 and Dr Daniel Martins-de-Souza6We analysed protein composition of
synaptosomes (containing pre- and postsynapses) and cytosol in PFC of 4 weeks old Tcf4tg and wt
mice. Several proteins associated with cellular signalling, protein or energy metabolism, transport
and cell growth were differentially expressed. In cytosolic fraction of Tcf4tg mice, we observed
an upregulation of β -tubulins, yet downregulation of cytoskeletal associated proteins. Ribosomal
proteins and GTPases were consistently downregulated (see: Table 4.3) and two vesicle-associated
membrane proteins, VAMP1 (Synaptobrevin 1) and VAMP2 (Synaptobrevin 2), were upregulated
in transgenes 4.72 and 2.69 fold respectively. In synaptosomes, proteins involved in signalling,
oxidoreductases, ribosomal subunits, Ser/Thr kinases and GTPases were mainly upregulated
(see: Table 4.4 in the Appendix on page 49). Among them we found a postsynaptic density
scaffolding protein HOMER1, vesicle-associated VAMP2 (Synaptobrevin 2) and CaMK II alpha
(calcium/calmodulin-dependent protein kinase II alpha subunit) upregulated 7.63×, 2.16× and
1.96× respectively.
CaMK II alpha, HOMER1, VAMP1 and VAMP2 were validated by western blotting in pooled
protein synaptosome or cytosolic protein fractions, as presented in Fig. 4.6. Whole blots are shown
in the Appendix in Fig. 7 on page 107.
5Department of Psychiatry and Psychotherapy, Ludwig Maximilian University of Munich, Germany
6Department of Psychiatry, Ludwig Maximilians Universität, Munich, Germany
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Table 4.3: Proteomics in cytosol. The “fold change” column shows the ratio of tg to wt (values above 1
indicate upregulation, below 1 downregulation). Upregulated proteins are marked in bold.
Gene tg/wt no.
pept.
Description Localisation Biological process Molecular class Molecular function
upregulated






Adapter molecule Receptor signaling complex
scaffold activity





AGAP2 0.2980 2 ArfGAP with GTPase domain, ankyrin repeat and PH
domain 2
Nucleus Cell communication &
Signaling
GTPase GTPase activity
RAC1 0.6192 18 ras-related C3 botulinum toxin substrate 1 (rho family,






RAC3 0.5184 18 ras-related C3 botulinum toxin substrate 3 (rho family,
small GTP binding protein Rac3)
Cytoplasm Cell communication &
Signaling
GTPase GTPase activity
RAP1B 0.3846 7 RAP1B, member of RAS oncogene family Cytoplasm Cell communication &
Signaling
GTPase GTPase activity















Unclassified Molecular function unknown




Unclassified Molecular function un-
known
Srcin1 0.3778 6 p130Cas-associated protein OS=Mus musculus
GN=P140 PE=1 SV=2
unknown Cell communication &
Signaling
Unclassified Molecular function unknown
ABI1 0.4274 2 abl-interactor 1 Cytoplasm Cell growth & mainten-
ance
Adapter molecule Binding
CDH13 0.4002 2 cadherin 13, H-cadherin (heart) Plasma
Membrane
Cell growth & mainten-
ance
Adhesion molecule Cell adhesion molecule activ-
ity
DSC3 3.6364 2 desmocollin 3 Plasma
Membrane
Cell growth & main-
tenance
Adhesion molecule Cell adhesion molecule
activity





ANK2 0.5249 6 ankyrin 2, neuronal Plasma
Membrane





ARPC4 2.1580 26 actin related protein 2/3 complex, subunit 4,
20kDa











INA 0.6382 9 internexin neuronal intermediate filament protein, al-
pha
Cytoplasm Cell growth & mainten-
ance
Cytoskeletal protein Structural constituent of cyto-
skeleton
TUBB 1.5743 17 tubulin, beta class I Cytoplasm Cell growth & main-
tenance
Cytoskeletal protein Structural constituent of
cytoskeleton
CRYM 0.2895 2 crystallin, mu Cytoplasm Cell growth & mainten-
ance
Enzyme: Deaminase Hormone binding
MOG 0.1139 4 myelin oligodendrocyte glycoprotein Extracellular
Space
Cell growth & mainten-
ance
Immunoglobulin Antigen binding
CDK10 0.0682 2 cyclin-dependent kinase 10 Nucleus Cell growth & mainten-
ance
Serine/threonine kinase Protein serine/threonine
kinase activity
ANLN 3.8715 2 anillin, actin binding protein Cytoplasm Cell growth & main-
tenance
Structural protein Structural molecule activity
CLTC 0.4565 46 clathrin, heavy chain (Hc) Plasma
Membrane
Cell growth & mainten-
ance
Structural protein Structural molecule activity
Tubb4a 1.5385 9 Tubulin beta-4 chain OS=Mus musculus
GN=Tubb4 PE=1 SV=3
unknown Cell growth & main-
tenance
Structural protein Structural molecule activity
COTL1 0.1780 2 coactosin-like 1 (Dictyostelium) Cytoplasm Cell growth & mainten-
ance
Unclassified Molecular function unknown
ACLY 0.3295 4 ATP citrate lyase Cytoplasm Energy Metabolism ATPase ATPase activity
ATP6V1D 1.5375 5 ATPase, H+ transporting, lysosomal 34kDa, V1
subunit D
Cytoplasm Energy Metabolism ATPase ATPase activity
PSAT1 0.4838 2 phosphoserine aminotransferase 1 Cytoplasm Energy Metabolism Enzyme: Aminotrans-
ferase
Transaminase activity
GNPDA1 3.9417 2 glucosamine-6-phosphate deaminase 1 Cytoplasm Energy Metabolism Enzyme: Deaminase Deaminase activity




AHCYL1 4.6447 3 adenosylhomocysteinase-like 1 Cytoplasm Energy Metabolism Enzyme: Hydrolase Hydrolase activity
AHCYL2 6.8120 2 adenosylhomocysteinase-like 2 unknown Energy Metabolism Enzyme: Lyase Molecular function un-
known
PYGM 0.4640 2 phosphorylase, glycogen, muscle Cytoplasm Energy Metabolism Enzyme: Phos-
phorylase
Phosphorylase activity
CHST7 23.9751 3 carbohydrate (N-acetylglucosamine 6-O) sulfo-
transferase 7
Cytoplasm Energy Metabolism Enzyme: Sulphotrans-
ferase
Sulfotransferase activity
HSPD1 0.3861 3 heat shock 60kDa protein 1 (chaperonin) Cytoplasm Protein metabolism Heat shock protein Heat shock protein activity
RPL24 0.2988 3 ribosomal protein L24 Cytoplasm Protein metabolism Ribosomal subunit Structural constituent of ribo-
some
Continued on next page
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Gene tg/wt no.
pept.
Description Localisation Biological process Molecular class Molecular function
RPL28 0.2680 3 ribosomal protein L28 Cytoplasm Protein metabolism Ribosomal subunit Structural constituent of ribo-
some
RPS3A 0.5441 6 ribosomal protein S3A Cytoplasm Protein metabolism Ribosomal subunit Structural constituent of ribo-
some
RPS7 0.4024 3 ribosomal protein S7 Cytoplasm Protein metabolism Ribosomal subunit Structural constituent of ribo-
some
RPS8 0.4535 2 ribosomal protein S8 Cytoplasm Protein metabolism Ribosomal subunit Structural constituent of ribo-
some
PABPC1 0.3050 2 poly(A) binding protein, cytoplasmic 1 Cytoplasm Reg of nucleic acid
metabolism
RNA binding protein RNA binding
STAT3 23.6911 2 signal transducer and activator of transcription 3
(acute-phase response factor)
Nucleus Reg of nucleic acid
metabolism
Transcription factor Transcription factor activ-
ity
SUB1 0.2507 2 SUB1 homolog (S. cerevisiae) Nucleus Reg of nucleic acid
metabolism
Transcription factor Transcription factor activity


































SLC25A4 1.5195 35 solute carrier family 25 (mitochondrial carrier; ad-
enine nucleotide translocator), member 4
Cytoplasm Transport Transport/cargo pro-
tein
Transporter activity
NAPB 3.6088 2 N-ethylmaleimide-sensitive factor attachment pro-
tein, beta
Cytoplasm Transport Unclassified Molecular function un-
known
SDF2 3.2819 3 stromal cell-derived factor 2 Extracellular
Space
Unknown Secreted polypeptide Molecular function un-
known
CHCHD3 0.3076 2 coiled-coil-helix-coiled-coil-helix domain containing
3
Cytoplasm Unknown Unclassified Molecular function unknown




Unknown Unclassified Molecular function un-
known
Emc2 0.0637 2 Tetratricopeptide repeat protein 35 OS=Mus muscu-
lus GN=Ttc35 PE=2 SV=1
unknown Unknown Unclassified Molecular function unknown
Emc7 0.3128 2 UPF0480 protein C15orf24 homolog OS=Mus mus-
culus GN=ORF3 PE=2 SV=1
unknown Unknown Unclassified Molecular function unknown
FMNL2 0.0066 6 formin-like 2 Cytoplasm Unknown Unclassified Molecular function unknown
IQCH 0.4075 5 IQ motif containing H unknown Unknown Unclassified Molecular function unknown
Mblac2 2.1000 2 Beta-lactamase-like protein FLJ75971 homolog
OS=Mus musculus PE=2 SV=1
unknown Unknown Unclassified Molecular function un-
known
NEGR1 0.1173 2 neuronal growth regulator 1 Extracellular
Space
Unknown Unclassified Molecular function unknown
PHYHIP 0.4708 2 phytanoyl-CoA 2-hydroxylase interacting protein unknown Unknown Unclassified Molecular function unknown
TCP11L2 9.6993 2 t-complex 11 (mouse)-like 2 unknown Unknown Unclassified Molecular function un-
known
WDR7 21.7344 2 WD repeat domain 7 unknown Unknown Unclassified Molecular function un-
known
ZFAT 4.0161 2 zinc finger and AT hook domain containing Nucleus Unknown Unclassified Molecular function un-
known
Table 4.4: Proteomics in synaptosomes. The “fold change” column shows the ratio of tg to wt (values
above 1 indicate upregulation, below 1 downregulation). Upregulated proteins are marked in bold.
Gene tg/wt no.
pept.
Description Localisation Biological process Molecular class Molecular function
upregulated




Adapter molecule Receptor signaling complex
scaffold activity
PACSIN1 2.281 10 Protein kinase C and casein kinase substrate in
neurons 1
Cytoplasm Cell communication &
Signaling
Adapter molecule Receptor signaling complex
scaffold activity




Adapter molecule Receptor signaling complex
scaffold activity




Adhesion molecule Cell adhesion molecule
activity















Continued on next page
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Gene tg/wt no.
pept.
Description Localisation Biological process Molecular class Molecular function
SEPT 7 1.606 7 Cell division cycle 10 Cytoplasm Cell communication &
Signaling
Cell cycle control pro-
tein
Protein binding




Cell surface receptor Receptor activity












G protein GTPase activity




G protein GTPase activity
RALA 1.503 5 Ras related protein Ral A Cytoplasm Cell communication &
Signaling
GTPase GTPase activity





KRAS 2.327 2 KRAS Cytoplasm Cell communication &
Signaling
GTPase GTPase activity
RAB5A 2.806 2 Ras related protein Rab 5A Cytoplasm Cell communication &
Signaling
GTPase GTPase activity
RAB5C 2.806 2 Ras associated protein Rab5C Cytoplasm Cell communication &
Signaling
GTPase GTPase activity
RAP1A 3.183 2 Ras related protein 1A Cytoplasm Cell communication &
Signaling
GTPase GTPase activity





CDC42 4.229 2 CDC42 Cytoplasm Cell communication &
Signaling
GTPase GTPase activity





PRKAR2A 1.651 3 Protein kinase, cAMP dependent, regulatory type
II, alpha






























PPP2R1A 1.591 12 Protein phosphatase 2, regulatory subunit A , al-
pha isoform






MTCH2 0.3465 2 Mitochondrial carrier homolog 2 Cytoplasm Cell communication &
Signaling
Unclassified Molecular function unknown
SRCIN1 2.184 5 SNIP Cytoplasm Cell communication &
Signaling
Unclassified Molecular function un-
known
CTTN 0.4145 2 Cortactin Plasma
Membrane











COL5A2 0.1811 2 Collagen, type V, alpha 2 Extracellular
Space






CLTC 0.6502 24 Clathrin, heavy polypeptide Plasma
Membrane
Cell growth & mainten-
ance
Structural protein Structural molecule activity
ABAT 0.2476 3 Gamma Aminobutyrate Transaminase Cytoplasm Energy Metabolism Enzyme: Aminotrans-
ferase
Transaminase activity
GLUL 1.597 21 Glutamate ammonia ligase Cytoplasm Energy Metabolism Enzyme: Aminotrans-
ferase
Transaminase activity
GOT1 1.826 7 Glutamate oxaloacetate transaminase-1 Cytoplasm Energy Metabolism Enzyme: Aminotrans-
ferase
Transaminase activity
MDH2 1.572 16 Malate dehydrogenase mitochondrial Cytoplasm Energy Metabolism Enzyme: Dehydro-
genase
Catalytic activity
PDHA1 2.403 10 Pyruvate dehydrogenase complex, E1-alpha poly-
peptide 1
Cytoplasm Energy Metabolism Enzyme: Dehydro-
genase
Catalytic activity
ENO2 1.775 17 Enolase 2 Cytoplasm Energy Metabolism Enzyme: Hydratase Catalytic activity
TPI1 2.008 5 Triosephosphate isomerase 1 Cytoplasm Energy Metabolism Enzyme: Isomerase Isomerase activity
MGLL 2.143 2 Monoglyceride lipase Plasma
Membrane
Energy Metabolism Enzyme: Lipase Lipase activity
NDUFB5 1.562 3 NADH dehydrogenase 1 beta subcomplex, 5 Cytoplasm Energy Metabolism Enzyme: Oxidore-
ductase
Oxidoreductase activity
NDUFS7 1.567 6 NADH ubiquinone oxidoreductase Fe S protein 7 Cytoplasm Energy Metabolism Enzyme: Oxidore-
ductase
Oxidoreductase activity
CBR1 1.835 6 Carbonyl reductase 1 Cytoplasm Energy Metabolism Enzyme: Oxidore-
ductase
Oxidoreductase activity
NDUFA6 2.562 3 NADH dehydrogenase 1 alpha subcomplex, 6 Cytoplasm Energy Metabolism Enzyme: Oxidore-
ductase
Oxidoreductase activity
PFKP 0.32 2 Phosphofructokinase platelet type Cytoplasm Energy Metabolism Enzyme: Phosphotrans-
ferase
Catalytic activity
Continued on next page
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Gene tg/wt no.
pept.
Description Localisation Biological process Molecular class Molecular function
CKB 1.64 16 Creatine kinase brain type Cytoplasm Energy Metabolism Enzyme: Phospho-
transferase
Catalytic activity
PGK1 1.861 7 Phosphoglycerate kinase 1 Cytoplasm Energy Metabolism Enzyme: Phospho-
transferase
Catalytic activity
Pkm 2.05 18 Pyruvate kinase 3 Cytoplasm Energy Metabolism Enzyme: Phospho-
transferase
Kinase activity
CYB5R3 5.219 2 Cytochrome-b5 reductase Cytoplasm Energy Metabolism Enzyme: Reductase Catalytic activity
SLC25A5 0.6446 11 Solute carrier family 25 (mitoc carrier, translocator),
member 5
Cytoplasm Energy Metabolism Integral membrane pro-
tein
ATP binding
COX6C 0.257 2 Cytochrome c oxidase, subunit VIc Cytoplasm Energy Metabolism Regulatory/other
subunit
Oxidoreductase activity
ATP6V1A 1.55 19 ATP6V1A1 Cytoplasm Energy Metabolism Transport/cargo pro-
tein
Transporter activity
CADM3 1.57 4 Immunoglobulin superfamily member 4B Plasma
Membrane
Immune response Immunoglobulin Antigen binding
HSPA12A 0.2763 2 Heat shock 70kDa protein 12A unknown Protein metabolism Heat shock protein Heat shock protein activity
Rps9 1.598 3 Ribosomal protein S9 Cytoplasm Protein metabolism Ribosomal subunit Structural constituent of ri-
bosome
RPS5 3.276 2 Ribosomal protein S5 Cytoplasm Protein metabolism Ribosomal subunit Structural constituent of ri-
bosome
RPL9 6.266 2 Ribosomal protein L9 Cytoplasm Protein metabolism Ribosomal subunit Structural constituent of ri-
bosome
EIF4H 0.4628 6 Williams Beuren syndrome chromosome region 1 Cytoplasm Protein metabolism Translation regulatory
protein
Translation regulator activity


















NAV3 0.3103 2 Neuron navigator 3 Nucleus Reg of nucleic acid
metabolism
Unclassified Molecular function unknown
ATP1B2 3.874 2 ATP1B2 Plasma
Membrane
Transport ATPase ATPase activity





ATP6V0A1 1.637 4 ATPase H+ transporting lysosomal noncatalytic
accessory protein 1A
Cytoplasm Transport Ion channel Ion channel activity
KCTD12 4.098 2 Potassium channel tetramerisation domain Plasma
Membrane
Transport Ion channel Ion channel activity















Transport Voltage gated channel Voltage-gated ion channel
activity




Transport Voltage gated channel Voltage-gated ion channel
activity
SFXN3 0.5243 5 Sideroflexin 3 Cytoplasm Unknown Integral membrane pro-
tein
Molecular function unknown
SAMD4A 0.0716 2 Sterile alpha motif domain containing 4 unknown Unknown Unclassified Molecular function unknown
0.1471 4 DC12 protein unknown Unknown Unclassified Molecular function unknown
DLGAP3 2.908 2 Discs, large homolog-associated protein 3 Cytoplasm Unknown Unclassified Molecular function un-
known
OCIAD2 4.491 2 OCIA domain containing 2 Cytoplasm Unknown Unclassified Molecular function un-
known
NEGR1 4.985 3 Neuronal growth regulator 1 Extracellular
Space
Unknown Unclassified Molecular function un-
known
LRRC57 11.59 2 Leucine rich repeat containing 57 unknown Unknown Unclassified Molecular function un-
known
FMNL2 17.4 6 Formin like 2 Cytoplasm Unknown Unclassified Molecular function un-
known




Figure 4.6: Validation of proteomics candidates by western blotting. Western blots were performed on
pooled samples from 4 weeks old Tcf4tg and wt mice. A) CaMK II alpha in synaptosomes. B) HOMER1 in
synaptosomes. C) VAMP1 in cytosolic fraction. D) VAMP2 in cytosolic fraction and synaptosomes. Whole
blots are presented in the Appendix in Fig. 7 on page 107.
4.2 Analyses in Tcf4C knockout mice
We generated heterozygotic Tcf4 knockout mice Tcf4C. They breed well and show no major
developmental impairments nor increased mortality. However, this may be different in homozygotic
animals. We have not studied them, but the Sanger Institute has reported partial lethality at postnatal
day 14 in homozygotic Tcf4 knockout-first Eucomm mice (Tcf4E) and several morphological
deviations (craniofacial abnormalities, decreased body length and weight, reduced grip strength
and abnormal morphology of pelvis and joints) in homozygotic Tcf4E females199. Thus, increased
mortality should be expected in Tcf4C homozygotes. The phenotype may be even more severe,
considering that the knockout in Tcf4C should be more effective than in the Tcf4E line.
4.2.1 Tcf4 expression in Tcf4C mice
To validate Tcf4C as a knockout line, we measured Tcf4 RNA levels in PFC and hippocampus
of Tcf4C (n=5) and wt animals (n=6), using RT-qPCR. Tcf4 transcripts were detected with six
primer pairs targeting different exons in different regions of Tcf4. They were designed in a way that
would allow distinguish different Tcf4 isoforms, based on Ensembl.org200. Levels of exons 1–2 in
Tcf4C mice were comparable to wt. Exons 5–6, located directly downstream of the deleted exon 4,
were clearly reduced in both PFC (p<0.0001, t-test) and hippocampus (p=0.0277, t-test). The
consecutive exons were gradually increasing — exons 7–9 showed less pronounced decrease in
PFC (p=0.0174, t-test) and a tendency in hippocampus (Fig. 4.7A,B).
Additionally, we compared the abundance of different exons in wt mice. After adjustment
for different qPCR efficiencies, we observed different patterns of Tcf4 exons expression in PFC
and hippocampus. In PFC, the most abundant were exons 7–9 (Fig. 4.7C) while in hippocampus,
exons 5–6 were expressed at highest levels (Fig. 4.7D). Direct comparison of hippocampus and PFC
was impossible due to differences in expression of the housekeeping genes. Atp5b, also considered
as a reference gene, was excluded due to incompatibility with the other two (Fig. 4.7F,G).
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Figure 4.7: Tcf4 expression in Tcf4C knockout mice. A) Tcf4 exons expression in PFC of Tcf4C mice
(n=5), normalized to wt. Exons 5–6 (p<0.0001, t-test) and 7–9 (p=0.0174) show decreased levels. B) Tcf4
exons expression in hippocampus of Tcf4C mice (n=5), normalized to wt. Exons 5–6 are reduced (p=0.0277,
t-test). C) Tcf4 exon expression in PFC of wt animals (n=6), normalized to exons 1–2. Exons 7–9 show
highest expression. D) Tcf4 exon composition in hippocampus of wt animals (n=6), normalized to exons 1–2.
Exons 5–6 show highest expression. E) Housekeeping genes in PFC normalized to Actb. F) Housekeeping
genes in PFC normalized to Rpl13. G) Housekeeping genes in hippocampus normalized to Actb and Rpl13.
4.2.2 Morphometrics in Tcf4C mice
Since PTHS patients display abnormal facial features42, we checked whether the Tcf4C mice
display any alterations in facial and body features. As presented in Fig. 4.8A, we measured body
length, head length, width and height and the distance between the eyes. Analysis showed no
significant differences in any of the parameters nor in their ratios (Fig. 4.8B-E). We also monitored
Figure 4.8: Tcf4C mouse morphometrics. A) Measured dimensions. B-E) No morphological differences
between the genotypes were found. B) Body length. C) The distance between the eyes. D) The distance
between the eyes / head width ratio. E) Head width / head height ration. Bars represent means with SEM.
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body weight, which was mildly reduced in the Tcf4C animals at the age of 4 (t-test, p=0.0125) but
not at 14 weeks (Fig. 5A, Appendix A, page 103).
4.3 Behavioural profiling of mice
To better understand Gene×Environment interaction, we began with studying the influence of
environment on behaviour, by comparing wt mice subjected to IR or SD. To do this we established
an approach to analysing huge behavioural data sets that cover various aspects of murine behaviour
measured in different tests and in independent mouse cohorts. The method is described in details in
our article Data calibration and reduction allows to visualize behavioural profiles of psychosocial
influences in mice towards clinical domains 178.
IR and SD were tested in two independent cohorts and by different experimenters. To analyse
them, we normalized IR and SD to their control groups, which were identical in both cohorts (EE-1
and EE-2 respectively). To compare different behavioural measures to each other, we gave them
arbitrarily assigned directionality. We merged measures reflecting the same behaviours into single
traits, which we then fused into behavioural domains by using multivariate statistics. Finally, we
visualised the data as behavioural profiles in single graphs (Fig. 4.9) and we calculated Severity
scores, that reflect the degree of deviation form the EE control. Detailed methods description and
full data tables are presented in our publication178 (attached in Appendix D).
4.3.1 Different effects of Isolation rearing and Social defeat in wt mice
Both IR and SD had prominent impact on the behaviour. In many aspects they were similar,
but showed also some differencies. Isolated animals displayed locomotor hyperactivity in novel
environment in OF, reduced exploratory behaviour in HB, increased latency to enter the dark
compartment in LD, reduced pain sensitivity and freezing in cue FC. The last result should be taken
with caution, as it may reflect pain insensitivity instead of cognitive impairment (Fig. 4.9A). On
the domain level IR had significant influence on novelty-induced locomotor activity (Ambulation),
Pain sensitivity, Motivation and Fear memory (Fig. 4.9B).
SD group showed pronounced reducions of exploration in HB and of fighting time in TST as
well as prolonged latencies to enter the dark compartment in LD. Both context and cue FC were
impaired, but pain sensitivity was normal (Fig. 4.9C). Thus Fear memory, Motivation and Curiosity
are the domains, that undergo greatest changes upon SD (Fig. 4.9D).
Both IR and SD have detrimental impact on latencies in LD, cue FC and exploratory behaviour
in HB (Fig. 4.9E), but SD affects the latter two significantly more than IR (marked as black,
encircled stars). SD has also a stronger influence on context FC and motivation in TST. On the
other hand IR, in contrast to SD, affects pain sensitivity in HP and ambulation in OF. This is
also visible on the domain level (Fig. 4.9F) — SD has strong detrimental effects on Fear memory,
Motivation and Curiosity, while IR impairs Fear memory and Motivation milder, but has pronounced
effects on Pain sensitivity and Ambulation. The meaning of prolonged latency to exit the bright
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Figure 4.9: Behavioural profiles of wildtype IR and SD mice. Radar charts present behavioural profiles
on trait (left) and domain level (right). IR (blue line) and SD means (red lines) are relative EE controls
(black lines) set as zero. Deviations towards the centre of the graph (values below zero) mean worsened
the performance. Shading in graphs A–D represents 99.17% CI, while in E–F represent plot areas. Stars
mark significant differences of IR (blue) and SD (red) from the controls. IR profiles are depicted on A) train
level and B) domain level. Analogously, SD profiles are presented on C) trait and D) domain level. Overlaid
figures on E) trait and F) domain level allow visual comparison of IR and SD profiles and impairment severity.
Black encircled stars show significant differences between them. Overall degree of behavioural alterations
is expressed plot area sizes (smaller areas indicate stronger impairments) and severity score calculated on
trait level (higher score indicates greater changes). Abbreviations: isolation rearing (IR), social defeat (SD),
enriched environment (EE), confidence interval (CI) Fear conditioning (FC), Elevated plus maze (EPM),
Light-dark preference (LD), Open field (OF), Hole board (HB), Hot plate (HP), Tail suspension test (TST).
Figure adapted from Badowska et al.178.
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compartment and enter the dark one is not clear, but it may have similar origin as prolonged
latencies to emerge from a small enclosure201. It may reflect unfocused activity due to excessive
ambulation137 or initial immobility201 possibly caused by neophobia or reduced motivation.
Both IR and SD have significant impact on five traits each, but SD appears to induce greater
changes in overall behaviour. To compare it, we calculated Severity scores on the trait level
(Fig. 4.9E). SD displayed higher score (5.2 with 95% CI [3.9, 6.4]) than IR (3.9 with 95% CI [1.7,
6.1]), which suggests that SD affected behaviour stronger than IR. However, this difference has not
reached significance level.
Stress hormones upon social defeat To confirm that SD induces stress in mice, we measured
stress hormones in blood plasma immediately after a single SD session and in non-stressed EE
mice. We measured corticosterone, noradrenaline (associated with activity) and adrenaline — the
best marker of distress202 — in plasma by mass spectrometry. Stress increased corticosterone levels
(p=0.0079, Mann Whitney test) (Fig. 4.10A). As expected202, noradrenaline levels remained stable
(Fig. 4.10B) and adrenaline showed a tendency for an increase upon stress (Fig. 4.10C).
Figure 4.10: Stress hormones are increased in blood after acute SD. Stress hormones were monitored
in blood plasma after acute SD stress (n=5) and in EE mice (n=5). A) Coritcosterone was increased upon SD
compared to EE (p=0.0079, Mann Whitney test). B) Noradrenalie levels were unchanged by SD. C) SD
mice showed a tendency for increased adrenaline (p=0.1508, Mann-Whitney test).
4.3.2 Gene × Environment interaction in Tcf4tg mice
In a battery of tests, we analysed behaviour of Tcf4tg and wt mice in IR or EE. We used two
cohorts: tested form the age of 8 weeks (Tcf4tgIR-EE-young or Young), or at 1 year of age
(Tcf4tgIR-EE-aged or Ageing) to check if ageing contributes to the behavioural deficits.
Gene × Environment interaction in Tcf4tg mice
Behavioural analysis of the Tcf4tg vs. wt cohorts revealed cognitive impairments of Tcf4tg mice
which were manifested only upon IR. In the Young cohort, we observed housing-dependent
impairments of cue FC (Fig. 4.11B) in Tcf4tg mice both 48 h and 1 month after foot shock
acquisition. We also observed a tendency for impaired initial learning in MWM (Fig. 4.11C) and
a very pronounced impairment of reversal learning in Tcf4tg animals housed in IR (Fig. 4.11D).
Memory recall in probe tests was not altered by the Tcf4 overexpression (Fig. 4.11E).
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Figure 4.11: Cognition in Tcf4tg mice upon IR and EE. A) Context FC: Genotype has no effect on
context memory, but EE reduces freezing 1 month after shock (p<0.0001). B) Cue FC: In IR Tcf4tg mice
showed reduced cue memory 48 h (p<0.05, Bonferroni) and 1 month after the shock (p=0.0381, t-test).
G–J) MWM, mean latencies to reach the platform. C) Initial learning: EE mice learned faster than IR mice
(p=0.0001, RM ANOVA). D) Reversal learning: Tcf4tg mice performed worse than wt in IR, but not in EE:
genotype (p=0.024, RM ANOVA), housing (p=0.0001, RM ANOVA) and their interaction effects (p=0.038,
RM ANOVA). E) Probe tests. IR mice spent less time in TQ than EE mice (p=0.0051) in the probe test after
initial learning, but not after reversal learning and 1 month later. Abbreviations: Fear conditioning (FC),
Morris water maze (MWM), target quadrant (TQ).
Figure 4.12: Cognition in aged Tcf4tg mice upon IR and EE. A) Context FC: 24 h after shock, freezing
was reduced by IR (p=0.001) and Tcf4tg-IR mice froze less than wt-IR mice (p=0.0273, Mann Whitney
test)which we also saw one month later (p=0.0333, t-test with Welch’s correction and housing effect
p=0.0485). B) Cue FC was impaired by IR 48 h (p<0.0001) and one month after the shock (p<0.0001).
C–F) WM, mean total distances were analysed, due to speed differences between IR and EE. C) Initial
learning. D) Reversal learning was mildly impaired in Tcf4tg-IR mice with housing (p=0.009, RM ANOVA)
and genotype effects (p=0.057, RM ANOVA). E) In DMP, housing (p<0.0001, RM ANOVA), genotype
(p=0.002, RM ANOVA) and G×E interaction (p=0.013, RM ANOVA) influenced performance of mice.
F) In the first probe test (after initial learning) Tcf4tg mice performed worse (p=0.0454) but not in the second
test (after reversal). Tests were analysed using two-way ANOVA, unless stated differently. Abbreviations:
Fear conditioning (FC), Morris water maze (MWM), delayed matching to place (DMP).
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In the Ageing cohort, Tcf4tg mice showed cognitive deficits only when housed in IR but not
when housed in EE (Fig. 4.12). Freezing in context FC (Fig. 4.12A) was reduced in Tcf4tg mice
only when housed in IR. In cue FC we observed a similar tendency; however, the difference
between Tcf4tg and wt mice in IR was not significant (Fig. 4.12B). In MWM initial learning was
unaffected (Fig. 4.12C), but worsened performance was observed in isolated Tcf4tg mice in reversal
learning (Fig. 4.12D) and delayed matching to place (DMP) (Fig. 4.12E). Time spent in target
quadrant (TQ) was the same in all groups (Fig. 4.12F).
Replication of findings in IR
In the G×E cohort we replicated several observations concerning wildtype IR behaviour (see:
Appendix A): prolonged latency to enter dark (Fig. 1B), increased ambulation in OF (Fig. 1F,G),
reduced exploration in HB (Fig. 1K), reduced fighting in TST (Fig. 2G) and pain insensitivity
(Fig. 1J,K). Apart from that, we detected some abnormalities of IR mice that have not been tested
in the wt cohort: increased running in OF and swimming speed MWM (Fig. 1H,I) and more arm
choices in Y-maze (Fig. 2A). These observations are complementary to increased ambulation in
IR and may all together reflect hyperactivity in novel environment. Isolated mice showed reduced
number of alternations in Y-maze (Fig. 2B), and impairment of PPI (Fig. 2E) and spatial learning
in MWM (Fig. 4.11C and 2L) (for detailed statistical analyses see Appendix A: Table 2). Upon
ageing we have additionally seen increased body weight in IR mice from the 8th month of age
Figure 4.13: Environmental effects in the G×E cohorts. Radar charts represent effects of IR (blue) and
SD (red) on cognition (domain level) and positive and negative symptoms (symptom class level), regardless
of genotype. We used data from two G×E cohorts: young IR–EE and Tcf4tg SD–control. Lines represent
performance relative to corresponding reference groups — EE or control (black). Significant effects are
indicated by stars in corresponding colours. IR mice, compared to EE, showed positive, negative symptoms
and in the cognitive class: impaired context and cue fear memory as well as reduced performance in
MWM spatial learning and perseveration tasks. SD mice, in comparison to control condition, displayed no
significant positive and negative symptoms, but showed impairments in all spatial memory tasks: memory
recall, perseveration and spatial learning.
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(Fig. 3A) and possibly associated with it reduction in rearing (Fig. 3E). Also anxiety in EPM was
increased in 1 year old IR mice.
4.3.3 Behavioural analysis of Tcf4C mice
Based on our experiences with Tcf4tg animals, we decided to house the Tcf4C knockouts in IR to
enhance the potential phenotype. Tcf4C mice showed normal context FC (Fig. 4.14A) and only
mildly increased freezing in all phases of cue FC (Fig. 4.14B). However, in MWM spatial learning
was dramatically impaired (Fig. 4.14C–E) and no significant difference between the groups was
detected in the probe test (Fig. 4.14F). Subtle increase of anxiety was observed in OF (Fig. 5D)
and reduction of alternations in Y-maze (Fig. 6C,E). Startle response to 120 dB pulse in PPI was
increased in Tcf4C mice (Fig. 6J).
Figure 4.14: Cognition in Tcf4C mice. A) Context FC was not affected in Tcf4C animals. B) Cue FC
was reduced in Tcf4C in all phases (p=0.0039, two-way ANOVA -- particularly in cue memory recall
1 month later (p<0.05, Bonferroni). C) WM, Tcf4C mice showed pronounced impairment of initial learning
(p<0.0001, two-way RM ANOVA), D) reversal learning (p<0.0001, two-way RM ANOVA) E) and DMP
(p=0.0182, two-way RM ANOVA). F) No significant differences in probe test were observed. Bar graph
represent mean with SEM. Abbreviations: Fear conditioning (FC), Morris water maze (MWM), delayed
matching to place (DMP).
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4.3.4 Behavioural profiles of Tcf4tg and Tcf4C mice
We applied the approach described in section 4.3 and in our paper178, to analyse behaviour of
Tcf4tg and Tcf4C mice. In case of Tcf4tg mice, we used the data from two G×E experiments: 1) the
Tcf4tg Young cohort, 2) a cohort, analysed Ananya Chowdhury in the MSc thesis203, in which
Tcf4tg mice were subjected to SD or control condition (individual housing with daily handling).
For Tcf4C, the data from the cohort housed in IR, described above, were used. Detailed statistical
tests are presented in Table 4.5 on domain, superdomain and symptom class level and in Table 1 in
the Appendix A on measure, trait level.
Tcf4tg showed no major impairments in EE, except from a mild reduction in curiosity (Fig. 4.15A).
In the control condition they exhibited mild deficits in spatial learning (Fig. 4.15A) and enhanced
perseveration (Fig. 4.15B). Upon IR and SD Tcf4tg mice displayed impairment of spatial learning
(Fig. 4.15C); however, in IR it failed to reach significance after correction for multiple testing.
In both IR and SD, Tcf4tg mice showed enhanced perseveration, and impaired spatial learning
and memory recall upon SD (Fig. 4.15D). Strong disruption of spatial learning was also evident
in Tcf4C mice, next to a mild deficit in working memory (Fig. 4.15C). Detailed analysis of the
cognition symptom class in Tcf4tg mice revealed normal performance in EE, mild impairment
in the control condition (Fig. 4.15A), strong perseveration upon IR and moderate perseveration
and impairment of memory recall upon SD (Fig. 4.15B). Tcf4C mice, on the other hand, dis-
played striking impairments in all aspects of spatial learning and mildly reduced working memory
(Fig. 4.15E,F).
We have also analysed the environment effects in the two Tcf4tg G×E cohorts. Similarly
like in the wildtype study (see: section 4.3.1), IR compared to EE, induced positive symptoms
(hyperactivity), negative symptoms (pain insensitivity, reduced curiosity and motivation) and
cognitive deficits (fear memory and spatial learning) (Fig. 4.13). Since SD was normalised to the
control condition, we cannot compare these data to the wildtype study. In SD animals, we found
cognitive impairments in memory recall, perseveration and spatial learning (Fig. 4.13). They also
showed anxiety and reduced motivation, but the difference did not pass the significance threshold
for negative symptom class.
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Figure 4.15: Behavioural profiles of Tcf4tg and Tcf4C mice. Radar charts represent behavioural superdo-
mains (A,C,E) and cognitive domains (B,D,F) of young adult Tcf4tg (A–D) and Tcf4C mice (E,F), relative
to the wt animals in the same condition. Significant differences are indicated by stars in corresponding
colours. A,B) Tcf4tg mice in EE (green) showed no impairments, except from reduced curiosity (A). In
the control condition (orange) Tcf4tg mice displayed moderate spatial learning deficit(A) and perseveration
(B). C) Tcf4tg exhibited strong impairment of spatial learning upon SD and a tendency upon IR. D) Tcf4tg
showed increased perseveration and diminished cue memory upon IR and impairments of spatial learning,
perseveration and reduced memory recall upon SD. E,F) Tcf4C mice displayed a strong impairment of



















































































































































































































































































































































































































































































































































4.4 Isolation rearing-induced hypoalgesia in wt mice
In the course of our studies we observed that IR, but not SD178, leads to hypoalgesia – reduced
sensitivity to pain — known to occur in isolated mice134,135. It affects various kinds of pain: e.g.
thermal, chemical204 and electric shocks (Fig. 2J,K, Appendix A). Pain insensitivity is also an
endophenotype of schizophrenia observed in patients205–207 and their relatives208 – which supports
the use of social isolation in rodents for modelling psychotic diseases. However, the mechanism of
hypoalgesia in isolated rodents is not understood. Several mechanisms in peripheral and central
nervous system could be potentially involved, e.g. changes in neuronal plasticity, neurotransmission,
hormone release, endocannabinoids or endogenous opioids.
As the opioid system may be involved in IR-induced hypoalgesia209–211, we focused on
endorphins — analgesic peptides212 that originate from proopiomelanocortin (POMC) in pituitary
gland and hypothalamus and are released to the blood and act on opioid receptors213. Endorphins
regulate several biological processes including analgesia, reward and cognition214 and are involved
in schizophrenia215. However, there is no consistent data on whether levels of β -endorphin, the
most studied endorphin, are altered in the blood of schizophrenic patients 216–220. Inconsistency
may be due to several factors that can play a role e.g. diurnrhythm221–224 or body weight225,226.
To investigate potential mechanisms of isolation-induced hypoalgesia we analysed a cohort of
C57Bl/6N mice (Charles River), subjected to IR (n=7), EE (n=6) or 3 weeks of SD (n=7) from the
age of 4 weeks. At the age of 12 weeks the animals were sacrificed and blood, hypothalamic, PFC,
and hippocampal tissue was isolated. Lumbar DRGs and spinal cord were prepared by Theresa
Kungl7.
We attempted to measure basal β -endorphin serum levels in IR mice and EE controls. We also
analysed gene expression in hypothalamus (important for hormone release and analgesia), DRGs
(the first pain information processing point in peripheral after pain receptors) and PFC (involved in
top–down mechanisms pain regulation).
4.4.1 β -endorphin ELISA
The level of β -endorphin, measured in mouse serum using an ELISA kit, showed no significant
difference between EE and IR animals. However, the values measured in serum were very low
(just above the lower detection range of the kit). Expected concentrations were around 1000 pg/ml
(Fig. 8 in Appendix C, page 108). Trials with the measured blood plasma instead of serum were
not successful. Thus this result has to be taken with caution and optimally the measurement should
be performed with an alternative method, e.g. mass spectrometry.
7Dept. Neurogenetics, Max-Planck-Institute of Experimental Medicine, Göttingen, Germany
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4.4.2 RNAseq analysis in hypothalamus and dorsal root ganglia
Hypothalamus Differential RNA expression analysis revealed 13 genes upregulated in IR mice
(Tab. 4.6), among which were Ramp3, Oxt, Avp and Vgf. We also observed downregulation of
hemoglobin genes Hba and Hbb, which is contradictory to observations in rats127, thus it may
be a preparation artefact. In GSEA no gene sets passed the FDR<25% threshold. At nominal
p-value<1% one gene set (“Spindle”) was upregulated in hypothalamus upon IR (Tab. 4.8) and
6 gene sets were downregulated (Tab. 4.9).
Dorsal root ganglia (DRGs) 63 genes were differentially regulated in DRGs of socially isolated
mice. Among them P2ry1 was upregulated and Vgf, Bdnf and Npy1r were downregulated (Tab. 4.7).
GSEA revealed 4 gene sets significantly enriched at FDR<25% and 12 at the nominal p-value<1%
(Tab. 4.10. 3 gene sets were downregulated at the nominal p-value<1% (Tab. 4.11).
Table 4.6: Genes downregulated in hypothalamus upon isolation rearing. The “log2 fold change”
column shows the fold change of IR (n=3) in reference to EE (n=3).
Gene log2 fold change p-value q-value
Vgf -0.551035 5.65882E-06 0.00728805
Avp -0.700171 1.95312E-08 3.45873E-05
Oxt -0.884047 7.10254E-11 3.35406E-07
Hbb-b1,Hbb-b2 -0.953084 1.22439E-08 0.00002478
Aldh1a2 -0.958683 4.36736E-05 0.0475942
Hba-a1,Hba-a2 -0.960583 1.05089E-09 2.48133E-06
Hba-a1,Hba-a2 -0.995811 1.95938E-10 6.93963E-07
Synpo2 -0.99893 0.000001669 0.00236447
Beta-s -1.00092 4.75175E-14 3.36591E-10
Ptpn3 -1.06501 5.25983E-10 1.49032E-06
Ramp3 -1.24534 4.26193E-05 0.0475942
Prkcd -1.58436 0 0
Slc17a7 -1.70666 2.71124E-08 4.26779E-05
Table 4.7: Genes regulated in DRGs upon isolation rearing. The “log2 fold change” column shows the
fold change of IR (n=3) in reference to EE (n=3).
Gene log2 fold change) p-value q-value
upregulated
Myh1 5.28286 1.33855E-05 0.00449921
Myh4 5.11314 5.79981E-13 1.13615E-09
Tnnt3 4.73327 1.13685E-07 6.36871E-05
Atp2a1 4.44052 1.47011E-07 7.90623E-05
Ckm 3.98091 9.9351E-06 0.0035152
Acta1 3.19523 3.70517E-11 3.832E-08
Bub1b 1.23776 3.13201E-05 0.00877288
Ptgds 0.986996 0 0
Agtr1a 0.773642 4.50134E-07 0.000208691
H2-Ab1 0.596775 4.07763E-05 0.0109647
Thbs1 0.542664 0.000205695 0.044606
Cd74 0.520954 0.000170995 0.037689
Continued on next page
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Table 4.7 – Continued from previous page
Gene log2 fold change) p-value q-value
Col3a1 0.44349 4.1547E-08 2.53909E-05
Chrna6 0.406638 1.54371E-05 0.00506225
Lpar3 0.351372 0.00016359 0.0366578
P2ry1 0.340415 7.65321E-05 0.0190551
Dcn 0.324887 0.000154903 0.036538
Dpp10 0.307874 2.13286E-05 0.00651733
Acpp 0.30243 0.000028578 0.00835284
Col1a2 0.295389 6.70262E-05 0.0173302
downregulated
Hsph1 -0.269234 0.000110112 0.0269173
Serpina3n -0.279389 0.000151786 0.0364423
Calca -0.304452 6.06486E-06 0.00226506
Itga7 -0.324319 1.11202E-05 0.00383363
Sfrp5 -0.327904 0.000162263 0.0366578
Lgmn -0.341363 1.01553E-06 0.000440447
Pak1ip1 -0.357659 2.92483E-05 0.00836687
Gap43 -0.363329 1.13635E-06 0.000477446
Tfrc -0.372069 2.98611E-07 0.000143387
Jun -0.372814 7.23423E-06 0.00262876
Chl1 -0.374771 5.19592E-07 0.000232864
Ngfr -0.384488 8.64147E-09 6.11498E-06
Plxna4 -0.436119 3.88159E-09 3.06988E-06
Nptx1 -0.459688 5.88496E-11 5.27489E-08
Ptchd2 -0.465143 2.06001E-05 0.00644112
Serpinb1a -0.497715 6.91746E-09 5.16696E-06
Ly86 -0.50427 1.70444E-08 1.09125E-05
Adcyap1 -0.513163 2.29052E-09 1.92476E-06
Flrt3 -0.520852 0.000209712 0.0447552
Eif2s3y -0.527505 0.000158595 0.0366578
Etv5 -0.5374 9.70157E-12 1.1858E-08
Lars2 -0.540064 9.01501E-13 1.51509E-09
Sema6a -0.550827 0.000064524 0.0170103
Nkain1 -0.625398 1.58729E-05 0.00508121
Sox11 -0.62693 7.31773E-05 0.0185636
Rn45s -0.663448 0 0
Angptl2 -0.679788 2.98396E-06 0.00114627
Hba-a1,Hba-a2 -0.711127 4.37299E-11 4.19963E-08
Hba-a1,Hba-a2 -0.714693 7.00462E-12 9.41771E-09
Npy1r -0.717397 1.54751E-08 1.04032E-05
Tifa -0.729562 2.39201E-07 0.000123695
Hbb-b1,Hbb-b2 -0.755756 5.91527E-13 1.13615E-09
Beta-s -0.762768 0 0
Nts -0.871439 2.90484E-06 0.00114627
Bdnf -0.919004 5.20532E-08 3.04285E-05
Pappa -1.04208 2.75491E-12 4.11553E-09
Vgf -1.04544 0 0
Plaur -1.12381 3.70315E-05 0.010161
Tmem173 -1.1371 2.51355E-05 0.00750993
Atf3 -2.01481 0 0
Gpr151 -2.07325 2.34476E-06 0.000955313
Ecel1 -2.26513 2.86617E-07 0.000142725
Sprr1a -5.02805 2.87046E-11 3.21611E-08
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Table 4.8: Gene sets upregulated in hypothalamus upon isolation rearing. GSEA revealed no gene sets
significantly deregulated at FDR<25%, but “Spindle” is the top upregulated gene set at nominal p-value<1%.
NAME SIZE ES NES NOM p-val FDR q-val FWER p-val
SPINDLE 38 -0.6309913 -1.5952135 0.009230769 1 0.999
CELL CYCLE CHECKPOINT GO 0000075 45 -0.57641065 -1.4996719 0.026239067 1 1
TELOMERIC DNA BINDING 9 -0.7804627 -1.4428499 0.08396947 1 1
Table 4.9: Gene sets downregulated in hypothalamus upon isolation rearing. 6 gene sets associated
with transmembrane transport, secretion and neurite development are downregulated upon IR at nominal
p-value<1%, but not at FDR<25%.
NAME SIZE ES NES NOM p-val FDR q-val FWER p-val
PHOSPHATE TRANSMEMBRANE TRANSPORTER ACTIVITY 12 0.8746991 1.6164454 0 1 0.93
SECRETORY GRANULE 17 0.7633645 1.5262561 0.008169935 1 1
INORGANIC ANION TRANSPORT 17 0.7525263 1.5033239 0.025316456 1 1
ANCHORED TO MEMBRANE 11 0.8161317 1.499629 0.017350158 1 1
AMINO ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 29 0.6955017 1.497823 0.020249221 1 1
NEURITE DEVELOPMENT 47 0.62744933 1.4962971 0.01433121 1 1
INORGANIC ANION TRANSMEMBRANE TRANSPORTER ACTIVITY 18 0.7388429 1.4873075 0.021276595 1 1
ANCHORED TO PLASMA MEMBRANE 11 0.8161317 1.4856927 0.032786883 1 1
MONOOXYGENASE ACTIVITY 21 0.7071364 1.4703019 0.03069467 1 1
DIGESTION 38 0.633322 1.4671487 0.030120483 1 1
SKELETAL DEVELOPMENT 95 0.56289417 1.4608468 0.011126565 1 1
ACUTE INFLAMMATORY RESPONSE 11 0.805388 1.4567382 0.03069467 1 1
GENERATION OF NEURONS 76 0.5691497 1.4501585 0.030478954 1 1
AXONOGENESIS 38 0.62605125 1.4492811 0.033280507 1 1
EXOPEPTIDASE ACTIVITY 29 0.65743476 1.4420316 0.05304212 1 1
OXIDOREDUCTASE ACTIVITY ACTING ON NADH OR NADPH 24 0.671245 1.4372844 0.048309177 1 1
REGULATION OF MUSCLE CONTRACTION 18 0.7050116 1.4246622 0.065318815 1 1
CARBOXYLIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 43 0.60864633 1.421431 0.056574922 1 1
NEURON DEVELOPMENT 55 0.5885536 1.4203693 0.033282906 1 1
HORMONE METABOLIC PROCESS 26 0.67117655 1.419442 0.044207316 1 1
ANION CATION SYMPORTER ACTIVITY 16 0.7275763 1.4185106 0.05 1 1
PHAGOCYTOSIS 13 0.7500188 1.4153485 0.04700162 1 1
ION TRANSMEMBRANE TRANSPORTER ACTIVITY 259 0.4848874 1.4136977 0.009815951 1 1
NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION 9 0.7938968 1.412717 0.059800666 1 1
ION CHANNEL ACTIVITY 140 0.51552075 1.4119701 0.011363637 1 1
BODY FLUID SECRETION 10 0.7882244 1.4114146 0.06935484 1 1
SYMPORTER ACTIVITY 30 0.6400289 1.411332 0.05206738 1 1
ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 44 0.6038959 1.4098958 0.042089984 1 1
SUBSTRATE SPECIFIC TRANSMEMBRANE TRANSPORTER ACTIVITY 324 0.4754348 1.4073892 0.002350176 1 1
NEUROGENESIS 85 0.5433593 1.4070809 0.023876404 1 1
POSITIVE REGULATION OF CYTOKINE SECRETION 7 0.8249709 1.4018607 0.08094435 1 1
NEURON DIFFERENTIATION 69 0.55657935 1.3999331 0.039492242 1 1
OXIDOREDUCTASE ACTIVITY ACTING ON THE ALDEHYDE OR OXO
GROUP OF DONORS
22 0.66011435 1.3980609 0.073836274 1 1
RECEPTOR MEDIATED ENDOCYTOSIS 32 0.61942405 1.391357 0.06456693 1 1
GROWTH FACTOR BINDING 29 0.64603925 1.3902059 0.052227344 1 1
OXIDOREDUCTASE ACTIVITY GO 0016705 29 0.64717835 1.3876555 0.06259781 1 1
AMINO ACID METABOLIC PROCESS 75 0.54597354 1.3866458 0.050754458 1 1
CYTOKINE AND CHEMOKINE MEDIATED SIGNALING PATHWAY 19 0.68204933 1.3807732 0.07620529 1 1
SUBSTRATE SPECIFIC TRANSPORTER ACTIVITY 366 0.4591599 1.3791789 0.005707763 1 1
EXTRACELLULAR SPACE 209 0.48399374 1.3786215 0.012562814 1 1
OXIDOREDUCTASE ACTIVITY GO 0016616 48 0.58165526 1.3758867 0.06268222 1 1
Table 4.10: Gene sets upregulated in DRGs upon isolation rearing. GSEA showed upregulation of
four contractile fiber-associated gene sets at FDR<25% and upregulation several gene sets associated with
response to stimuli and transcriptional activity at nominal p-value<1% in IR mice.
NAME SIZE ES NES NOM p-val FDR q-val FWER p-val
STRUCTURAL CONSTITUENT OF MUSCLE 32 -0.83375263 -1.8147119 0 0.012796508 0.012
CONTRACTILE FIBER 24 -0.85539 -1.7810092 0 0.01965319 0.037
CONTRACTILE FIBER PART 22 -0.8451829 -1.7275283 0 0.05542059 0.149
MYOFIBRIL 19 -0.8686934 -1.7019317 0 0.081350945 0.267
MUSCLE DEVELOPMENT 92 -0.6301342 -1.613492 0 0.39160344 0.858
ACTIN CYTOSKELETON 124 -0.5964722 -1.6131645 0.001697793 0.32829913 0.86
REGULATION OF MUSCLE CONTRACTION 18 -0.7999004 -1.5672011 0.009140768 0.5953036 0.981
Continued on next page
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Table 4.10 – Continued from previous page
NAME SIZE ES NES NOM p-val FDR q-val FWER p-val
POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION 20 -0.77064747 -1.5632821 0.014842301 0.5525919 0.986
REGULATION OF BINDING 56 -0.6385182 -1.5530825 0.006980803 0.56979066 0.99
STRIATED MUSCLE DEVELOPMENT 39 -0.6750973 -1.5507587 0.015873017 0.53100055 0.992
TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATH-
WAY
35 -0.6931986 -1.5491892 0.005395684 0.49290568 0.993
RESPONSE TO LIGHT STIMULUS 45 -0.6622498 -1.5343223 0.005328597 0.5486485 0.997
REGULATION OF HEART CONTRACTION 24 -0.7321811 -1.510626 0.03125 0.6809449 1
SKELETAL MUSCLE DEVELOPMENT 30 -0.6943268 -1.506939 0.019855596 0.6605015 1
REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 135 -0.55532265 -1.504274 0.003412969 0.638151 1
POSITIVE REGULATION OF TRANSCRIPTION FACTOR ACTIVITY 24 -0.7070367 -1.4663235 0.035971224 0.92684716 1
REGULATION OF DNA BINDING 45 -0.6376562 -1.4650983 0.031578947 0.88285565 1
MUSCLE CELL DIFFERENTIATION 22 -0.71898586 -1.4601359 0.042226486 0.8774138 1
MYOBLAST DIFFERENTIATION 17 -0.75436294 -1.4585813 0.059615385 0.8452153 1
POSITIVE REGULATION OF BINDING 28 -0.6861234 -1.4572084 0.032380953 0.81304485 1
REGULATION OF TRANSCRIPTION FACTOR ACTIVITY 38 -0.64849234 -1.451817 0.031034483 0.81936884 1
POSITIVE REGULATION OF DNA BINDING 26 -0.69031984 -1.4511931 0.028368793 0.7867177 1
MYOSIN COMPLEX 15 -0.7661521 -1.4367992 0.04725898 0.86807853 1
RESPONSE TO RADIATION 58 -0.59707314 -1.42647 0.026269702 0.9167564 1
CALCIUM MEDIATED SIGNALING 16 -0.74069923 -1.4194865 0.063097514 0.93962485 1
DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION 18 -0.71530676 -1.4192829 0.0591716 0.90500766 1
POSITIVE REGULATION OF T CELL ACTIVATION 18 -0.72044635 -1.4188728 0.06214689 0.87515736 1
CYTOSKELETAL PART 223 -0.4950115 -1.4084319 0.004761905 0.9284144 1
REGULATION OF LYMPHOCYTE ACTIVATION 31 -0.65021044 -1.405502 0.048327137 0.9199887 1
Table 4.11: Gene sets downregulated in DRGs upon isolation rearing GSEA showed downregulation of
three gene sets at nominal p-value<1%.
NAME SIZE ES NES NOM p-val FDR q-val FWER p-val
KERATINOCYTE DIFFERENTIATION 15 0.83402413 1.6222495 0.00203666 1 0.87
HORMONE ACTIVITY 40 0.6971614 1.6105977 0 1 0.906
CELL PROJECTION PART 16 0.79349333 1.56011 0.011135858 1 0.986
REGULATION OF SECRETION 34 0.6784604 1.5398166 0.02293578 1 0.996
DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 25 0.68825275 1.5004619 0.03456221 1 1
REGULATION OF PROTEIN SECRETION 17 0.75157595 1.4649369 0.039911307 1 1
CELLULAR CARBOHYDRATE CATABOLIC PROCESS 22 0.67175215 1.4365059 0.0494382 1 1
CARBOHYDRATE CATABOLIC PROCESS 23 0.6717515 1.4344515 0.06535948 1 1
GLUCOSE METABOLIC PROCESS 26 0.6462377 1.431045 0.038812786 1 1
OXIDOREDUCTASE ACTIVITY 259 0.46074706 1.422999 0 1 1
REPRODUCTIVE PROCESS 133 0.48050532 1.370164 0.02356021 1 1
4.4.3 RT-qPCR validation of RNAseq candidate genes
RT-qPCR in hypothalamus and DRGs To validate the candidate genes from RNAseq, we
performed RT-qPCR on hypothalamic and DRG cDNA of 12 weeks old animals subjected to IR
(n=7), SD (n=7) or EE (n=6). We confirmed downregulation of Bdnf and Npyr1 in DRGs and
Vgf in hypothalamus and DRGs. Similar downregulation was present also in the SD group. In
the hypothalamus Oxt showed a tendency of reduced levels in IR and SD mice, and Avp was
significantly downreagulated only in SD mice. This result may be explained by the fact that SD
mice were kept in isolation for 5 weeks after the end of stress and at the moment of sacrifice they
displayed also IR symptoms.
To prove that hypoalgesia is an IR-specific phenomenon, we will repeat the experiment, but
sacrifice the mice at earlier age, to avoid the prolonged isolation period after the end of stress. The
experiment is ongoing. First analysis of pain sensitivity in 7.5 weeks old mice showed a tendency
for increased pain threshold in IR group compared to EE and SD mice (Fig. 9 Appendix C)
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Figure 4.16: IR-induced hypoalgesia: validation of RNAseq candidates by RT-qPCR. A) In hypothal-
amus, oxytocin (Oxt) and arginine vasopressin (Avp) mRNAs were reduced in IR mice, but failed to reach
significance due to high standard deviations. However, downregulation of Avp was significant in SD mice
(p=0.023). Vgf was downregulated in IR (p=0.0138) and SD mice (p=0.0099). B) In DRGs IR-induced
downregulation of Bdnf (p=0.0012, Mann Whitney test), Npyr1 (p=0.0065), Vgf (p=0.0002) were confirmed.
Similar changes were observed in SD mice: Bdnf (p=0.0022, Mann Whitney test), Npyr1 (p=0.0078) and
Vgf (p=0.0001). C,D) Rpl13 and Cyc1 were chosen as the reference genes due to best consistency and
similar means between the experimental groups. Actb was slightly decreased in IR and SD mice and Atp5b
showed higher deviations between the animals. Bar graphs represent means with SEM (n=6–7 per group).
Differences were compared with unpaired t-tests, unless stated differently.
RT-qPCR in PFC Candidate screening using RT-qPCR showed no significant deregulation of
genes associated with the opioid system (Penk, Pdyn, Oprk1), a cannabinoid receptor gene (Cnr1),
schizophrenia-associated genes influencing pain sensitivity (Disc1, Comt1, Nrg1-III227) nor genes
associated with interneurons (Prvlb, Gad1, Gad2) and dopaminergic system (Drd1a)(Fig. 10,
page 109). Only Pomc, encoding proopiomelanocortin — the precursor of β -endorphin — was
upregulated in IR compared to EE in PFC (6, Fig. 10B) and showed a similar tendency in the




5.1 Behavioural profiling in mice
IN THE WILDTYPE STUDY described in our paper
178, we developed an approach to behavioural
analyses, inspired by the way Van Os and Kapur5 presented their classification of symptoms in
psychotic diseases. They distinguished five domains: psychosis (positive symptoms), volition
(negative symptoms), cognition, affective dysregulation and bipolar symptoms. Similar attempts to
classify symptoms into domains are being made in the Research Domain Criteria (RDoC) project39.
We adapted this stategy to study murine behaviour as syndromes, which is more clinically relevant
than looking at single symptoms. Consequently, we created behavioural profiles of mouse models,
based on multiple behavioural tests.
Data calibration and normalization allow to compare independent experiments. This is im-
portant, since only a limited number of animals can be tested in a single cohort and often several
cohorts are needed to test different experimental conditions. In our approach, we try to overcome
this problem. It can be applied to equate data from different cohorts, handled by different ex-
perimenters and even from different laboratories — provided that all cohorts contain identical
calibrator groups (in our case wildtype mice in enriched environment). This way we could compare
not only different housing conditions, but also mice carrying different mutations or treated with
different drugs. Calibration makes it also possible to compare results expressed in different scales
and units (e.g. seconds, meters). Consequently, we can include different tests that measure similar
behaviours into one analysis. We could also create profiles containing not only behavioural, but
also histological, electrophysiological, molecular and other kinds of data. By comparing profiles of
different mouse mutants, we can evaluate their relevace to particular psychiatric diseases or their
aspects. For example, in our study, social defeat (SD) induced depressive-like behaviour associated
with negative symptoms, isolation rearing (IR) was more relevant for positive symptoms178 and
Tcf4 overexpression affected specifically the cognitive domain (see page 68).
We applied multivariate statistics to merge measures of similar behaviours into higher-order
categories: traits, domains superdomains and symptom classes. In this process, called dimension
reduction, we reveal broader patterns of behaviour and reduce the effects of correction for multiple
testing on significance thresholds. We used 15 animals per group, which is the standard n in
behavioural studies on mice. Power analysis showed that this number is sufficient to detect only
large effect sizes. Detecting smaller effects requires testing more animals or restricting the analyses
to fewer domains, to reduce the influence multiple testing on significance threshold.
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We present behavioural profiles in radar charts, which allows to plot huge data sets in a single
figure. By overlaying them, we can also compare experimental groups to each other. Plots can be
generated at every level of dimension reduction. On the trait level they show all performed tests
and are useful mainly for behavioural scientists. Plots on the domain level are more interesting for
clinicians, who may compare different mouse mutants to choose the one that reflects a particular
class of symptoms best.
5.1.1 Comparison of IR and SD as models of psychotic diseases
Both IR and SD induced remarkable impairments in curiosity, fear conditioning and motivation, but
with greater impact of SD. Stronger overall impairment in SD mice is reflected by the higher severity
score. However, some behaviours impaired by IR are unaffected or barely changed upon SD. IR
mice displayed typical for isolated rodents136,139,228–230 hyperactivity in OF, which may be relevant
for positive symptoms of schizophrenia231. Similarly, striking hypoalgesia, repeatedly reported
in isolated rodents134,135,230, is an endophenotype of schizophrenia205–208,232. The differences in
behavioural profiles of IR and SD show that these two paradigms should be used to model different
aspects of psychiatric diseases. While SD appears as relevant for negative symptoms, IR seems to
be more suitable for positive symptoms.
It has to be noted, that our study focused on behavioural phenotype based on limited num-
ber of tests. For a broader symptom coverage and higher clinical relevance, the analysis should
include more behavioural tests and be supplemented with other data, e.g. EEG recordings, electro-
physiology, histology or gene expression.
5.1.2 G×E-dependent cognitive deficits in Tcf4tg mice
While environmental conditions (IR, SD or EE) strongly affected several murine behaviours, effects
of Tcf4 overexpression were mild and restricted to cognition. Both young and aged Tcf4tg mice
displayed impaired fear conditioning and reversal learning upon IR, whereas EE rescued the
phenotype. This influence of environment on manifestation of the Tcf4-dependent deficits proves
the Gene×Environment interaction in the Tcf4tg mice.
Aged Tcf4tg mice, in comparison to young mice, showed no additional impairments upon IR
except from subtly reduced rearing and increased swim speed. Reversal learning deficits were
milder in the aged cohort, but were confirmed in the delayed matching to place (DMP) test. As no
clear worsening of the symptoms was apparent in 12 months old Tcf4tg mice, we conclude that the
Tcf4 phenotype is independent of ageing.
Tcf4tg mice upon IR and SD, displayed impaired reversal learning in MWM, confirmed by
disrupted delayed matching to place. Decline in reversal learning is a measure of behavioural
rigidity, or perseveration — a psychological term describing overall, perseverance in doing some-
thing to an awesome level or past an adequate point; (...) improper repeating of actions which are
frequently correlated with injury to the brain’s frontal lobe, incapacity (...) to switch from one
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method or process to another one 154. Perseveration and reversal learning deficits are associated
with dysfunction of the orbitofrontal cortex (OFC) and ventral striatum18,233–235 and have been
reported in schizophrenia and psychotic disorders17,18. In mice, reversal learning is specifically
disrupted by social deprivation145,236.
Comparison of behavioural profiles of Tcf4tg mice subjected to IR and SD1 revealed that
both IR and SD trigger cognitive impairments in the Tcf4tg mice. Upon IR, Tcf4tg mice showed
impaired fear memory and typical for IR behavioural rigidity145,236. Upon SD they displayed
milder rigidity and pronounced impairments of spatial learning and memory recall in MWM. In the
control condition (individual housing with daily handling), used as reference for SD, Tcf4tg mice
displayed similar deficits to the Tcf4tg IR mice (Fig. 4.15), but less severe. This is consistent with
the observations in rats, that handling can diminish the effects of isolation230. It suggests that Tcf4
overexpression increases vulnerability to harsh environment and the type environmental treatment
determines which brain structures, and consequently, which behaviours will be affected the most.
5.1.3 Cognitive deficits and Tcf4 expression in Tcf4C knockout mice
We generated the heterozygous Tcf4 knockout mouse line Tcf4C. Tcf4 exons 5–6, located directly
downstream the deleted exon 4, had reduced expression in these mice and the levels subsequent
exons were gradually increasing. Expression patterns of Tcf4 exons in wt mice differed between PFC
and hippocampus: exons 5–6 were highest expressed in hippocampus, but not in PFC. Exons 5–6
showed strongest downregulation in Tcf4C mice, which is in line with the exclusively hippocampal
phenotype observed in the Morris water maze.
Several TCF4 isoforms of various lengths and exon composition were found in humans45,237
and in mice200(Fig. 5.1A). Genetic analyses show that the Pitt-Hopkins syndrome is caused by
deletions and nonsense mutations that occur in exons 8–2045,80,237 (Fig. 5.1B). Transcription of
this region is barely affected by the knockout, thus the Tcf4C mice should not be considered as a
PTHS model, but rather as a tool to study functions of particular Tcf4 isoforms.
Tcf4C animals showed no significant alterations in any of the analysed facial and body dimen-
sions, even though craniofacial abnormalities and decreased body length were reported by the
Sanger Institute in Tcf4E homozygotic females199. However, our method — manual measurements
with a calliper – may be insufficient to detect subtle alterations in the facial features. Perhaps
analysis of skull landmarks238 or with the use of computer tomography239 would reveal subtle
dismorphisms in the Tcf4C mice.
5.1.4 Tcf4, G×E and behavioural profiling — conclusions
Behavioural experiments with Tcf4 overexpressing and knockout mice revealed cognitive deficits in
both cases — mild and environment-dependent in Tcf4tg mice; and strong, but restricted to spatial
learning in Tcf4C knockouts. It appears that cognition in mice depends on Tcf4 gene dosage in the
1the Tcf4tg SD–ctrl data set was published in the MSc thesis of Ananya Chowdhury203
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Figure 5.1: Comparison of PTHS mutations with the mutation in Tcf4C mice. A) Figure adapted from
Ensembl Genome Browser200. In the Tcf4C line the exon 4 is deleted, which leads to frame shift and
formation of non-functional Tcf4 transcripts. Mouse Tcf4 has numerous isoform, some of which start
downstream to exon 4, e.g. short isoforms Tcf4-007 and Tcf4-008 located in the 3’ region of the gene. These
isoforms may be still functional in our knockout line. B) The PTHS-associated mutations are deletions and
nonsense mutations in the 3’ region of the human TCF445,80,237. Therefore deleting exon 4 in the 5’ region
of mouse Tcf4 may be not reflecting the situation in PTHS patients; however, is useful for studying functions
of the long isoforms, e.g. Tcf4-001 and Tcf4-003.
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bell-shape fashion46. Disrupted balance, either up- or downregulation, has negative consequences
(Fig. 5.2). Similar pattern has been observed for another schizophrenia risk element240, the
NRG1-ERBB4 signalling241.
It should be noted that Tcf4tg mice have limited clinical relevance. TCF4 expression may
be elevated in psychotic patients73–75 and the Tcf4tg mice show some schizophrenia-relevant
symptoms. However, they overexpress an intron-less Tcf4 open reading frame (overexpression
of the full gene is impossible due to the huge gene size), while the schizophrenia-risk SNPs in
TCF4 are located in the introns. Therefore the Tcf4 transgenic mice should be considered not as a
clear-cut model of schizophrenia, but rather as a model for studying Tcf4 functions in the forebrain.
Similarly, Tcf4C knockouts are not a model of the Pitt-Hopkins syndrome, but rather a tool for
studying certain Tcf4 isoforms. Nevertheless, both mouse strains are useful for investigating the
Tcf4 functions in the brain and may help understand both diseases.
Figure 5.2: Bell-shaped relationship between Tcf4 expression and cognition. Tcf4 dosage influences
cognitive performance — either reduced or increased levels of Tcf4 have detrimental effect (marked in red).
5.2 Expression analyses in Tcf4tg mice
5.2.1 RNA sequencing
As TCF4 is a transcription factor, we expect the phenotype changes to be driven primarily by
changes in gene expression on RNA level. Therefore we performed RNAseq. We found up-
regulation of Mov10 and downregulation of Adora2a, Penk, Tac1, Drd1a, Pde10a, Pde1b and
Foxp2 in PFC of Tcf4tg mice. In hippocampus, Top3b, BC1 and Plxna1 were up- and Mov10 was
downregulated.
Genes downregulated in PFC of Tcf4tg mice:
Adora2a encodes the A2A receptor of adenosine — a widespread inhibitory neuromodulator in
the brain, important for fine-tuning and synchronization of neuronal activity, sleep homeostasis,
hypoxia, sensorimotor gating and cognition (reviewed in242–244). According to the adenosine-
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hypofunction hypothesis of schizophrenia242, A2A receptors are proposed as a target for anty-
psychotic drugs, since they have antagonistic actions to dopamine D2 receptors244. Adenosine
receptors are blocked by caffeine243, which in high doses has prosychotic242,244 and anxiogenic245
effects. ADORA2A is also linked to panic disorder245 and Adora2a-/- mice show increased anxi-
ety243.
Penk encodes proenkephalin A, an endogenous opioid polypeptide hormone that after proteolytic
cleavage gives rise to enkephalins246. Enkephalins bind to δ-opioid receptors and both are involved
in analgesia, reward and anxiety (reviewed in247). Downregulation of Penk in PFC has been linked
to schizophrenia248,249 and postpartum psychosis250.
Drd1a encodes the dopamine receptor D1, which regulates AMPAR phosphorylation and
trafficking to the membrane, and thus is a prominent modulator of synaptic plasticity in PFC
(reviewed in101). Alterations in D1 activity during adolescence may have a particularly strong
effect on synaptic plasticity and cortical development101.
Tac1 encodes Protachykinin-1, a precursor of several peptides, e.g. Substance P, associated
with pain perception and neuropsychiatric disorders (reviewed in251). TAC1 is downregulated in
the PFC of psychotic patients252.
Pde10a and Pde1b, both highly expressed in striatum, encode cAMP and cAMP-inhibited
cGMP 3’,5’-cyclic phosphodiesterases. They regulate cAMP/PKA and cGMP/PKG signalling and
inhibitors of PDE10A are proposed as drugs for schizophrenia8,253.
Foxp2 encodes a transcription factor crucial for human speech254, singing in birds255 and
sensorimotor integration in mice (reviewed in256). As one of the TCF4 risk alleles influences verbal
memory70, Foxp2 is a highly interesting candidate. Many targets and partners of FOXP2 have been
associated with psychiatric diseases, including schizophrenia (reviewed in256).
Mov10 (Putative helicase MOV-10) was upregulated in PFC and downregulated in the hippo-
campus of tg mice. It is an element of the RNA-induced silencing complex (RISC) that silences
mRNA expression, after binding microRNAs (reviewed in257).
Genes upregulated in the hippocampus of Tcf4tg mice:
BC1, Brain cytoplasmic RNA, is a small non-coding RNA. Its transcription is regulated through
an E-box258, which can be a target of TCF4. Our RNA isolation protocol captures only mRNAs,
but BC1 was detected probably due to its polyA region259. BC1 represses translation predominantly
in dendritic synapses260,261. Upon neuronal activity BC1 inhibits activity-induced increases of
Fragile X mental retardation protein 1 (FMRP) and PSD95 in mouse hippocampus262. BC1-/-
mice appear healthy, breed well263 and show normal spatial learning264. However, they display
high anxiety264, increased γ-oscillations in EEG, neuronal hyperexcitability and startle-induced
seizures262. BC1 is present only in rodents, thus it has low relevance for human patients.
Top3β , encoding DNA topoisomerase 3-β-1, was upegulated in hippocampus of Tcf4tg mice.
In humans TOP3β is associated with schizophrenia and cognitive impairment265. It is coupled to
FMRP265, a cytoplasmatic modulator of microRNA-RISC complexes257.
Plxna1 encodes Plexin-A1, a coreceptor for class 3 semaphorins, which is expressed in neurons
of hippocampal CA1–CA3 regions, sensory cortex266 and cortical subplate50. It plays a role in
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axon guidance267, regeneration268 and pruning (reviewed in108,269). Plexins induce changes in
cytoskeletal architecture and synapse elimination269. Because of their developmental function, they
can be involved in autims and schizophrenia269.
Mov10 was described above in the PFC section.
5.2.2 Proteomic analysis
We analysed cytosolic and synaptosomal proteome in PFC of 4 weeks old Tcf4tg and wt mice. In
the cytosol we observed consistent downregulation of several ribosomal proteins and GTPases and
several cell growth & maintenance proteins. β-tubulins and actin-binding proteins were upregulated,
which may be in line with increased frequency of synaptic spines, observed in STED microscopy.
Numerous signalling proteins were upregulated in synaptosomes, mainly Ca2+ binding proteins,
GTPases and Ser/Thr kinases (including three CaMKII subunits). Several energy metabolism
proteins (oxydoreductases and phosphotransferases), few ribosomal proteins and ion channels
were also upregulated. Additionally, we validated upregulation of CaMKII, HOMER1, VAMP2
in synaptosomes as well as VAMP1 and 2 in cytosol. VAMPs are Vesicle-associated membrane
proteins (known also as Synaptobrevins). HOMER1 is a scaffolding protein that is upregulated
during LTP and seizures. CaMKII (Calcium/calmodulin-dependent protein kinase type II) promotes
LTP and LTD and formation of immature spines, by acting of actin and actin-binding proteins
and CDK5 (also upregulated in Tcf4tg)270,271. It is also involved in cognition and psychiatric
disorders270.
5.2.3 Expression analyses — conclusions
There was no overlap between differentially expressed genes found by RNAseq and proteomics.
This lack of coherence could be explained by deregulation of microRNAs and other non-coding
RNAs (e.g. small RNAs or circRNAs). In Tcf4tg mice, BC1 and Top3b, both involved in suppression
of translation initiation, were upregulated in hippocamus. Additionally Mov10, associated with the
RISC complex, was upregulated in PFC and downregulated in hippocampus. All three candidates
closely interact with Fragile X mental retardation protein 1 (FMRP). The Fragile X syndrome
is characterized by, among others, intellectual disability and distinct facial features272. FMRP is
an RNA-binding protein that modulates microRNA-RISC complexes and is important for RNA
transport and translation repression257. FMRP-deficiency in mice and humans leads to immature
(long and thin) spine morphology and increase of dendritic spine number in the cortex, that are
characteristic for early developmental stages273,274. Based on our RNA sequencing data, regulatory
RNAs seem to be a promising candidate explaining the inconsistency between RNAseq and
proteomic data. In future experiments we will adapt our protocol for microRNA and perform
microRNAs sequencing.
Murine Adora2a, Foxp2, Drd1a and Tac1 are highly expressed in striatum, moderately in
the isocortex and low or undetectable in the hippocampal formation50. Downregulation of these
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genes in PFC of Tcf4 Tcf4tg mice may be an artefact caused by striatal contamination of cortical
preparation. To validate this result we need to analyse cortical samples obtained, e.g. by laser
capture microdissection. The results may be also influenced by a gender bias in our sample.
Unfortunately, our attempt to validate the candidate genes by RT-qPCR was unsuccessful due to
the low number of replicates.
Upregulation of synaptic proteins that promote plasticity, e.g. HOMER1 and CaMKII, may
be in line with enhanced LTP in the Tcf4tg mice and increased levels of cytosolic β-tubulins
and actin-binding proteins could reflect increase of synaptic spine frequency observed in STED
microscopy.
5.3 Spine frequency and synapse morphology
Tcf4tg mice showed increased spine frequency in PFC at the age of 4 weeks. Elevated synapse
number109 and consequent thickening of cortical gray matter lead to poorer cognitive perform-
ance101. Schizophrenic patients display reduced spine numbers105,106 and excessive pruning in
the cortex101,107. At 12 weeks of age, Tcf4tg mice showed no changes in spine number neither in
control conditions nor after social defeat. It suggests that cognitive impairments of Tcf4tg mice
do not result directly from the spine excess. Possibly, abnormal spine numbers during the critical
period affect establishment of connectivity between PFC and other brain structures and represent a
potential mechanism of schizophrenia107.
Electron microscopy analysis showed no differences in synapse structure and quantity between
Tcf4tg and wt mice, which does not support the STED data. Perhaps the change in spine frequency is
too subtle to be detected in electron microscopy. Number of myelinated axons and myelin thickness
were also not changed, which is inconsistent with the RNAseq results showing deregulation of
myelin genes in the cortex. However, since myelination is unequal in different cortical layers275,
analysis of cortical transverse sections may not fully reflect overall myelin condition in PFC.
5.4 Electrophysiology
In Tcf4tg mice, early LTP (e-LTP) was normal and LTD was enhanced in hippocampal CA1 slices.
It suggests abnormal LTD-related receptor trafficking in postsynapses. During the first 15 min after
stimulation e-LTP was also enhanced in Tcf4tg mice, but then it came back to wt level. Presumably,
after the initial 15 min some compensatory mechanisms are activated, potentially associated with
LTP-LTD interaction. These phenomena are not understood and it is difficult to draw conclusions.
e-LTP (first 40 min) depends on synaptic release and receptor trafficking. Late LTP (L-LTP, up to
2 h after stimulation), depends on protein synthesis. If indeed Bc1 and Top3b-dependent synaptic
translation is altered in Tcf4tg mice, we could expect changes in L-LTP. We also plan to do a
depotentiation experiment (LTP followed by LTD), which may help us understand physiological
changes related to the sequence of learning and relearning in the Morris water maze reversal task.
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Similar enhancement of LTD in CA1 was observed in Pde4d knockout mice, which displayed
impairments of fear memory and reversal learning in MWM276. However, blocking LTD was
found to reduce reversal learning in Morris water maze277. Thus, the relationship between LTD and
reversal learning remains unclear. Nevertheless, excessive LTD may be relevant to schizophrenia,
since drugs promoting LTD are propsychotic whereas drugs promoting LTP are antipsychotic21
Enhanced LTD may be in line with downregulation of Adora2a, that we observed in RNA
sequencing of PFC. In corticostriatal synapses, activation adenosine receptor A2A, encoded by
Adora2a, suppresses LTD and promotes LTP. This machinery is to some degree similar in other
brain structures, but has not been well studied. In CA1 region, antagonists of A2A receptors reduce
LTP, with unknown effects on LTD278. According to Morrison and Murray21, delusions originate
from disturbed striatal LTP-LTD balance. Tcf4tg mice do not overexpress Tcf4 in striatum, thus
we should not expect a “delusional” phenotype. However, disturbance of LTP–LTD balance in the
cortex and hippocampus would have consequences for learning and memory.
5.5 Isolation-induced hypoalgesia
In our publication178, we demostrated that hypoalgesia in mice is induced by IR, but not by SD. As
hypoalgesia is also observed in schizophrenic patients205–207,232 and their relatives208, we believe
that IR is a suitable model of some aspects of schizophrenia.
RNA sequencing of IR and EE revealed no changes in expression of the opioid system genes in
hypothalamus nor in DRGs; however, a slight upregulation of Pomc – the β-endorphin precursor –
was found in PFC of IR mice. In order to exclude or confirm the role of endogenous opioids, such
as endorphins, it is necessary to monitor their levels in the blood before and after a pain stimulus.
RNAseq analysis of IR and EE animals revealed changes in gene expression in DRGs and
hypothalamus, presented in Fig. 5.3. We validated downregulation of Vgf (Neurosecretory protein
VGF), Npy1r (Neuropeptide Y receptor type 1) and Bdnf (Brain derived neurotrophic factor) in
DRGs upon IR. These genes encode pronociceptive peptides, that are increased in DRGs during
hyperalgesia279–283. However, in the RT-qPCR experiment, the same genes were downregulated
also in DRGs of SD animals, that showed normal pain sensitivity. This is most likely caused by a
5 weeks of social isolation that followed the stress period, before the SD mice were sacrificed. To
control for this, we are going to perform another experiment, in which the mice will be sacrificed
soon after the last stress session. If SD mice develop IR-symptoms on top of the SD-symptoms, it
would mean that hypoalgesia is independent of the developmental aspect. Our preliminary data
seem to confirm this hypothesis.
Our results suggest that gene expression changes in primary sensory neurons of DRGs contribute
to IR-induced hypoalgesia. This is in contrast to the study by Horiguchi et al.204 claiming that
isolation-induced hypoalgesia is due to changes in the central nervous system and not in the
periphery. However, our data do not rule out a potential involvement of cortical mechanisms.
RNAseq of hypothalamus showed downregulation of several genes potentially relevant for pain
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Figure 5.3: Isolation rearing-induced changes in DRGs and hypothalamus. Social isolation rearing and
associated with it sensory deprivation lead to a decrease in basal expression levels of several pronociceptive
genes. In dorsal root ganglions (DRGs), expression of Npy1r (neuropeptide Y receptor type 1), Bdnf (brain
derived neurotrophic factor) and Vgf (Neurosecretory protein VGF) are downregulated. In hypothalamus,
Vgf, Avp (arginine vasopressin) and Oxt (oxytocin) levels are reduced (in case of Oxt and Avp only a tendency
in RT-qPCR), which may also play a role hypoalgesia. Additionally disturbed balance between oxytocin and
arginine vasopressin (oxytocin show stronger downregulation) may contribute to aggressiveness, typical for
isolated mice.
perception: Vgf, Ramp3, Oxt and Avp. Vgf reduction (validated by RT-qPCR) was not as prominent
as in DRGs, but still significant. There is no evidence of contribution of Ramp3 in pain, but Ramp1,
a member of the same protein class, plays a role in migraine284. Downregulation of haemoglobin
genes may indicate reduced vascularisation, but we cannot rule out that it could be a preparation
artefact.
We observed reduction of oxytocin (Oxt) and arginine vasopressin (Avp) in RNAseq and strong
tendencies in RT-qPCR — two hypothalamic peptides that regulate pain perception285, social
behaviour88,286–288 and cognition288. Oxytocin is famous of its prosocial effects287–289 while
vasopressin contributes to aggression287,290. In IR mice both peptides were downregulated in
hypothalamus, but oxytocin reduction was stronger (Oxt −0.884047 and Avp −0.700171 fold
change). Misbalance between “prosocial” oxytocin and “antisocial” vasopressin291 could explain
the aggressive behaviour characteristic of isolation syndrome.
In humans, childhood abuse alters oxytocin levels in adulthood (reviewed in287,288). Oxytocin
and vasopressin seem to be involved in psychiatric diseases, including schizophrenia88,287,292.
Administration of oxytocin in animal models of schizophrenia has antypsychotic-like effects
(reviewed in288), improves social performance in humans and is being tested as a medication for
schizophrenia and other mental illnesses288.
Interestingly, mRNAs encoding Oxt and Avp, similarly to BC1, were found in axons of magno-
cellular hypothalamic neurons of rats, even though axonal transport of mRNA is a rare case293.
These Oxt and Avp mRNA levels can dramatically increase in response to environmental stimuli293.
Possibly, BC1 may regulate local their translation. In Tcf4tg mice levels of Oxt and Avp mRNAs
were normal in PFC and hippocampus. It is unlikely that these animals would show altered oxytocin
or vasopressin blood levels, as Tcf4 is not overexpressed in hypothalamus. However, in patients
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DISCUSSION
with TCF4 risk alleles altered BC1 abundance could contribute to hormonal deregulations.
In summary, we demonstrate that expression of pronociceptive Vgf, Npy1r and Bdnf are reduced
in dorsal root ganglions upon isolation rearing. We also show reduction of Vgf, oxytocin and
arginine vasopressin RNA levels in hypothalami of isolated mice. Potential disturbance of the
oxytocin–vasopressin balance may explain the aggressiveness of IR mice. We found no clear
evidence for involvement of the endogenous opioid system and our data suggest that not only
central, but also peripheral mechanisms contribute to reduced pain sensitivity upon IR.
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Summary
IIN THIS STUDY, we aimed at understanding Gene×Environment interaction in mouse modelsof psychiatric diseases. To address this question, we first focused on studying the influence ofenvironmental factors on behaviour of wildtype C57Bl/6N mice. In a battery of behavioural
experiments we analysed behaviour of mice subjected to two paradigms inducing psychopathologies
in mice — Social Isolation Rearing (IR) and Social Defeat (SD) —, calibrated them to Enriched
Environment (EE) (used as a control) and compared to each other. We developed an approach
to analysing huge behavioural data sets and visualising them as behavioural profiles in a single,
comprehensive figure178. By applying multivariate statistics, we grouped tests that measure similar
behaviours and merged them into higher-order categories (e.g. anxiety, curiosity, etc.) — to
which we refer as dimension reduction. IR mice exhibited reduced curiosity, motivation and
pain sensitivity, cognitive impairments and hyperactivity. SD mice displayed strong cognitive
impairments, as well as anxiety and reduced motivation. We conclude that IR is better to model
positive symptoms and SD is more appropriate for negative symptoms of psychotic diseases.
Such a holistic view on murine behaviour has more relevance to human psychiatric syndromes
than looking at single behavioural measures. The advantages of our approach are that it allows
comparing independent mouse cohorts and possibly including also other data types, e.g. from
histological experiments, to create a fuller profile of disease-relevant symptoms.
We adapted this approach for studying Gene×Environment and ageing interaction in a trans-
genic mouse model overexpressing a schizophrenia susceptibility gene Tcf4. Brzózka et al.57
have earlier shown mild cognitive impairments in these mice in standard group housing. Here, we
analysed two cohorts of Tcf4 transgenic and wildtype mice housed in IR or EE and tested them in
early adulthood or aged. We show that manifestation of the phenotype of the Tcf4 transgenic mice
depends on environmental factors — IR and SD enhance the deficits and EE rescues the phenotype.
Additionally, we demonstrate that these deficits are restricted to cognitive functions and no other
aspects of behaviour.
To understand Tcf4 functions, we supplemented behavioural testing with analyses on cellular
and molecular level. We found that the Tcf4 transgenic mice displayed an increased number of
dendritic spines in prefrontal cortex and enhanced LTD in hippocampus. In proteomic analyses, we
observed upregulation of synaptic proteins HOMER1 and synaptobrevins, as well as of CamKII, a
kinase involved in synaptic plasticity, and β -tubulins. RNA sequencing data suggest that TCF4




To have a broader view of Tcf4 functions, we analysed also heterozygotic Tcf4 knockouts (Tcf4C
mice). In humans, disruption of one of the TCF4 alleles causes the Pitt-Hopkins syndrome (PTHS),
a neurodevelopmental disease with mental retardation. Tcf4 knockout mice show a dramatic of
impairment hippocampus-dependent spatial learning, but no other PTHS-like features. The specific
disruption of hippocampal function can be explained by the fact that the knockout affects mRNA
levels of only the Tcf4 exons that are particularly highly expressed in hippocampus. The isoforms
that are typically mutated in PTHS patients are almost unaffected in these mice.
We conclude that Tcf4 regulates specifically learning and memory in mice and either Tcf4
overexpression or depletion leads to cognitive impairments. In case of Tcf4 overexpressors,
manifestation of these impairments depends also on environmental factors during puberty. The
influence of environment on the Tcf4 knockout phenotype has not been studied yet and should be
assessed in the future.
In a side project, we investigated the mechanisms of IR-induced pain insensitivity in wildtype
mice, which we observed repeatedly in our behavioural studies. Transcriptome analysis of hy-
pothalami and dorsal root ganglia of IR mice revealed strong downregulation of pronociceptive
genes Vgf, Bdnf and Npyr1. We also observed tendencies for downregulation of mRNAs encoding
hypothalamic peptides oxytocin and arginine vasopressin — which may contribute not only to
diminished pain sensitivity, but also to abnormally aggressive behaviour of isolated mice.
79
Bibliography
1. McGrath, J. et al. A systematic review of the incidence of schizophrenia: the distribution of
rates and the influence of sex, urbanicity, migrant status and methodology. BMC medicine 2,
13 (2004).
2. Insel, T. R. Rethinking schizophrenia. Nature 468, 187–193 (2010).
3. Laursen, T. M. Life expectancy among persons with schizophrenia or bipolar affective
disorder. Schizophrenia research 131, 101–104 (2011).
4. Saha, S., Chant, D. & McGrath, J. A systematic review of mortality in schizophrenia: is the
differential mortality gap worsening over time? Archives of general psychiatry 64, 1123–1131
(2007).
5. Jim van Os, S. K. Schizophrenia. Lancet 374, 635–45 (2009).
6. Andreasen, N. C. The evolving concept of schizophrenia: from Kraepelin to the present and
future. Schizophrenia research 28, 105–109 (1997).
7. Tandon, R. et al. Definition and description of schizophrenia in the DSM-5. Schizophrenia
research 150, 3–10 (2013).
8. Millan, M. J. et al. Cognitive dysfunction in psychiatric disorders: characteristics, causes and
the quest for improved therapy. Nature reviews Drug discovery 11, 141–168 (2012).
9. Tost, H. & Meyer-Lindenberg, A. Puzzling over schizophrenia: schizophrenia, social environ-
ment and the brain. Nature medicine 18, 211–213 (2012).
10. Maurer, K., Riecher-R, A. et al. The influence of age and sex on the onset and early course of
schizophrenia. The British journal of psychiatry 162, 80–86 (1993).
11. Schultz, S. K. et al. The life course of schizophrenia: age and symptom dimensions. Schizo-
phrenia Research 23, 15–23 (1997).
12. Paus, T., Keshavan, M. & Giedd, J. N. Why do many psychiatric disorders emerge during
adolescence? Nature Reviews Neuroscience 9, 947–957 (2008).
13. Gottesman, I. I. & Gould, T. D. The endophenotype concept in psychiatry: etymology and
strategic intentions. American Journal of Psychiatry 160, 636–645 (2003).
14. Allen, A. J., Griss, M. E., Folley, B. S., Hawkins, K. A. & Pearlson, G. D. Endophenotypes
in schizophrenia: a selective review. Schizophrenia research 109, 24–37 (2009).
15. Uhlhaas, P. J. & Singer, W. Abnormal neural oscillations and synchrony in schizophrenia.
Nature Reviews Neuroscience 11, 100–113 (2010).
80
BIBLIOGRAPHY
16. Barch, D. M. & Ceaser, A. Cognition in schizophrenia: core psychological and neural
mechanisms. Trends in cognitive sciences 16, 27–34 (2012).
17. Crider, A. Perseveration in schizophrenia. Schizophrenia bulletin 23, 63 (1997).
18. Murray, G. et al. Reinforcement and reversal learning in first-episode psychosis. Schizophrenia
bulletin 34, 848–855 (2008).
19. Millan, M. J. & Bales, K. L. Towards improved animal models for evaluating social cognition
and its disruption in schizophrenia: The CNTRICS initiative. Neuroscience & Biobehavioral
Reviews 37, 2166–2180 (2013).
20. Brisch, R. et al. The role of dopamine in schizophrenia from a neurobiological and evolution-
ary perspective: old fashioned, but still in vogue. Frontiers in Psychiatry 5 (2014).
21. Morrison, P. D. & Murray, R. From real-world events to psychosis: the emerging neurophar-
macology of delusions. Schizophrenia bulletin 35, 668–674 (2009).
22. Kapur, S. & Mamo, D. Half a century of antipsychotics and still a central role for dopamine D2
receptors. Progress in Neuro-Psychopharmacology and Biological Psychiatry 27, 1081–1090
(2003).
23. Lieberman, J. A. et al. Effectiveness of antipsychotic drugs in patients with chronic schizo-
phrenia. New England Journal of Medicine 353, 1209–1223 (2005).
24. Sullivan, P. F. Puzzling over schizophrenia: schizophrenia as a pathway disease. Nature
medicine 18, 210–211 (2012).
25. Maher, B. The case of the missing heritability. Nature 456, 18–21 (2008).
26. Stefansson, H. et al. Common variants conferring risk of schizophrenia. Nature 460, 744–747
(2009).
27. Li, T. et al. Common variants in major histocompatibility complex region and TCF4 gene are
significantly associated with schizophrenia in han chinese. Biological psychiatry 68, 671–673
(2010).
28. Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium et al.
Genome-wide association study identifies five new schizophrenia loci. Nature genetics 43,
969–976 (2011).
29. Steinberg, S. et al. Common variants at VRK2 and TCF4 conferring risk of schizophrenia.
Human molecular genetics 20, 4076–4081 (2011).
30. Cross-Disorder Group of the Psychiatric Genomics Consortium et al. Identification of risk
loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet
381, 1371 (2013).
31. Ripke, S., Schizophrenia Working Group of the Psychiatric Genomics Consortium et al.
Biological insights from 108 schizophrenia-associated genetic loci. Nature (2014).
32. Doherty, J. L. & Owen, M. J. Genomic insights into the overlap between psychiatric disorders:
implications for research and clinical practice. Genome Medicine 6, 29 (2014).
81
BIBLIOGRAPHY
33. Bergen, S. E. & Petryshen, T. L. Genome-wide association studies (GWAS) of schizophrenia:
does bigger lead to better results? Current opinion in psychiatry 25, 76 (2012).
34. Kwon, E., Wang, W. & Tsai, L. Validation of schizophrenia-associated genes CSMD1,
C10orf26, CACNA1C and TCF4 as miR-137 targets. Molecular psychiatry 18, 11–12 (2011).
35. Van Os, J., Linscott, R. J., Myin-Germeys, I., Delespaul, P. & Krabbendam, L. A systematic
review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness–
persistence–impairment model of psychotic disorder. Psychological medicine 39, 179–195
(2009).
36. Eysenck, H. & Eysenck, S. Psychoticism as a dimension of personality. Crane, Russak &
Company, New York (1976).
37. Purcell, S. M. et al. Common polygenic variation contributes to risk of schizophrenia and
bipolar disorder. Nature 460, 748–752 (2009).
38. Insel, T. et al. Research domain criteria (RDoC): toward a new classification framework for
research on mental disorders. American Journal of Psychiatry 167, 748–751 (2010).
39. Cuthbert, B. N. & Insel, T. R. Toward new approaches to psychotic disorders: the NIMH
Research Domain Criteria project. Schizophrenia bulletin 36, 1061–1062 (2010).
40. Navarrete, K. et al. TCF4 (E2-2, ITF2) A schizophrenia-associated gene with pleiotropic
effects on human disease. American Journal of Medical Genetics Part B: Neuropsychiatric
Genetics 162, 1–16 (2013).
41. Sweatt, J. D. Pitt-Hopkins syndrome: intellectual disability due to loss of TCF4-regulated
gene transcription. Experimental & molecular medicine 45, e21 (2013).
42. Amiel, J. et al. Mutations in TCF4 encoding a class I basic helix-loop-helix transcription factor,
are responsible for Pitt-Hopkins syndrome, a severe epileptic encephalopathy associated with
autonomic dysfunction. The American Journal of Human Genetics 80, 988–993 (2007).
43. Ephrussi, A., Church, G. M., Tonegawa, S. & Gilbert, W. B lineage–specific interactions of
an immunoglobulin enhancer with cellular factors in vivo. Science 227, 134–140 (1985).
44. Ellenberger, T., Fass, D., Arnaud, M. & Harrison, S. C. Crystal structure of transcription
factor E47: E-box recognition by a basic region helix-loop-helix dimer. Genes & development
8, 970–980 (1994).
45. Sepp, M., Pruunsild, P. & Timmusk, T. Pitt-Hopkins syndrome-associated mutations in TCF4
lead to variable impairment of the transcription factor function ranging from hypomorphic to
dominant-negative effects. Human molecular genetics 21, 2873–2888 (2012).
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178. Badowska, D. M., Brzózka, M. M., Chowdhury, A., Malzahn, D. & Rossner, M. J. Data
calibration and reduction allows to visualize behavioural profiles of psychosocial influences
in mice towards clinical domains. European archives of psychiatry and clinical neuroscience
1–14 (2014).
179. Urban, N. T., Willig, K. I., Hell, S. W. & Nägerl, U. V. Sted nanoscopy of actin dynamics in
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Figure 1: Basic behaviour of Tcf4tg mice upon IR and EE. A) Body weight was higher in EE mice
(p<0.0001). B–C) Light-dark preference B) Latency to enter dark box was longer in IR than EE mice
(p<0.0001). C) Dark preference. D–H) Open field. D) Time in the centre was reduced by EE (p<0.0001)
and Tcf4tg (p=0.0064), particularly in EE Tcf4tg (p<0.01, Bonferroni). E) Rearing was affected by IR
(p<0.0001) and Tcf4tg (p=0.0458). F–H) Time moving, distance and speed were increased by IR (p<0.0001
for all). I) In Water Maze IR mice swam faster (p<0.0001). J–K) Hole board. J) Nose pokes. K) Exploration
time was increased by EE (p=0.0044) but reduced in EE Tcf4tg mice (p<0.05, Bonferroni, genotype effect




Figure 2: Basic behaviour of Tcf4tg mice upon IR and EE. A–D) Y-maze. A) Total arm exploration is
increased upon IR (p<0.0001). B) Total number of alternations is reduced by IR (p=0.0003). C) IR mice
explore arms of the maze more than EE in first (p<0.0001) and second interval (p<0.0001). D) IR mice
make fewer alternations in first (p=0.0145) and second interval (p=0.0259). E) Prepulse inhibition is reduced
by IR at 75 dB (p=0.0134) and 80 dB (p=0.0057). F) Startle response to 120 dB pulse is affected by housing
(p<0.0001) and genotype (p=0.0013). In EE group it is reduced in Tcf4tg (p<0.01, Bonferroni). G) In tail
suspension test IR mice fight less (p<0.0001) implying reduced motivation. H–I) Social interaction. Neither
sociability nor social memory are alterations were observed. J) Hot plate. Thermal pain sensitivity was
increased by IR (p<0.0001). K) Pain threshold for electric shocks is increased upon IR (p<0.0001). L) Water
Maze, visible platform: EE mice reach the platform faster than IR mice (p<0.0001, RM ANOVA). Bar
graphs represent mean with SEM. All tests were analysed using Two-way ANOVA, unless stated differently.
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Figure 3: Basic behaviour of aged Tcf4tg mice upon IR and EE. A) Body weight was increased in IR
mice from the age of 8 months and Tcf4tg mice were slightly heavier that wt in IR group. B–C) Light-dark
preference. B) IR mice entered the dark compartment later than EE mice (p<0.0001). C) IR mice displayed
higher dark preference (p<0.0001). D–G) Open field. D) IR mice spent less time in the centre (p=0.002).
E) Rearing was reduced upon IR (p=0.0133) and particularly in Tcf4tg mice (p=0.0344, t-test), but without
G×E. F) Time moving (p<0.0001), G) covered distance (p<0.0001) and H) running speed (p<0.0001)
were increased upon IR. I) In Water Maze mean swim speed (all phases) was affected by housing (p<0.0001)
and G×E (p=0.0352). In IR group Tcf4tg mice swam faster than wt (p<0.05, Bonferroni). J–K) Hole board.
J) Number of hole nose pokes was reduced in IR (p=0.002), similarly to K) exploration time (p=0.0072). Bar
graphs represent mean with SEM. All tests were analysed using Two-way ANOVA, unless stated differently.
101
APPENDIX A: BEHAVIOUR
Figure 4: Basic behaviour of aged Tcf4tg mice upon IR and EE. A) EPM. IR mice spent less time in
open (p<0.001) and more time in closed arms (p=0.0332). B–E) Y-maze. B) IR animals explored more arms
in total than EE (p<0.0001). C) IR mice made in total fewer alternations than EE mice (p=0.0045). D) In
both intervals IR mice made more arm choices than EE mice (both p<0.0001). E) IR mice made fewer
alternations in first interval (p=0.0119). In the second interval effects of housing and genotype were not
significant; however, in EE group Tcf4tg mice made more alternations than wt mice (p<0.05, Bonferroni).
F) In TST IR mice showed reduced fighting time (p<0.0001). G–H) Social interaction. G) Sociability was
not altered in any of the groups. H) Social memory was increased in IR mice (p=0.0203). I) In hot plate
test pain threshold was increased upon IR (p<0.0001). J–K) MWM. J) In visible platform phase IR mice
learned slower than EE mice (p<0.0001, RM ANOVA). K–L) Perseveration (% distance in previous target
quadrant) was not altered in reversal learning nor in delayed matching to place. Bar graph represent mean
with SEM. All tests were analysed using Two-way ANOVA, unless stated differently.
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Figure 5: Basic behaviour of Tcf4C mice. A) Body weight was reduced in Tcf4C mice at the age of
4 weeks (p=0.0472, Mann Whitney test, Tcf4C n=23, wt n=16) but not at 14 weeks (Tcf4C n=16, wt n=14).
B–C) Light-dark preference. No significant changes were detected. D–H) Open field. D) Tcf4C mice spent
less time in the centre, which suggest mildly increased anxiety. E–H) Neither rearing nor locomotor activity
was altered in any of the parameters. I) In Morris Water Maze swimming speed was reduced in Tcf4C
mice (p=0.02229, Mann Whitney test). J–K) Hole board exploration was not changed in Tcf4C. Bar graph
represent mean with SEM.
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Figure 6: Basic behaviour of Tcf4C mice. A) Elevated plus maze. B–E) Y-maze. B) Total arm exploration
was not altered in Tcf4C mice. C) Total alternation number was mildly reduced in Tcf4C animals (p=0.014,
t-test). D) Tcf4C mice explored the arms less than wt in first (p=0.0469, t-test), but not in the second
interval. E) Number of alternations was reduced in Tcf4C mice only in the second interval (p=0.0475,
t-test). G) Sociability and social memory were normal. H) Pain sensitivity was unaffected in Tcf4C
mice. I–J) Prepulse inhibition was normal, but startle response to 120 dB pulse was reduced in Tcf4C mice
(p=0.0311, Two-way RM ANOVA), particularly in post-test (p<0.05, Bonferroni). K) In MWM visible


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 7: Validation of proteomics candidates by western blotting (whole blots). Proteins from synapto-
somes and cytosolic fractions of prefrontal cortices of 4 weeks old TMEBBl6 male mice. For details see
Results section 4.1.5 on page 45
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Appendix C: Hypoalgesia
Figure 8: Serum β -endorphin levels in mice housed in IR and EE. No difference was detected between
the two groups of animals. The result has to be interpreted with caution due to very low measured concentra-
tions and high standard deviations.
Figure 9: Pain sensitivity in 7.5 weeks old EE, IR and SD mice. To avoid the influence of prolonged
isolation after the end of the stress period, we assessed whether differences in pain sensitivity apparent
after 3.5 weeks of IR (n=13), SD (n=6) and EE (n=13). Hot plate test revealed no significant differences;
however the median of IR latencies is higher than of EE and SD mice. Presumably, hypoalgesia in IR animals
develops over time, starts to emerge already after 3 weeks of IR and would be more pronounced after longer
time. The result suggests that hypoalgesia may be specific to IR and not to SD.
The cut-off value in this experiment was 90 s. Animals that failed to jump or lick their back paws within this
time were assigned the value of 90 s. A) Bar graphs represent medians with interquartile range. B) Dot plots
show the same data for individual animals.
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Figure 10: RT-qPCR in PFC and hypothalamus of wt EE, IR and SD mice. Genes associated with
pain sensitivity or psychotic disorders were chosen. A–E) PFC, cDNA in dilution 1:25. F–K) PFC,
dilution 1:40. L–O) Hypothalamus, dilution 1:100. A) Pomc was upregulated in IR compared to EE in
PFC (p=0.0222, Kruskal-Wallis test). C–O) None of the other tested genes showed significant differences
between the groups. Plots show single animals (dots) and group means (relative to Actb). Average Ct
ranges are shown in boxes. Genes: Actb β -actin, Pomc proopiomelanocortin, Pdyn prodynorphin, Penk
proenkephalin, Cnr1 cannabinoid receptor 1, Drd1a dopamine receptor 1a, Disc1 disrupted in schizophrenia,
Comt1 catechol-O-methyltransferase, Nrg1-III neuregulin 1 type III, Prlvb parvalbumin, Gad1 and Gad2
glutamate decarboxylase 1 and 2, Oprk1 opioid kappa receptor 1. Other genes included in the screen are not
shown due to low expression or high standard deviations.
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